Top

Victor G. Prieto, M.D., Ph.D.

Department of Anatomical Pathology, Division of Pathology-Lab Medicine Div

About Dr. Victor G. Prieto

I am a Pathologist/Dermatopathologist with special interest in melanoma. I joined MDACC in 1999 in both Departments of Pathology and Dermatology. I was the Fellowship Director of the Dermatopathology Program between 2001 and 2012 and Fellowship Director of the Surgical Pathology Program between 2015 and 2020. I was the section chief of the dermatopathology section between 1999 and 2016. I became the Chair of the Department of Anatomical Pathology in 2015. I have been the Co-Director of the melanoma tissue bank at MDACC for the last 18 years. During this time, I have participated in multiple melanoma projects, both within the institution and within the umbrella of the NCI and SPORE groups. I have examined the pattern of expression of iNOS, retinoid receptors, galectin-3, tyrosin kinases, and related molecules in primary and metastatic melanoma. I have studied the morphologic predictors of melanoma behavior and I am involved in the assessment of the application of immunotherapies and newer targeted therapies in melanoma. I am also a contributor to the Blue Book of the WHO on cutaneous neoplasms.

Primary Appointment

Professor, Department of Pathology, Division of Pathology-Lab Medicine Div, The University of Texas MD Anderson Cancer Center, Houston, TX

Professor, Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

1991	University of Barcelona, Department of Cellular Biology, Barcelona, ES, Ph.D. in Medicine
1986	School of Medicine, University of Alicante, Barcelona, ES, MD
1979	Institute Joaquin Turina, Madrid, ES, C.O.U in Preuniversity Course
1978	International School Lope de Vega, Benidorm, ES, Bachillerato, equivalent to high school

Postgraduate Training

2020-2020	Certified Leadership Coach -- CoachRICE, MD Anderson Cancer Center and The Doerr Institute For New Leaders at Rice University, Houston, TX
2016-2016	Clinical Research, Biostatistics for Clinical Investigators, University of Texas- Houston Medical School, Houston, Texas
1995-1996	Clinical Fellowship, Dermatopathology, New York Hospital-Cornell Medical Center, New York, New York
1994-1995	Clinical Fellowship, Oncologic Pathology, Memorial Sloan Kettering Cancer Center, New York, New York
1993-1994	Clinical Residency, Anatomic Pathology, Cornell, New York, New York
1991-1993	Research Fellowship, Dermatopathology, New York Hospital-Cornell Medical Center, New York, New York
1989-1991	Clinical Residency, Anatomic Pathology, Hospital del Mar, Barcelona
1987-1989	Clinical Residency, Anatomic Pathology, Hospital de la Esperanza, Barcelona

Licenses & Certifications

2017	The American Board of Medical Quality
2012	International Committee for Dermatopathology (Diploma in Dermatopathology)
2001	Texas Medical Board
1999	European Board of Pathology
1997	American Board of Pathology (Dermatopathology)
1995	American Board of Pathology (Anatomic Pathology)
1993	Federal Licensing Examination (FLEX) Part II
1992	United States Medical License Examination (USMLE) Steps I-II

Experience & Service

Other Professional Positions

Department Chair, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2024

Intramural Institutional Committee Activities

Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2024 - Present

Member, Pathology Actionable Findings, The University of Texas MD Anderson Cancer Center, 2024 - Present

Member, Interprofessional Education (IPE) Steering Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

Member, Senior Faculty Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

Member, Reach Committee, The University of Texas MD Anderson Cancer Center, 2022 - Present

Member, QAPI, The University of Texas MD Anderson Cancer Center, 2019 - Present

Member, Clinical Enterprise Leaders Live (CELL), The University of Texas MD Anderson Cancer Center, 2018 - Present

Member, Beaker AP Steering Committee, The University of Texas MD Anderson Cancer Center, 2016 - Present

Member, Frozen Section Committee. Pathology, The University of Texas MD Anderson Cancer Center, 2014 - Present

Member, CLIA Lab Quality, The University of Texas MD Anderson Cancer Center, 2014 - Present

Member, Clinical Genomics And Biomarker Council, The University of Texas MD Anderson Cancer Center, 2014 - Present

Member, Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2006 - Present

Member, Advisory Board/Executive Committee, Department of Pathology, The University of Texas MD Anderson Cancer Center, 2004 - 2010

Chair, Internal Review Committee for Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, 2002 - 2003

Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2000 - 2013

Member, Melanoma and Skin Cancer Research Program Steering Committee, The University of Texas MD Anderson Cancer Center, 1999 - 2010

Pathology and Laboratory Medicine Representative, PRS Budget & Finance Committee, The University of Texas MD Anderson Cancer Center

Extramural Institutional Committee Activities

Member, International Collaboration on Cancer Reporting (ICCR) Dataset Authoring Committee, The University of Texas MD Anderson Cancer Center, 2024 - Present

Member, AAPath Membership Committee, The University of Texas MD Anderson Cancer Center, 2023 - Present

Member, GSBS Faculty, The University of Texas MD Anderson Cancer Center, 2021 - Present

Member, AAPath GME Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

Member, Academic Advisory Council, The University of Texas MD Anderson Cancer Center, 2020 - 2024

Chair, Community of Chairs, The University of Texas MD Anderson Cancer Center, 2020 - 2024

Member, SWOG Melanoma Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

Member, Texas Society of Pathologists Board, Texas Society of Pathologists, 2019 - Present

Member, Community of Chairs, The University of Texas MD Anderson Cancer Center, 2015 - 2024

Member, CAP - Graduate Medical Education Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2025

Board Member, Promotion and Tenure Committee, The University of Texas MD Anderson Cancer Center, 2013 - 2015

Member, Executive Committee of the Faculty Senate, The University of Texas MD Anderson Cancer Center, 2010 - 2012

Member, Faculty Compensation Committee, The University of Texas MD Anderson Cancer Center, 2005 - 2008

Member, Executive Committee of the Faculty Senate, The University of Texas MD Anderson Cancer Center, 2002 - 2004

Member, Finance Committee - Faculty Senate, The University of Texas MD Anderson Cancer Center, 2002 - 2014

Chair, Academic Planning Subcommittee. Faculty Senate, The University of Texas MD Anderson Cancer Center, 2002 - 2010

Member, Budget Subcommittee; Clinical Council GME, The University of Texas MD Anderson Cancer Center, 2001 - 2015

Member, Steering Committee. Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, 2000 - 2002

Faculty Representative, Laboratory Improvement Committee, The University of Texas MD Anderson Cancer Center, 1998 - 1999

Editorial Activities

Member of Editorial Board, Modern Pathology, 2020 - 2021

Member of Editorial Board, American Journal of Dermatopathology, 2009 - Present

Section Chief, Archives of Pathology and Laboratory Medicine, 2004 - Present

Co-Editor-In-Chief, Electronic Journal of Pathology, 2000 - 2008

Member of Editorial Board, Journal of Cutaneous Pathology, 1996 - Present

Honors & Awards

2024	Certificate of Appreciation in International Leadership 2024, International League of Dermatological Societies
2023	Pío del Río Hortega Award, Sociedad Española de Anatomía Patológica
2020	Neil Smith Medal, British Society for Dermatopathology
2018	Harlan J. Spjut Award, Houston Society of Clinical Pathology
2018	Walter R. Nickle Award, American Society of Dermatopathology
2012 - 2013	ASDP Mentorship in Dermatopathology Award, American Society of Dermatopathology (ASDP)
2004	Educator of the Month, The University of Texas M. D. Anderson Cancer Center
1999	Lamar Callaway Award, Duke University Medical Center
1998	Fetter Award, Department of Pathology, Duke University Medical Center
1997	Munksgaard award, Journal of Cutaneous Pathology

Professional Memberships

European Commission of the European Union

2021 - Present

Texas Society of Pathologist

2019 - Present

Community of Chairs-Chair

2019 - 2023

CAP House of Delegates

2017 - Present

Association for Pathology Informatics

2016 - Present

Association of Pathology Chairs

2016 - Present

Houston Society of Clinical Pathologists

2003 - Present

College of American Pathologists

2003 - Present

Latino American Society of Dermatopathology

2000 - Present

Harris County Medical Society

2000 - Present

American Association for the Advancement of Science

1999 - Present

International Society of Dermatopathology

1999 - Present

American Society of Clinical Pathology

1998 - Present

Arthur Purdy Stout Society

1997 - Present

North Carolina Society of Pathology

1997 - 1999

Society for Investigative Dermatology

1992 - 2015

American Society of Dermatopathology

1992 - Present

United States and Canadian Academy of Pathology

1990 - Present

Sociedad Española de Anatomía Patológica. (Spanish Soc. Anatomic Pathol.)

1990 - Present

Selected Presentations & Talks

Local Presentations

2025. Overcoming Your Strengths: Competency Lecture Series. Invited. Anna Moreno. Houston, Texas, US.
2020. Interesting Case Conferences. Conference. Interesting Case Conferences. Houston, TX, US.
Consensus Conference. Conference. Consensus Conference. Houston, TX, US.
Sarcoma Conference. Conference. Sarcoma Conference. Houston, TX, US.
Weekly Dermatopathology Conference. Conference. Weekly Dermatopathology Conference. Houston, TX, US.
Weekly Faculty Conference. Conference. Weekly Faculty Conference. Houston, TX, US.
GVHD Conference. Conference. GVHD Confernece. Houston, TX, US.

Regional Presentations

2025. Evaluate Efficacy of Immunotherapy in Correlation with Survival. Invited. Houston, Texas, US.
2023. Update in Melanocytic Lesions. Conference. Update in Melanocytic Lesions. Houston, US.
2021. Use of IHC and Special Studies in the diagnosis melonyctic lesion. Conference. Use of IHC and Special Studies in the diagnosis melonyctic lesion. Houston, TN, US.
1999. Pathology Quiz. Weekly unknown slides. Conference. Pathology Quiz. Weekly unknown slides, US.
1999. Weekly Dermatopathology Conference. Conference. Weekly Dermatopathology Conference. Durham, NC, US.

National Presentations

2024. Primary Female Urethral Mucosal Melanoma: Retrospective Analysis of Clinicopathological andMolecular Features. Conference. USCAP 113th Annual Meeting. Baltimore, MD, US.
2024. Development, Assessment and Performance of Advanced Deep Learning Algorithms Using HALO-AIDigital Analysis Platform in Melanocytic Lesions with Clinicopathological Correlation. Conference. USCAP 113th Annual Meeting,. Baltimore, MD, US.
2024. Protein Kinase R-like Endoplasmic Reticulum Kinase (PERK) immunoexpression and GeneExpression Profile of the Tumor Microenvironment of Acral Melanoma. Poster. USCAP 113th Annual Meeting. Baltimore, MD, US.
2024. Pitfalls in Dermatopathology and Stump the Champs/Chumps. Conference. JM of the ISDP. San Diego, CA, US.
2024. Optimizing Immunohistochemical Detection for Histologic Diagnosis of Fusariosis. Conference. USCAP 113th Annual Meeting. Baltimore, MD, US.
2024. Pathological response to neoadjuvant therapy: definition and clinical relevance. Invited. Steamboat Surgical Update. Houston, TX, US.
2023. Abstract #2521. Conference. Abstract #2521. Boston, MA, US.
2023. Update in Melanocytic Lesions. Conference. MDACC Grand Rounds. Houston, TX, US.
2023. Use of Ancillary Techniques Applied to the Diagnosis of Melanocytic Lesions Microscope Session. Conference. Florida Society of Pathologists. Palm Beach, FL, US.
2023. Update in Cutaneous Adnexal Neoplasms. Conference. Florida Society of Pathologists. Palm Beach, FL, US.
2023. New WHO Classification of Melanocytes Lesions. Proposal of Multiple Melanoma Pathways. Conference. Florida Society of Pathologists. Palm Beach, FL, US.
2023. The issue with the tissue – pathological review in neoadjuvant trials. Conference. Annual Meeting. San Francisco, CA, US.
2023. Skin reactions to new targeted and immune therapies. Conference. William and Joan Caro Lectureship in Dermatopathology at Northwestern. Chicago, IL, US.
2023. Inmunohistoquímica y técnicas especiales lesiones melánicas. Conference. SILADEPA, US.
2023. Spitzoid melanocytic lesions. WHO Classification. Conference. North Carolina Society of Pathologists. Asheville, NC, US.
2023. Conferencia inaugural de piel SILADEPA 2023. Conference. SILADEPA, US.
2023. TRPS1 May be an Effective Discriminatory Marker for Basal Cell Carcinoma and Squamous Cell Carcinoma: An Immunohistochemical Analysis of TRPS1 in Non-Melanocytic Cutaneous Neoplasms. Conference. USCAP 112th Annual Meeting. New Orleans, LA, US.
2023. Skin reactions to targeted therapies. Conference. ISDP. New Orleans, LA, US.
2023. Alpha-5 Nicotinic Acetylcholine Receptor Expression in Merkel Cell Carcinoma: Possible Etiologic Roles. Conference. USCAP 112th Annual Meeting. New Orleans, LA, US.
2023. Whole Exome Sequencing of Acral Lentiginous Melanoma Reveals Novel Somatic Mutations and Potential Differences in Patients from Different Ethnicities. Conference. USCAP 112th Annual Meeting. New Orleans, LA, US.
2023. Assessing the Impact of the COVID-19 Pandemic on Training at the MD Anderson Cancer Center Anatomical Pathology Fellowship. Conference. USCAP 112th Annual Meeting. New Orleans, LA, US.
2023. Dermatopathology in the molecular age: Tricky diagnoses in melanocytic lesions being helped by molecular data. Conference. USCAP 112th Annual Meeting. New Orleans, LA, US.
2023. Melanocytic Lesions: How Not to Miss the Invisible Gorilla Emphasis in Melanocytic Lesions. Conference. TSP. Dallas, TX, US.
2022. Common Pitfalls and Mimickers in Dermatopathology. Conference. CAP 22 Annual Meeting. New Orleans, LA, US.
2022. Emergency Diagnoses in Dermatopathology. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. Retrospective Review at a Tertiary Care Cancer Center. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. Extramammary Post-Radiation Atypical Vascular Lesions: A Clinicopathologic Study of Eight Cases. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. High Expression of Nectin-4 in a Subset of Adnexal Carcinomas: A potential target for enfortumab vedotin therapy. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. SOX11 Serves as an Effective Discriminatory Marker, When Used in Conjunction with CK20 and TTF1, for Merkel Cell Carcinoma: A Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expressions in Merkel Cell Carcinomas and Pulmonary Small Cell Carcinomas. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. PD-L1 Expression by Tumor-Associated Macrophages (TAMs) of M2 Subtype is Associated with Overall Survival in Acral Lentiginous Melanoma of Different Ethnicities. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. TRPS1 Expression is Frequently Seen in Mammary and Extramammary Paget Diseases, Except for Those Arising in the Perianal Skin. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. Diagnostic Utility of PRAME Immunohistochemistry in Subungual and Acral Melanocytic Lesions. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. Multi-omics analysis of digital papillary adenocarcinoma reveals upregulation of MAGEA4 and infrequent zinc finger genes rearrangements. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. Characterizing the Clinicopathologic and Molecular Landscape of Acral Lentiginous Melanoma: A Retrospective Review of 331 Patients. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2022. Exploratory Analyses of Tumor-Infiltrating Inflammatory Cells in Male Genitourinary Melanoma. Conference. USCAP 111th Annual Meeting. Los Angeles, CA, US.
2021. Virtual: Lesiones melanociticas de dificil evaluacion: Como diagnosticar melanoma. Conference. Virtual: Lesiones melanociticas de dificil evaluacion: Como diagnosticar melanoma, US.
2021. Virtual: Rational use of immunohistochemistry and molecular test. Conference. Virtual: Rational use of immunohistochemistry and molecular test, US.
2021. Virtual: Lesiones melanociticas en ninos y su abordaje. Conference. Virtual: Lesiones melanociticas en ninos y su abordaje, US.
2021. Virtual: STUMP THE CHUMPS/CHAMPS. Conference. Virtual: STUMP THE CHUMPS/CHAMPS, US.
2020. Breast Core Needle Biopsy of Spindle Cell Lesions: Keys to Evaluation using Morphology and IHC. Conference. CAP 2022. New Orleans, LA, US.
2020. Cutaneous toxicities of targeted therapies and immunotherapies. Conference. 100th Annual Meeting British Association of Dermatologists (Virtual). Houston, TX, US.
2020. Use of special studies in the diagnosis of melanocytic legions. Conference. 100th Annual Meeting British Association of Dermatologists (Virtual). Houston, TX, US.
2020. Case discussion. Pathology component. Conference. Case discussion. Pathology component. Spring Boat, Co, CO, US.
2019. Cutaneous lymphomas. What do we need to know. Conference. Cutaneous lymphomas. What do we need to know. Seoul.
2019. Update in cutaneous mesenchymal neoplasms. Conference. Update in cutaneous mesenchymal neoplasms. Seoul.
2019. Oncologic Pathology: A Review and Update of Diagnostic Problems. Conference. Oncologic Pathology: A Review and Update of Diagnostic Problems. Miami, FL, US.
2019. Update on Cutaneous Adnexal Neoplasm with Special Emphasis on New Entities & Differentiation Between Primary & Metastic Lesions. Conference. The Hawaii Dermatopathology Conference. Maui, HI, US.
2019. Problems of Melanoma. Conference. Maui, HI, US.
2019. Use Immunohistochemistry & New Techniques applied to the diagnosis of Melanocytic Lesions. Conference. Use Immunohistochemistry & New Techniques applied to the diagnosis of Melanocytic Lesions. Maui, HI, US.
2019. Sentinel lymph node analysis in cutaneous melanoma. Conference. Maui, HI, US.
2019. Update on CAP Protocol and AJCC-TNM (8th Edition) Stagin Parameter of Cu. Conference. Update on CAP Protocol and AJCC-TNM (8th Edition) Stagin Parameter of Cu. Orlando, FL, US.
2018. myPlan MYRIAD Melanoma Case Review & Scientific Update. Conference. myPlan MYRIAD Melanoma Case Review & Scientific Update. Park City, UT, US.
2018. Discussion with Pathology Chairs (Melanoma). Conference. Discussion with Pathology Chairs (Melanoma). Austin, TX, US.
2018. Case Presentation 21-25 (Derm Self-Assessment). Conference. Case Presentation 21-25 (Derm Self-Assessment). San Diego, CA, US.
2018. What's New and Practical. Conference. What's New and Practical. San Diego, CA, US.
2018. Update in Cutaneous Adnexal Tumors. Conference. Update in Cutaneous Adnexal Tumors. Miami, FL, US.
2018. Case Presentation "highlight most important histologic features in melanoma". And Differentiate melanoma from capsular nevus. Conference. Case Presentation "highlight most important histologic features in melanoma". And Differentiate melanoma from capsular nevus. Steamboat Springs, CO, US.
2017. CAP Engaged Leadership Academy. Conference. CAP Engaged Leadership Academy. Chicago, IL, US.
2017. Special techniques in the diagnosis of melanocytic lesions. Conference. Special techniques in the diagnosis of melanocytic lesions. Seoul.
2017. Update in adnexal tumors. Conference. Update in adnexal tumors. Seoul.
2017. NEW CUTANEOUS ADNEXAL TUMOURS. Conference. NEW CUTANEOUS ADNEXAL TUMOURS, US.
2017. 1004-17 Diagnosing Melanocytic Lesions: Integrating Morphologic, Immunohistochemical and Molecular Features and an Update on the 8th AJCC Staging System. Conference. 1004-17 Diagnosing Melanocytic Lesions: Integrating Morphologic, Immunohistochemical and Molecular Features and an Update on the 8th AJCC Staging System. Chicago, IL, US.
2017. Dermatopathology Hot Topics- Participant. Conference. USCAP. San Antonio, TX, US.
2017. Overcoming your strengths. Conference. Overcoming your strengths. Houston, TX, US.
2016. Use of immunohistochemistry to distinguish between primary adnexal lesions and metastatic adenocarcinomas. Conference. Use of immunohistochemistry to distinguish between primary adnexal lesions and metastatic adenocarcinomas. Greenville, SC, US.
2016. Update on the AJCC Stagging of Melanoma. Conference. Update on the AJCC Stagging of Melanoma. Greenville, SC, US.
2016. Diagnosing Melanocytic Lesions: Integrating Morphologic, Immunohistochemical, and Molecular Features: An Approach to Diagnosis and Reporting. Conference. Las Vegas, NV, US.
2016. Grand Rounds Presentation. Conference. Grand Rounds Presentation, US.
2016. I Can't Believe It, Surprises in Dermatology Panel Discussion. Conference. I Can't Believe It, Surprises in Dermatology Panel Discussion. Seattle, WA, US.
2016. Cutaneous Oncology, Case Presentations/ Panel Discussion. Conference. Cutaneous Oncology, Case Presentations/ Panel Discussion. Steamboat Springs, CO, US.
2015. Diagnosing Melanocytic Lesions: Integrating Morphologic, Immunohistochemical and Molecular features. Conference. Diagnosing Melanocytic Lesions: Integrating Morphologic, Immunohistochemical and Molecular features. Long Beach, CA, US.
2015. Dermatopathology. Conference. Dermatopathology. Chicago, IL, US.
2015. Google X- Stand up for Cancer. Conference. Google X- Stand up for Cancer. San Fransico, CA, US.
2015. Grand Rounds. Conference. Grand Rounds. Gainesville, FL, US.
2015. Application of Immunohisotchemistry and Additional Techniques to the Diagnosis of Cutaneous Melanocytic Lesions. Conference. Boston, MA, US.
2015. Dermatopathology "Toughies": Saved by the Bell. Conference. Dermatopathology "Toughies": Saved by the Bell. Boston, MA, US.
2015. 2015 ADASP Annual Meeting. Conference. 2015 ADASP Annual Meeting. Boston, MA, US.
2015. Question and answer/ Case presentations. Conference. Question and answer/ Case presentations. Steamboat Springs, CO, US.
2014. Annual Skin SPORE Scientific Retreat. Conference. Annual Skin SPORE Scientific Retreat. Tampa, FL, US.
2014. Determine the most important clinical, histological, and immunohistochemical features in the differential diagnosis of primary and metastatic adenocarcinomas in the skin. Conference. Determine the most important clinical, histological, and immunohistochemical features in the differential diagnosis of primary and metastatic adenocarcinomas in the skin. Detroit, MI, US.
2014. Superficial soft tissue tumors involving the skin. Conference. Superficial soft tissue tumors involving the skin. Detroit, MI, US.
2014. Developing Trends in Melanoma: Ancillary Techniques for Diagnosis and New Targeted Therapies and their Cutaneous Side Effects. Conference. Developing Trends in Melanoma: Ancillary Techniques for Diagnosis and New Targeted Therapies and their Cutaneous Side Effects. Tampa, FL, US.
2014. Cutaneous Lymphoid Lesions: Not All are Mycosis Fungoides. Conference. Cutaneous Lymphoid Lesions: Not All are Mycosis Fungoides. Daegu.
2014. Cutaneous Lymphoid Lesions: Not all are Mycosis Fungoides. Conference. Surgical Pathology Updates. Seoul.
2014. Case Discussion; Pathology. Conference. 12th Oncology Update - 12th Controversies Conference. Steamboat Springs, CO, US.
2013. Follicular and Sebaceous Adnexal Tumors. Conference. 50th Annual Meeting. Washington, DC, US.
2013. (Abstract) Immunohistochemical Expression of Hormone Receptors in Melanoma of Pregnant Women, Non-Pregnant Women and Men: A Comparison Study. Conference. 102nd Annual Meeting. Baltimore, MD, US.
2012. Diagnosing Cutaneous Adnexal Tumors: The Tip of Iceberg. Conference. Annual Meeting. Boston, MA, US.
2012. Limited Tissue Samples in the Era of Personalized Medicine: Diagnostic Challenges, Molecular Analysis and Controversies. Conference. Annual Meeting. Boston, MA, US.
2012. The Role of Immunohistochemistry in the Evaluation of Skin Tumors. Conference. CAP '12 - THE Pathologists' Meeting. San Diego, CA, US.
2011. Atypical Melanocytic proliferations of chronically sun-exposed skin: Introduction. Conference. Atypical Melanocytic proliferations of chronically sun-exposed skin: Introduction. Tampa, FL, US.
2011. Mucosal Melanocytic Lesions. Conference. Mucosal Melanocytic Lesions. Tampa, FL, US.
2011. Diagnostic Pearls and Pitfalls in Sentinel Lymph Nodes for Melanoma. Clinical Implications. Conference. Annual Meeting. Seattle, WA, US.
2011. Use of Immunohistochemistry in melanocytic Lesions. Conference. The Medical College of Wisconsin, Department of Pathology. Milwaukee, WI, US.
2011. Nevoid Melanoma. Conference. University of Arkansas for the Medical Sciences. Little Rock, AR, US.
2011. Features That You Cannot Miss in a Skin Biopsy. Conference. American Society of Dermatopathology. San Antonio, TX, US.
2011. Dermatopathology in the immunocompromised patient. Conference. Dermatopathology in the immunocompromised patient. New Orleans, LA, US.
2010. Diagnosing Adnexal Tumors with Confidence: Solving The Puzzle. Conference. Diagnosing Adnexal Tumors with Confidence: Solving The Puzzle. San Francisco, CA, US.
2010. Sentinel LymphNodes in Melanoma. Histologic Pitfalls and Clinical Implications. Conference. Annual Meeting. San Francisco, CA, US.
2010. Diagnostic Pearls and Pitfalls in Sentinel Lymph Nodes for Melanoma Clinical Implications. Conference. Annual Meeting. Atlanta, GA, US.
2010. Resolving Difficult Diagnoses in Dermatopathology. Conference. Scientific Symposiums International, HI, US.
2010. Annual Meeting. Conference. Annual Meeting. Chicago, IL, US.
2009. Quantitative assessment of AKT activation in melanoma. Conference. Quantitative assessment of AKT activation in melanoma. Orlando, FL, US.

International Presentations

2025. Nueva clasificación de la MS (WHO) de lesiones melanocíticas. Invited. LATAM Webinar Series. Houston, US.
2025. Malignant Fibrous and Fibrohistiocytic Tumors. Invited. Virtual. Houston, US.
2025. Histologic evaluation of neoadjuvant therapy applied to cutaneous malignancies and its impact on survival. Invited. Virtual. Houston, US.
2024. Multicontinental Match. Invited. XLIII Symposium of the ISDP. Queenstown, NZ.
2024. Update on Spitzoid Lesions: WHO Classification. Conference. Chilean Society of Dermatology and Venereology. Vina Del Mar, CL.
2024. Update on the WHO classification of melanocytic lesions. Conference. The 5th Annual Meeting of Asian Society of Dermatopathology. Osaka, JP.
2023. Diagnosis of Systemic Diseases in Skin Biopsy: Dermatopathology to the Rescue. Conference. IDSP. Dubai, AE.
2023. Updates in Dermatopathology. Invited. Congreso de la SLAP. Buenos Aires, AR.
2023. "Diagnosis of Systemic Diseases in Skin Biopsy: Dermatopathology to the Rescue". Invited. ISDP-DIAL. Dubai, AE.
2023. Diagnosis of Neoplastic Pathology. Conference. CSCO. Jinan, CN.
2023. Update in Dermatopathology/Ancillary Techniques. Conference. 25th World Congress of Dermatology. Asia, SG.
2023. Advance Histopathology. Conference. 25th World Congress of Dermatology. Asia, SG.
2023. Importance of Dermatopathology. Conference. ILDS Annual Meeting. Asia, SG.
2023. The mistake from which I’ve learnt the most/El error que más me ha enseñado. Conference. Annual Meeting. Seville, ES.
2023. Updates in Dermatopathology. Conference. VIII Eurasian Congress. Astana, KZ.
2023. Alteraciones moleculares en los distintos tipos de tumores de Spitz. Conference. Virtual. San Andes Cholula, MX.
2022. Adnexal tumors, and the new classification of spitzoid lesions from the WHO". Conference. DSI. Chandigarh, IN.
2021. Virtual: Le propongo el tema de lesiones linfoproliferativas B en la piel. Conference. Virtual: Le propongo el tema de lesiones linfoproliferativas B en la piel, CO.
2020. Targeted therapies and immunotherapy in melanoma. Conference. Targeted therapies and immunotherapy in melanoma. Madrid, ES.
2019. How not to miss the invisible gorilla in a pathology slide. Conference. How not to miss the invisible gorilla in a pathology slide. Frankfurt, DE.
2019. Acral melanoma and practical molecular studies. Conference. Acral melanoma and practical molecular studies. Bangkok, TH.
2019. Use Immunohistochemistry for Diagnosis of Melanocytic Lesions. Conference. Use Immunohistochemistry for Diagnosis of Melanocytic Lesions. Bangkok, TH.
2019. Sentinel lymph node analysis in cutaneous melanoma. Conference. Sentinel lymph node analysis in cutaneous melanoma. Bangkok, TH.
2019. Update on AJCC 8th Edition Melanoma Staging. Conference. Update on AJCC 8th Edition Melanoma Stagin. Bangkok, TH.
2019. Melanocyctic Lesions. Conference. Melanocyctic Lesions. Lisbon, PT.
2017. USE OF SPECIAL STUDIES APPLIED TO THE DIAGNOSIS OF MELANOCYTIC LESIONS. Conference. USE OF SPECIAL STUDIES APPLIED TO THE DIAGNOSIS OF MELANOCYTIC LESIONS. Lahore, PK.
2017. Advanced Workshop on Melanoma Pathology. Conference. Advanced Workshop on Melanoma Pathology. San Paulo, BR.
2017. Sentinel lymph node in melanoma. Conference. Sentinel lymph node in melanoma. San Paulo, BR.
2016. Cutaneous Lymphoma: What's New. Conference. ISDP. New Delhi, IN.
2016. Aggressive tumors of the skin appendages: Merkel cell carcinoma and other new entities. Conference. Aggressive tumors of the skin appendages: Merkel cell carcinoma and other new entities. Madrid, ES.
2016. Soft tissue tumors of the skin. Conference. Soft tissue tumors of the skin. Shanghai, CN.
2016. Adnexal tumors of the skin: Differential diagnosis with metastatic carcinomas to the skin. Conference. Adnexal tumors of the skin: Differential diagnosis with metastatic carcinomas to the skin. Shanghai, CN.
2016. Soft tissue and Dermatopathology. Conference. Soft tissue and Dermatopathology. Aviles, ES.
2016. Tumores pigmentados de piel. Conference. Mexico City, MX.
2015. Lectures on Skin Pathology. Conference. Lectures on Skin Pathology, SG.
2015. Update in Oncologic Surgical Pathology. Conference. Update in Oncologic Surgical Pathology. Venice, IT.
2015. Histopathologic clues in B cell lymphomas. Conference. Histopathologic clues in B cell lymphomas. Medellin, CO.
2015. Histopathology of T cell lymphomas. Conference. Medellin, CO.
2015. Cutaneous Lymphomas. Conference. Cutaneous Lymphomas. Istanbul, TR.
2015. Melanoma: Biomarkers and Special Stains. Conference. Melanoma: Biomarkers and Special Stains. Istanbul, TR.
2015. Vascular Tumors. Conference. Vascular Tumors. Manchester, GB.
2015. Personalised medicine- how useful are ancillary investigations in ambiguous melanocytic lesions. Conference. Personalised medicine- how useful are ancillary investigations in ambiguous melanocytic lesions. Manchester, GB.
2015. Update Malignant Melanoma. Conference. Update Malignant Melanoma. Bamber, DE.
2015. 1st International Symposium of Cancers of the Skin. Conference. 1st International Symposium of Cancers of the Skin. Madrid, ES.
2014. Adnexal Tumors Part 2. Conference. Adnexal Tumors Part 2. Warsaw, PL.
2014. Cutaneous Lymphoma. Conference. Cutaneous Lymphoma. Warsaw, PL.
2014. Adnexal Tumors Part 1. Conference. Adnexal Tumors Part 1. Warsaw, PL.
2014. Differential diagnosis of difficult melanocytic lesions. Use of immunohistochemistry and special techniques. Conference. Differential diagnosis of difficult melanocytic lesions. Use of immunohistochemistry and special techniques. Warsaw, PL.
2014. Melanocytic lesions in children. Conference. Melanocytic lesions in children. Warsaw, PL.
2014. Sentinel lymph node biopsies in melanoma. Conference. Sentinel lymph node biopsies in melanoma. Warsaw, PL.
2014. Melanocytic Tumors. Conference. Melanocytic Tumors. Warsaw, PL.
2014. Analysis of immunohistochemical studies in melanocytic lesions. Conference. Analysis of immunohistochemical studies in melanocytic lesions. Managua, NI.
2014. Adnexal Neoplasms of the Skin. Conference. Adnexal Neoplasms of the Skin. Santiago, CL.
2014. Cutaneous Lymphomas. Conference. Cutaneous Lymphomas. Santiago, CL.
2014. Competition Cases. Conference. Competition Cases. Santiago, CL.
2014. Surgical Pathology Updates - Update in Melanocytic Lesions. Conference. Surgical Pathology Updates. Bamberg, DE.
2014. AJCC Classification. Conference. Surgical Oncology Update. Quito, EC.
2014. Genetics of Melanoma. Conference. Dermatopathology Lecture. Barcelona, ES.
2014. Soft Tissue Tumors of the Skin. Conference. CIQC 2014 Symposium. St. Johns, CA.
2014. Use of Special Studies in Melanocytic Lesions. Conference. New Evolving Concepts Symposium. Sydney, AU.
2014. Uncommon types of Melanoma - Vulvar Melanomas. Conference. 5th World Conference of Melanoma. Venice, IT.
2013. Melanocytic Lesions. Conference. Oncologic Congress. Quito, EC.
2013. Bone Neoplasms. Conference. Oncologic Congress. Quito, EC.
2013. Superficial Tumors of Soft Tissue. Conference. Oncologic Congress. Quito, EC.
2013. The Role of Immunohistochemistry in the Evaluation of Skin Tumors, Specifically Pigmented Lesions. Conference. The Usage of IHC Stains for Melanocytic Lesions Presentation. New Foundland, CA.
2013. Opportunities with Novel Antibodies and Special Stains. Conference. XXXIV Symposium of the International Society of Dermatopathology. Florence, IT.
2013. Lesiones melanociticas en niños. Conference. III Congreso Internacional de Dermatopatología. Mexico City, MX.
2013. Application of Immunohistochemistry in Differential Diagnosis of Melanocytic Lesions. Conference. Pathology of the 21st Century - From Molecular Diagnostics to Personalized Cancer Therapy. Guangzhou, CN.
2013. Vascular Tumours. Conference. 3rd London Dermatopathology Symposium 2013. London, GB.
2012. Update on Differential Diagnosis of Melanocytic Lesions. Conference. VI International Symposium: Advances in Dermato-oncology. Valencia, ES.
2012. My Most Interesting Case. Conference. The International Society Of Dermatopathology (ISDP). Santa Cruz de la Sierra, BO.
2012. Melanocytic lesions: what has molecular analysis taught us regarding classification and therapy. Conference. The University of Texas MD Anderson Cancer Center. Madrid, ES.
2011. Sentinel lymph node in melanoma. Conference. Sentinel lymph node in melanoma. Santiago, CL.
2011. VideoMicroscopy-Challenging melanocytic and lymphoid proliferations. Conference. VideoMicroscopy-Challenging melanocytic and lymphoid proliferations. Helsinki, FI.
2011. Spitzoid and blue melanocytic lesions. Conference. Spitzoid and blue melanocytic lesions. Helsinki, FI.
2011. The 2011 International Diagnostic Pathology Course. Conference. The 2011 International Diagnostic Pathology Course. Tokyo, JP.
2011. Sentinel Lymph Node Biopsy in Melanoma. Conference. Department of Pathology, The University of Texas MD Anderson Cancer Center. Udine, IT.
2011. Surgical Pathology Update. Conference. Surgical Pathology Update. Leipzig, DE.
2011. Pigmented Lesions of the Skin. Conference. The University of Texas M.D. Anderson Cancer Center. Kuwait City, KW.
2011. Superficial Soft Tissue Tumors. Conference. The University of Texas M.D. Anderson Cancer Center. Kuwait City, KW.
2010. Clinical Pathology Cases. Conference. Clinical Pathology Cases. Cancun, MX.
2010. Malignant Melanoma-Present Facts and Future Perspectives. Conference. The International Society of Dermatopathology. Barcelona, ES.
2010. Annual Meeting. Conference. Annual Meeting. Armenia, CO.

Formal Peers

2024. Short Course_Baltimore,MD. Invited. Baltimore, MD, US.
2020. Use of special studies applied to the diagnosis and management of melanocytic lesions. Invited. Columbus, OH, US.
2020. Use of special techniques applied to the diagnosis of melanocyctic legions. Invited. New York, NY, US.
2016. Sentinel Lymph Nodes/Resident Lecture. Invited, US.
2016. Dermatopathology. Invited, US.
2016. Follicular and Sebeaceous Neoplasms. Invited. Boston, MA, US.
2016. Molecular Classification of Melanoma. Invited. Boston, MA, US.
2016. Linfomas cutáneos. Invited. Concepción, CL.
2016. Lesiones superficiales de partes blandas en piel. Invited. Concepción, CL.
2016. Lesiones melanocíiticas de piel. Aportes de FISH y espectrometria de masas al diagnóstico. Invited. Concepción, CL.
2016. Dermatopathology. Invited, US.
2016. Moderator. Invited, US.
2015. Dermatopathology. Invited. Philadephia, PA, US.
2015. Use of Special Techniques Applied to the Diagnosis of Melanocytic Lesions. Invited. Boston, MA, US.
2015. Dermatopathology. Invited, US.
2014. How Not to Miss the Invisible Gorilla. Invited. Los Angeles, CA, US.
2014. Biomarkers in Melanoma. Invited. Gainesville, FL, US.
2014. Saved by the Patient. Invited. Denver, CO, US.
2014. Participation in an expert panel for discussion of Clinical Cases. Invited. Steamboat Springs, CO, US.
2013. Biomarkers in melanoma. Invited. Cali, CO.
2013. Biomarkers in Melanoma. Invited. Cali, CO.
2013. Melanocytic lesions in children (Lesiones melanocíticas en niños). Invited. Oaxaca, MX.
2013. Adnexal neoplasms. Invited. Orlando, FL, US.
2013. Mitotic figures in nevi (Figuras mitóticas en nevi). Invited. Oaxaca, MX.
2013. Follicular and Sebaceous Adnexal Tumors. Invited. Washington DC, US.
2013. Seminar of Dermatopathology Case. Invited. Palm Springs, CA, US.
2013. Opportunities with Novel Antibodies and Special Stains. Invited. Florence, IT.
2013. The Role of Immunohistochemistry in the Evaluation of Skin Tumors, Specifically Pigmented Lesions. Invited. New Foundland, CA.
2013. The Role of Immunohistochemistry in the Evaluation of Skin Tumors, Specifically Pigmented Lesions. Invited. Newfoundland, CA.
2013. Developing Trends in Melanoma: Application of Ancillary Techniques for Diagnosis and Prognosis. Invited. Chicago, IL, US.
2013. Use of New Targeted Therapies and their Associated Cutaneous Side Effects. Invited. Chicago, IL, US.
2013. Surgical Pathology Update. Invited. Lima/Cusco, PE.
2013. Soft tissue tumors of the skin (Tumores cutános de partes blandas). Invited. Lima/Cusco, PE.
2013. Use of immunohistochemistry in melanocytic lesions (Uso de inmunohistoquímica en lesiones melanocíticas). Invited. Lima/Cusco, PE.
2013. The Advances In Molecular Testing In Melanoma. Invited. Orlando, FL, US.
2013. Difficult cases to diagnose. Invited. Hamburg, DE.
2013. How not to miss the gorilla hidden in the slide (No pierdan de vista al gorila escondido en la laminilla). Invited. Mexico City, MX.
2013. Melanocytic lesions in children (Lesiones melanocíticas en niños). Invited. Mexico City, MX.
2013. Problems in Tumor Pathology. Invited. Manchester, GB.
2013. Adnexal Tumors. Invited. Manchester, GB.
2013. Vascular Tumours. Invited. London, GB.
2013. Melanocytic Tumors. Invited. Manchester, GB.
2013. Application of Immunohistochemistry in Differential Diagnosis of Melanocytic Lesions. Invited. Guangzohou, CN.
2013. Tumores metastásicos a piel vs tumores de anexos cutáneos: abordaje clínico, patológico y de inmunofenotipo. Invited. Mexico City, MX.
2013. Melanoma: la trascendencia de un reporte histopatólogico completo. Invited. Mexico City, MX.
2013. Melanoma: la trascendencia de un reporte histopatólogico completo. Invited. Mexico City, MX.
2013. La histología controvertida del melanoma: lo que se oculta en la arquitectura y las células. Invited. Mexico City, MX.
2013. (Abstract) Immunohistochemical Expression of Hormone Receptors in Melanoma of Pregnant Women, Non-Pregnant Women and Men: A Comparison Study. Invited. Balimore, MD, US.
2013. Update on Pediatric Skin Tumors. Invited. Baltimore, MD, US.
2013. Abordaje de los tumores "recientes" de partes blandas en la piel: una guia útil!. Invited. Mexico City, MX.
2013. Self-Assessment Course A & B & Discussion. Invited. Miami, FL, US.
2013. Melanocytic nevi mimiking melanoma; DPN, Spitz nevi, blue nevus, PSCN, PEM. Invited. Seoul/Daegu.
2013. Histopathological reporting; regression, mitotic rate, TIL, etc. Invited. Seoul/Daegu.
2013. Participation in an expert panel for discussion of Clinical Cases. Invited. Steamboat Springs, CO, US.
2013. Participation in a Consensus conference regarding human and animal melanomas. Invited. Bethesda, MD, US.
2012. Ganglio centinela en melanoma maligno. Procesamiento e interpretación. Invited. San Jose, CR.
2012. Melanoma maligno en niños y adolescentes. Invited. San Jose, CR.
2012. Factores pronósticos histopatológicos del melanoma maligno. Invited. San Jose, CR.
2012. Lesiones melanocíticas de difícil interperetación. Invited. San Jose, CR.
2012. Lesiones melanocíticas de difícil interpretación; Factores pronósticos histopatológicos del melanoma maligno. Invited. San Jose, CR.
2012. Ganglio centinela en melanoma maligno. Procesamiento e interpretación; Melanoma maligno en niños y adolescentes. Invited. San Jose, CR.
2012. Analysis of Sentinel Lymph Node to Help Clinical Management of Patients with Cutaneous Melanoma. Invited. Boston, MA, US.
2012. Use of Immunohistochemistry to try to Distinguish between Nevus and Melanoma: Anathema?. Invited. Boston, MA, US.
2012. Analysis of Sentinel Lymph Node to Help Clinical Management of Patients with Cutaneous Melanoma. Invited. Boston, MA, US.
2012. Histologic diagnosis of Melanoma: Recommendations of the CAP and ACC. Invited. Mexico City, MX.
2012. Use of immunohistochemistry in the diagnosis of melanocytic lesions. Invited. Mexico City, MX.
2012. Evening Slide Symposium. Invited. Chicago, IL, US.
2012. Tumor Burden in Melanoma Sentinel Lymph Nodes. Invited. Santa Cruz de la Sierra, BO.
2012. Limited Tissue Samples in the Era of Personalized Medicine: Diagnostic Challenges, Molecular Analysis and Controversies. Invited. Boston, MA, US.
2012. Use of Immunohistochemistry to try to Distinguish between Nevus and Melanoma: Anathema?. Invited. Boston, MA, US.
2012. Diagnosing Cutaneous Adnexal Tumors: The Tip of Iceberg. Invited. Boston, MA, US.
2012. Evening Slide Symposium. Invited. Chicago, IL, US.
2012. My Worst Nightmare. Invited. Santa Cruz de la Sierra, BO.
2012. Update on Differential Diagnosis of Melanocytic Lesions. Invited. Valencia, ES.
2012. The Role of Immunohistochemistry in the Evaluation of Skin Tumors. Invited. San Diego, CA, US.
2012. Case Seminar. Invited. Mexico City, MX.
2012. Inflammatory Dermatosis. Invited. Olso, NO.
2012. Dysplastic Nevus. Invited. Olso, NO.
2012. Melanocytic Lesions: What Has Molecular Analysis Taught Us Regarding Classification and Therapy. Invited. Madrid, ES.
2012. Immunohistochemistry Applied to the Diagnosis of Spitzoid Lesions. Invited. Mexico City, MX.
2012. Spitzoid Focused on Childhood. Invited. Olso, NO.
2012. Cutaneous Lesions of the Breast. Invited. Alicante, ES.
2012. Head and Neck Melanocytic Lesions. Invited. Bogota, CO.
2012. Dysplastic Nevus. Invited. Bogota, CO.
2012. Childhood Melanoma. Invited. Bogota, CO.
2011. The Role of Immunohistochemistry in Sentinel Lymph Nodes in Melanoma. Invited. Frymburk, CZ.
2011. The Role of Immunohistochemistry in Distinguishing Between Primary and Metastatic Carcinomas of the Skin. Invited. Frymburk, CZ.
2011. Immunohistochemistry Applied to the Diagnosis of Melanocytic Lesions. Invited. Santander, ES.
2011. The use of Immunohistochemistry in Adnexal Cutaneous Neoplasms. Invited. Milwaukee, WI, US.
2011. Pathology of Challenging Melanocytic Neoplasms. Invited. San Antonio, TX, US.
2010. Sentinel Lymph Nodes in Melanoma. Histologic Pitfalls and Clinical Implications. Invited. San Francisco, CA, US.
2010. Annual Meeting. Invited. Alicante, ES.
2008. Annual Meeting. Invited. San Francisco, CA, US.
2008. Annual Meeting. Invited. San Antonio, TX, US.
2007. Update in melanocytic lesions. Invited. Puerto Vallarta, MX.
2007. Update in melanocytic lesions. Invited. Leipzig, DE.
2007. Annual Meeting. Invited. Paris, FR.
2007. Clinico-pathology seminar. Invited. Tarragona, ES.
2007. Clinico-pathologic seminar. 7th Surgical Oncology Update. Invited. Steamboat Springs, CO, US.
2006. Update in Melanocytic Lesions. Invited. Stockholm, SE.
2006. Pathology examination of Sentinel Lymph Node and new techniques in patients with Cutaneous Melanoma. Invited. Oviedo, ES.
2006. Update in Melanocytic Lesions. Invited. Sao Paolo, BR.
2006. Skin adnexal tumors. Invited. Sao Paulo, BR.
2006. Skin adnexal tumors. Invited. Stockholm, SE.
2005. A critical review of Melanoma: genomic approaches with therapeutic promise. Invited, NY, US.
2005. Update in Melanocytic lesions. Invited. Durham, NC, US.
2005. Update in Melanocytic lesions. Invited. Duluth, MN, US.
2005. Actualización en linfomas cutáneos (Update in Cutaneous Lymphomas). Invited. Antigua, GT.
2005. Actualización en lesiones melánicas (Update in Melanocytic Lesions). Invited. Antigua, GT.
2005. A critical review of Melanoma: genomic approaches with therapeutic promise. Invited. Cold Spring Harbor, NY, US.
2005. Diagnostic problems in surgical pathology. Invited. Seattle, WA, US.
2005. Update in Cutaneous Lymphomas. Invited. Barcelona, ES.
2005. Update in Melanocytic Lesions. Invited. Barcelona, ES.
2004. Seminario de Autoevaluación. Invited. Lima, PE.
2004. Lesiones melánicas. Invited. Lima, PE.
2004. Skin eruptions in patients with bone marrow transplantation. Invited. Madrid, ES.
2004. Cutaneous lymphomas. Invited. Barcelona, ES.
2004. Seminar in Melanocytic Lesions. Invited. Kyoto, JP.
2004. Sentinel Lymph Node in Melanoma. Invited. Kyoto, JP.
2004. Update in Melanocytic Lesions. Invited. Kyoto, JP.
2004. Seminar in Anatomic Pathology. Invited, IT.
2004. Update in skin adnexal lesions. Invited. Udine, IT.
2004. Actualización en Patología Quirúrgica (Update in Surgical Pathology). Invited. Buenos Aires, AR.
2004. Use of Sentinel Lymph Node in Melanoma. Invited, NY, US.
2004. Visiting Professor. Invited, CA, US.
2003. Visiting Professor. Sentinel lymph node. Invited, TX, US.
2003. Visiting Professor. Invited, IL, US.
2003. Visiting Professor. Invited. Torrevieja, ES.
2003. Use of Sentinel Lymph Node in Melanoma. Spindle Melanocytic lesions. Surgical Pathology Update. Invited. Hong Kong, CN.
2003. Seminar in Dermatopathology. Invited, GT.
2003. Invited Participant. Workshop on Cancer Biometrics. Invited. Washington, DC, US.
2002. Visiting Professor. Invited. Torrevieja, ES.
2002. Examination of Sentinel Lymph Nodes from patients with malignant melanoma. Invited. Alicante, ES.
2002. Seminar in Dermatopathology. Invited, AR.
2002. Spindle Cell Melanocytic Lesions. Invited. Galveston, TX, US.
2002. Visiting Professor. Invited. Houston, TX, US.
2002. Visiting Professor. Invited. Houston, TX, US.
2002. Visiting Professor. Invited. Barcelona, ES.
2002. Visiting Professor. Invited. Barcelona, ES.
2002. Visiting Professor. Invited. Houston, TX, US.
2001. Seminar in pigmented lesions. Invited. Venice, IT.
2000. Self-assessment course. Invited. San Francisco, CA, US.
2000. Seminar in Dermatopathology. Invited. Nagoya, JP.
2000. Visiting Professor. Invited. Galveston, TX, US.
2000. Visiting Professor. Invited. Mobile, AL, US.
2000. Seminar: “Jornada de tumores pigmentados de la piel” (Cutaneous pigmented neoplasms). Invited. Mendoza, AR.
2000. Self-assessment seminar. Invited. Viña del Mar, CL.
1999. Self-assessment seminar. Invited. La Jolla, CA, US.
1999. Short Course: Pigmented Lesions of the Skin. Invited. Barcelona, ES.
1999. Slide Seminar in Dermatopathology. Invited. Barcelona, ES.
1999. Evening Specialty Conference. Invited. New Orleans, LA, US.
1999. Dermatopathology. Invited. Durham, NC, US.
1999. Specialty Topics in Pathology. Invited. Durham, NC, US.
1999. Dermatopathology Cases. Invited. Durham, NC, US.
1997. Seminar in Dermatopathology. Invited, ES.
1996. Short course in Dermatopathology. Invited. Santiago de Compostela, ES.
1996. Short course in Dermatopathology. Invited, ES.
1992. Short course in Dermatopathology. Invited. Santiago de Compostela (Galicia), ES.
1992. Seminar in Malignant Melanoma. Invited. New York, NY, US.
1990. "Escola Municipal d'Imfermeria". Invited. Barcelona, ES.
1989. IV Jornades Catalanes de Técnica Histopatológica (IV Seminars in Histopathologic Techniques). Invited. Barcelona, ES.
1987. II Jornades Catalanes de Técnica Histopatológica. Invited. Barcelona, ES.

Less

Grant & Contract Support

Date:	2024 - 2029
Title:	Melanoma SPORE Pathology Core
Funding Source:	NIH/NCI
Role:	Core B Co-Director
ID:	FP20546

Date:	2022 - 2023
Title:	S20-089F2 ComboMATCH
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	FP00018431

Date:	2022 - 2023
Title:	Leidos Biomedical Research, Inc
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	60653

Date:	2020 - 2023
Title:	Predictor of response to neoadjuvant therapy in melanoma
Funding Source:	Melanoma Research Alliance
Role:	Collaborator
ID:	683873

Date:	2019 - 2024
Title:	The University of Texas MD Anderson Cancer Center Spore in Melanoma
Funding Source:	NIH/NCI
Role:	Core Co-PI
ID:	5P50CA221703-02

Date:	2019 - 2024
Title:	A Phase II Randomized Study of Adjuvant versus Neoadjuvant MK-3475 (Pembrolizumab) for Clinically Detectable Stage III-IV High Risk Melanoma
Funding Source:	UT MD Anderson Cancer Center
Role:	Co-PI
ID:	S1801

Date:	2019 - 2024
Title:	Melanoma SPORE Pathology Core
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	5P50CA221703-02,

Date:	2016 - 2023
Title:	Leidos Biomedical Research, Inc
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	S20-089F8

Date:	2012 - 2015
Title:	SPORE in Melanoma(PC-B)
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-Core Director
ID:	918186

Date:	2012 - 2015
Title:	SPORE in Melanoma(PP-3)
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Co-PI
ID:	918182

Date:	2012 - 2016
Title:	Predictive biomarkers in metastatic melanoma patients receiving autologous T-cell therapy (PQ20)
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	RFA-CA-11-011

Date:	2012 - 2013
Title:	Nucleic acid extraction protocol development
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	951305

Date:	2011 - 2013
Title:	Studies on the Mechanism(s) of De Novo and Acquired Resistance to Selective RAF Inhibition
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	989579

Date:	2011 - 2014
Title:	Advancing staging & prognosis in early-stage melanoma
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	989193

Date:	2011 - 2011
Title:	MD Anderson Ovary Tissues Project(PP-1)
Funding Source:	The University of Texas MD Anderson Cancer Center
Role:	Collaborator
ID:	950899

Date:	2011 - 2013
Title:	Malignant melanoma: Regulation by AP-2 and PAR1
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	910433

Date:	2009
Title:	Gene expression profiles and microvascular density in ulcerated melanomas
Funding Source:	NIH/NCI
Role:	PI

Date:	2007 - 2009
Title:	Biomimetic Scaffolds for Abdominal Wall Repair
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	5-R21-AG026477-02

Date:	2006 - 2011
Title:	DC Vaccination to Enhance Adoptice T Cell Transfer
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	5-R01-CA111999-05

Date:	2005 - 2010
Title:	Biology and Significance of Melanoma Lymphatic Metastasis
Funding Source:	American Cancer Society (ACS)
Role:	Collaborator
ID:	RSG-05-250-01-CSM 04

Date:	2004 - 2009
Title:	Melanoma Detection By Oblique-Incidence Optical Spectroscopy
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	7-R01-CA106728-04

Date:	2004 - 2010
Title:	Genetic Predictors for DNA Repair Phenotype in CMM
Funding Source:	NIH/NCI
Role:	Collaborator
ID:	5-R01-CA100264-05

Date:	2004 - Present
Title:	Analysis of Thermacool TC Radio Frequency (RF) Device
Funding Source:	NIH/NCI
Role:	CO-I

Date:	2004 - 2009
Title:	Phase II Evaluation of GEFITINIB (ZD1839, IRESSA) in Metastatic Melanoma
Funding Source:	AstraZeneca and National Cancer Institute
Role:	CO-I

Date:	2002 - 2007
Title:	Heterogeneity of Human Melanoma, Cytokines and iNOS
Funding Source:	NIH/NCI
Role:	CO-I
ID:	1R01CA090282-01A1

Date:	2001 - 2006
Title:	Phase II study of Gleevec in Metastatic Melanoma (Analysis of Tyrosine-Kinase receptors)
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	01-284

Date:	2000 - 2003
Title:	Feasibility Study to Determine the Agreement of Sentinel Lymph Node Status and Melastatin mRNA Expression in Primary Cutaneous Malignant Melanoma
Funding Source:	Becton Dickinson Biosciences and U.T.- MDACC Agreement – CS00-224
Role:	Collaborator
ID:	LAB00-227

Date:	1999 - Present
Title:	Research on laser effects
Funding Source:	Department of Defense (DOD)
Role:	CO-I

Title:	Profiling Immune Architecture and Metabolic Landscape in Acral Melanoma
Funding Source:	Melanoma Research Alliance
Role:	PI

Title:	Research on laser effects
Funding Source:	Duke University. National Program of Free-Electron Laser (FEL). Department of Defense. Navy
Role:	CO-I

Title:	Analysis of Genetic Profiles in Melanoma
Funding Source:	Rythm
Role:	Collaborator

Selected Publications

Peer-Reviewed Articles

Lohray, R, Purnak, S, Arkatkar, S, Duvic, M, Prieto, V, Torres Cabala, CA, Huen, A. Tumor flare reaction with brentuximab-vedotin in mycosis fungoides. JAAD Case Reports 70:39-41, 2026. e-Pub 2026.
Sina N, Muhaj F, Lenskaya V, Ivan D, Prieto VG, Curry JL. Bispecific Dual-Immune Checkpoint Inhibitor Associated Cutaneous Toxicity: A Report of Lorigerlimab Adverse Skin Reaction in Two Cancer Patients. J Cutan Pathol, 2026. e-Pub 2026. PMID: 41548937.
Sina N, Torres-Cabala CA, Prieto VG. Nonspecific Granular Reactivity of EBER In-Situ Hybridization in a Patient of Black Hairy Tongue. Am J Dermatopathol 47(10):817-818, 2025. e-Pub 2025. PMID: 40743495.
Burton, EM, Milton, D, Tetzlaff, M, Wani, K, Ross, MI, Postow, MA, Segura Lazcano, R, Glitza, IC, Wong, MK, Patel, SP, Diab, A, Gershenwald, JE, McQuade, JL, Warner, AB, Prieto, V, Lee, JE, Goepfert, RP, Fisher, SB, Song, A, Malke, J, Simon, JM, Ariyan, C, Torres Cabala, CA, Davies, MA, Lazar, A, Wargo, J, Tawbi, H, Amaria, RN. Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma. Journal of Clinical Oncology 43(26):2856-2862, 2025. e-Pub 2025. PMID: 40638872.
Aung, TN, Liu, M, Su, D, Shafi, S, Boyaci, C, Steen, S, Tsiknakis, N, Vidal, JM, Maher, NG, Micevic, G, Tan, SX, Vesely, MD, Nourmohammadi, S, Bai, Y, Djureinovic, D, Wong, PF, Bates, KM, Chan, NN, Gavirelatou, N, He, M, Burela, S, Barna, R, Bosic, M, Bräutigam, K, Illabochaca, I, Chenhao, Z, Gama, J, Kreis, B, Mohacsi, R, Pillar, N, Pinto, J, Poulios, C, Toli, MA, Tzoras, E, Bracero, Y, Bosisio, F, Cserni, G, Dema, A, Fortarezza, F, Gonzalez, MS, Gullo, I, Queipo, FJ, Hacihasanoglu, E, Jovic, V, Lazar, B, Olinca, M, Neppl, C, Oliveira, RC, Pezzuto, F, Gomes Pinto, D, Plotar, V, Pop, O, Rau, TT, Skok, K, Sun, W, Serbes, ED, Solass, W, Stanowska, O, Szasz, M, Szymonski, K, Thimm, F, Vignati, D, Vigdorovits, A, Prieto, V, Sinnberg, T, Wilmott, JS, Cowper, SE, Warrell, J, Saenger, Y, Hartman, J, Plummer, JT, Osman, I, Rimm, DL, Acs, B. Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma. JAMA Network Open 8(7), 2025. e-Pub 2025. PMID: 40608341.
He, LJ, Wang, Y, Curry, JL, Ning, J, Aung, PP, Nagarajan, P, Prieto, V, Torres Cabala, CA, Cho, WC. TROP2 is highly expressed in cutaneous squamous cell carcinomas and a subset of adnexal carcinomas. Human Pathology 160, 2025. e-Pub 2025. PMID: 40523445.
Do, J, Wang, Y, Aung, PP, Nagarajan, P, Ning, J, Curry, JL, Ivan, D, Lenskaya, V, Torres Cabala, CA, Prieto, VG, Cho, WC. INSM1. Human Pathology 160, 2025. e-Pub 2025. PMID: 40505699.
Ding Q, Aung PP, Sun H, Solis Soto LM, Lu W, Raso MG, Rizvi YQ, Wistuba II, Sahin AA, Prieto VG. Upregulation of MMP9 expression in postradiation angiosarcoma of the breast. Virchows Arch. e-Pub 2025. PMID: 40335788.
Nagarajan, P, Yun, SJ, Prieto, V. Mucosal melanoma. Clinics in Dermatology 43(3):365-377, 2025. e-Pub 2025. PMID: 39277090.
Roland-McGowan, JN, Freeman, SC, Baghoomian, W, Carroll, BT, Kim, CC, Curiel-Lewandrowski, C, Chu, EY, Foster, EL, Nelson, KC, White, K, Ming, ME, Hartman, R, Leachman, S, Mengden-Koon, S, Chen, SC, Swetter, S, Prieto, V, Berry, EG, Yu, WY. Development of a treatment decision aid for patients with dysplastic nevi who are candidates for re-excision. Journal of the American Academy of Dermatology 92(5):1112-1114, 2025. e-Pub 2025. PMID: 39827941.
Lenskaya, V, Yang, RK, Aung, PP, Prieto, V, Nagarajan, P, Cho, WC. NSD3::FGFR1: A Novel Gene Fusion First to Be Described in Merkel Cell Carcinoma. American Journal of Dermatopathology 47(5):400-403, 2025. e-Pub 2025. PMID: 40036479.
Cunningham, CR, Dimopoulos, YP, García-Quiñones, IM, Milton, D, Delgado-Vélez, M, Cho, WC, Prieto, V, Lasalde-Dominicci, JA, Ballester, L, Aung, PP. Nicotinic Acetylcholine Receptor Expression in Merkel Cell Carcinoma Is Associated With Clinical and Histopathologic Parameters. Journal of cutaneous pathology 52(4):317-323, 2025. e-Pub 2025. PMID: 39814046.
Bayraktar, EC, Aung, PP, Gill, P, Shen, G, Vasudevaraja, V, Lai, Z, Chiriboga, L, Ivan, D, Nagarajan, P, Curry, JL, Torres Cabala, CA, Prieto, V, Jour, G. Genomic and Transcriptomic Profiling of Digital Papillary Adenocarcinomas Reveals Alterations in Matrix Remodeling and Metabolic Genes. Journal of cutaneous pathology 52(4):309-316, 2025. e-Pub 2025. PMID: 39757862.
Shaker, N, Phelps, R, Niedt, G, Sangueza, OP, Krishnan, R, Patel, A, Torres Cabala, CA, Aung, PP, Prieto, V, Dumur, CI, Pradhan, D. BRCA1-Associated Protein-1 Inactivated Melanoma Arising in a Pre-existing Nevus With ALK Fusion and Low Tumor Mutational Burden. American Journal of Dermatopathology 47(4):264-268, 2025. e-Pub 2025. PMID: 39912664.
Sargen, MR, Barnhill, RL, Elder, D, Swetter, S, Prieto, V, Ko, JS, Bahrami, A, Gerami, P, Karunamurthy, A, Pappo, A, Schuchter, LM, Leboit, PE, Yeh, I, Kirkwood, JM, Jen, M, Dunkel, IJ, Durham, MM, Christison-Lagay, ER, Austin, M, Aldrink, JH, Mehrhoff, C, Hawryluk, EB, Chu, EY, Busam, KJ, Sondak, V, Messina, JL, Puig, S, Colebatch, AJ, Coughlin, CC, Berrebi, KG, Laetsch, TW, Mitchell, SG, Seynnaeve, BK. Evaluation and Surgical Management of Pediatric Cutaneous Melanoma and Atypical Spitz and Non-Spitz Melanocytic Tumors (Melanocytomas). Journal of Clinical Oncology 43(9):1157-1167, 2025. e-Pub 2025. PMID: 39365959.
Beydoun HM, Jeyakumar JE, Addo A, Olivares S, Zhao L, Ma Y, Ko J, Bahrami A, Prieto VG, Florell S, Furtado LV, Busam K, Gerami P. A Clinical, Morphologic, and Molecular Comparison of Bonafide Spitz Melanomas and ASTs in the Pediatric Population. Am J Surg Pathol. e-Pub 2025.
Karp, JK, Lofgreen, A, Johnson, KA, George, MR, Barak, S, Bryant, BH, Berg, MP, Childs, JM, Knollman-Ritschel, BE, Prieto, VG, White, KL, McCloskey, CB. Continued Positive Job Search Experience for New Pathologists Seeking First Employment During the COVID-19 Pandemic (2020-2022). Arch Pathol Lab Med 149(1):14-19, 2025. e-Pub 2025. PMID: 38528091.
Pineda-Reyes, J, Arudra, SC, Aung, PP, Nagarajan, P, Curry, JL, Tetzlaff, M, Prieto, VG, Wang, W, Hwu, W, Torres Cabala, CA. Dual PD-L1/SOX10 Immunohistochemistry Combined with Digital Imaging Enhances Stratification Accuracy of Patients with Metastatic Melanoma. Am J Surg Pathol 48(12):1551-1556, 2024. e-Pub 2024. PMID: 39373029.
Cho, WC, Prieto, VG, Yang, RK. Spitz Melanoma with SLC20A1::ALK Fusion: A Novel Fusion Previously Undescribed in Spitz Melanocytic Neoplasm. Am J Dermatopathol 46(10):700-703, 2024. e-Pub 2024. PMID: 38941542.
Arruda, S, Prieto, VG, Shea, CR, Swearingen, A, Elmadany, Z, Sadick, NS. A Clinical Histology Study Evaluating the Biostimulatory Activity Longevity of Injectable Poly-L-Lactic Acid for Facial Rejuvenation. J Drugs Dermatol 23(9):729-734, 2024. e-Pub 2024. PMID: 39231078.
Fields, BC, Jain, AJ, Prieto, VG, Frink, SJ, Holder, AM. Pigmented Villonodular Synovitis. Am J Dermatopathol 46(9):e77-e78, 2024. e-Pub 2024. PMID: 39008502.
Fields Brittany C, Jain Anish J, Prieto,VG, Frink Spencer J, Holder Ashley M. Pigmented Villonodular Synovitis. Am J Dermatopathol 46(9):e77-e78, 2024. e-Pub 2024.
Seervai, RN, Taylor, MM, Rahbar, Z, Patel, SP, Nelson, KC, Prieto, VG, Curry, JL. Keratosis Pilaris-Like Reaction Associated with Chromatin Remodeling Complex Inhibition in Uveal Melanoma. JAMA Dermatol 160(6):682-685, 2024. e-Pub 2024. PMID: 38717752.
Salah, HT, Yang, RK, Roy Chowdhuri, S, Ross, MI, Aung, PP, Rothrock, AT, Torres Cabala, CA, Curry, JL, Prieto, VG, Nagarajan, P, Cho, WC. Spitz melanocytic neoplasms with MLPH::ALK fusions: Report of two cases with previously unreported features and literature review. J Cutan Pathol 51(6):407-414, 2024. e-Pub 2024. PMID: 38444194.
Dimopoulos YP, Kwon D, Milton DR, Iaeger PI, Hansel DE, Prieto VG, Chin KE, Aung PP. Assessing the Impact of the COVID-19 Pandemic on Training at the MD Anderson Cancer Center Anatomical Pathology Fellowship Program. Arch Pathol Lab Med 148(5):559-565, 2024. e-Pub 2023. PMID: 37639451.
Cho, WC, Saade, R, Nagarajan, P, Aung, PP, Milton, D, Marques-Piubelli, ML, Hudgens, CW, Ledesma, D, Nelson, KC, Ivan, D, Zhang, M, Torres Cabala, CA, Campbell, M, Alhalabi, O, Prieto, VG, Wistuba, II, Esmaeli, B, Curry, JL. Nectin-4 expression in a subset of cutaneous adnexal carcinomas. J Cutan Pathol 51(5):360-367, 2024. e-Pub 2024. PMID: 38200650.
Liu, YA, Aung, PP, Wang, Y, Ning, J, Nagarajan, P, Curry, JL, Torres Cabala, CA, Ivan, D, Prieto, VG, Ding, Q, Cho, WC. TRPS1 expression in non-melanocytic cutaneous neoplasms. J Pathol Transl Med 58(2):72-80, 2024. e-Pub 2024. PMID: 38389280.
Shehabeldin, A, Rohra, P, Sellen, LD, Zhao, J, Alqaidy, D, Aramin, H, Hameed, N, Perez, YE, Lai, Z, Tong, YT, Milton, D, Edgerton, ME, Fuller, GN, Hansel, DE, Prieto, VG, Ballester, L, Aung, PP. Utility of Whole Slide Imaging for Intraoperative Consultation. Arch Pathol Lab Med 148(6):715-721, 2024. e-Pub 2024. PMID: 37756559.
George, MR, Timmons, CF, Johnson, KA, Barak, S, Berg, MP, Bryant, BH, Childs, JM, Karp, JK, Knollmann-Ritschel, BC, Lofgreen, A, McCarthy, T, Prieto, VG, Procop, GW, Sandersfeld, T, White, KL, McCloskey, CB. Leadership perspectives on osteopathic medical school applicants to pathology residency training. Acad Pathol 11(1), 2024. e-Pub 2024. PMID: 38433776.
Liu, YA, Collins, K, Aung, PP, Nagarajan, P, Curry, JL, Prieto, VG, Torres Cabala, CA, Cho, WC. TRPS1 expression in primary and secondary extramammary Paget diseases. Hum Pathol 143:5-9, 2024. e-Pub 2024. PMID: 38000676.
Ronen, S, McAfee, JL, Curry, JL, Nagarajan, P, Aung, PP, Ivan, D, Prieto, VG, Tetzlaff, M, Torres Cabala, CA. Phenotypic switch in mycosis fungoides. Hum Pathol 142:27-33, 2023. e-Pub 2023. PMID: 37977511.
Shaker, N, Phelps, R, Niedt, G, Patel, A, Wu, D, Aung, PP, Prieto, VG, Church, A, Pradhan, D. Cutaneous Atypical Fibroxanthoma with Osteoclast-Like Giant Cell. Am J Dermatopathol 45(10):704-707, 2023. e-Pub 2023. PMID: 37708369.
Cho WC, Li W, Gu J, Wang WL, Ning J, Sfamenos S, Gill P, Nagarajan P, Curry JL, Lazar AJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase reverse transcriptase immunohistochemical expression is sensitive but not specific for TERT gene amplification in acral melanoma. J Cutan Pathol 50(9):845-851, 2023. e-Pub 2023. PMID: 37400233.
Vanderbeck K, Rothrock AT, Cho WC, Nagarajan P, Aung PP, Hudgens C, Bassett RL, Ivan D, Prieto VG, Curry JL, Torres-Cabala CA. PRAME and LEF1 in Combined Deep Penetrating Nevus and Combined Blue Nevus: Utility and Pitfalls. Am J Dermatopathol 45(8):549-556, 2023. e-Pub 2023. PMID: 37462205.
Niu N, Heberton MM, Tang Z, Aung PP, Nagarajan P, Curry JL, Prieto VG, Torres-Cabala CA, Cho WC. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review. J Cutan Pathol 50(8):711-716, 2023. e-Pub 2023. PMID: 36944579.
Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma. Arch Pathol Lab Med 147(7):758-766, 2023. e-Pub 2023. PMID: 36745184.
Marques-Piubelli ML, Seervai RNH, Mudaliar KM, Ma W, Milton DR, Wang J, Muhlbauer A, Parra ER, Solis LM, Nagarajan P, Speiser J, Hudgens C, Cho WC, Aung PP, Patel A, Pacha O, Nelson KC, Tetzlaff MT, Amaria RN, Torres-Cabala CA, Prieto VG, Wistuba II, Curry JL. Gene expression profiling and multiplex immunofluorescence analysis of bullous pemphigoid immune-related adverse event reveal upregulation of toll-like receptor 4/complement-induced innate immune response and increased density of TH 1 T-cells. J Cutan Pathol 50(7):661-673, 2023. e-Pub 2023. PMID: 37150813.
Vanderbeck K, Cho WC, Aung PP, Ivan D, Rothrock AT, Torres-Cabala CA, Prieto VG, Curry JL, Nagarajan P. Ductal differentiation. J Cutan Pathol 50(6):511-519, 2023. e-Pub 2023. PMID: 36454019.
Cho WC, Ding Q, Wang WL, Nagarajan P, Curry JL, Torres-Cabala CA, Ivan D, Albarracin CT, Sahin A, Prieto VG, Aung PP. Immunohistochemical expression of TRPS1 in mammary Paget disease, extramammary Paget disease, and their close histopathologic mimics. J Cutan Pathol 50(5):434-440, 2023. e-Pub 2023. PMID: 36808637.
Patel SP, Othus M, Chen Y, Wright GP, Yost KJ, Hyngstrom JR, Hu-Lieskovan S, Lao CD, Fecher LA, Truong TG, Eisenstein JL, Chandra S, Sosman JA, Kendra KL, Wu RC, Devoe CE, Deutsch GB, Hegde A, Khalil M, Mangla A, Reese AM, Ross MI, Poklepovic AS, Phan GQ, Onitilo AA, Yasar DG, Powers BC, Doolittle GC, In GK, Kokot N, Gibney GT, Atkins MB, Shaheen M, Warneke JA, Ikeguchi A, Najera JE, Chmielowski B, Crompton JG, Floyd JD, Hsueh E, Margolin KA, Chow WA, Grossmann KF, Dietrich E, Prieto VG, Lowe MC, Buchbinder EI, Kirkwood JM, Korde L, Moon J, Sharon E, Sondak VK, Ribas A. Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma. N Engl J Med 388(9):813-823, 2023. e-Pub 2023. PMID: 36856617.
Amaria RN, Postow M, Burton EM, Tetzlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Author Correction: Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 615(7953):E23, 2023. e-Pub 2023. PMID: 36894629.
Rothrock AT, Hameed N, Cho WC, Nagarajan P, Ivan D, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. BRAF V600E immunohistochemistry as a useful tool in the diagnosis of melanomas with ambiguous morphologies and immunophenotypes. J Cutan Pathol 50(3):223-229, 2023. e-Pub 2023. PMID: 36377266.
Holloman AM, Berg MP, Bryant B, Dixon LR, George MR, Karp JK, Knollmann-Ritschel BE, Prieto VG, Timmons CF, Childs JM, Lofgreen A, Johnson K, McCloskey CB. Experiential exposure as the key to recruiting medical students into pathology. Acad Pathol 10(2):100074, 2023. e-Pub 2023. PMID: 37124363.
McCloskey CB, Brissette M, Childs JM, Lofgreen A, Johnson K, George MR, Holloman AM, Bryant B, Berg MP, Dixon LR, Karp JK, Knollmann-Ritschel BEC, Prieto VG, Timmons CF, Hoffman RD. How influential are medical school curriculum and other medical school characteristics in students' selecting pathology as a specialty?. Acad Pathol 10(2):100073, 2023. e-Pub 2023. PMID: 37124364.
Cho WC, Nagarajan P, Ding Q, Prieto VG, Torres-Cabala CA. Trichorhinophalangeal Syndrome Type 1-Positive Cells in Breast Dermal Granulation Tissues and Scars. Am J Dermatopathol 44(12):964-967, 2022. e-Pub 2022. PMID: 35925150.
Prieto VG, Vollmer RT, Shea CR. Use of modifying phrases in surgical pathology reports. Virchows Arch 481(5):759-766, 2022. e-Pub 2022. PMID: 36098817.
Amaria RN, Postow M, Burton EM, Tezlaff MT, Ross MI, Torres-Cabala C, Glitza IC, Duan F, Milton DR, Busam K, Simpson L, McQuade JL, Wong MK, Gershenwald JE, Lee JE, Goepfert RP, Keung EZ, Fisher SB, Betof-Warner A, Shoushtari AN, Callahan M, Coit D, Bartlett EK, Bello D, Momtaz P, Nicholas C, Gu A, Zhang X, Korivi BR, Patnana M, Patel SP, Diab A, Lucci A, Prieto VG, Davies MA, Allison JP, Sharma P, Wargo JA, Ariyan C, Tawbi HA. Neoadjuvant relatlimab and nivolumab in resectable melanoma. Nature 611(7934):155-160, 2022. e-Pub 2022. PMID: 36289334.
Rothrock AT, Torres-Cabala CA, Milton DR, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Ivan D, Prieto VG, Aung PP. Diagnostic utility of PRAME expression by immunohistochemistry in subungual and non-subungual acral melanocytic lesions. J Cutan Pathol 49(10):859-867, 2022. e-Pub 2022. PMID: 35794643.
Rothrock AT, Truong LD, Shehabeldin A, Wong MKK, Cho WC, Nagarajan P, Vanderbeck K, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Amyloid deposition with a granulomatous reaction in a resection specimen. J Cutan Pathol 49(9):787-790, 2022. e-Pub 2022. PMID: 35734844.
Farah M, Milton DR, Gross ND, Nagarajan P, Gu J, Curry JL, Ivan D, Torres-Cabala CA, Myers JN, Prieto VG, Aung PP. Histopathologic features predictive of metastasis and survival in 230 patients with cutaneous squamous cell carcinoma of the head and neck and non-head and neck locations. J Eur Acad Dermatol Venereol 36(8):1246-1255, 2022. e-Pub 2022. PMID: 35426183.
Bartley BR, Huen A, Rady PL, Tyring SK, Nagarajan P, Aung PP, Curry JL, Ivan D, Torres-Cabala CA, Prieto VG, Cho WC. Eosinophilic homogeneous intracytoplasmic inclusion bodies. J Cutan Pathol 49(7):658-662, 2022. e-Pub 2022. PMID: 35262953.
Wilmas, K, Aria, AB, Landis, LN, Arudra, SC, Prieto, VG, Duvic, M. CD4/CD8 double-negative mycosis fungoides with large cell transformation and involvement of the lungs and leptomeninges. Dermatol Online J 28(2), 2022. e-Pub 2022. PMID: 35670681.
Aung PP, Wimmer DB, Lester TR, Tetzlaff MT, Prieto VG. Perianal condylomata lata mimicking carcinoma. J Cutan Pathol 49(3):209-214, 2022. e-Pub 2021. PMID: 33470447.
Cho WC, Gill P, Nagarajan P, Aung PP, Torres-Cabala CA, Curry JL, Ivan D, Lester L, Prieto VG. Cutaneous Lymphoid Hyperplasia with T-Cell Clonality and Monotypic Plasma Cells Secondary to a Tick Bite. Am J Dermatopathol 44(3):226-229, 2022. e-Pub 2022. PMID: 35050559.
Fung MA, Vidal CI, Armbrecht EA, Andea AA, Cassarino DS, Comfere NI, Emanuel PO, Ferringer T, Hristov AC, Kim J, Lauer SR, Linos K, Missall TA, Motaparthi K, Novoa RA, Patel R, Shalin SC, Sundram U, Calame A, Bennett DD, Duncan LM, Elston DM, Hosler GA, Hurley YM, Lazar AJ, Lowe L, Messina J, Myles J, Plaza JA, Prieto VG, Reddy V, Schaffer A, Subtil A. Appropriate use criteria for ancillary diagnostic testing in dermatopathology. J Cutan Pathol 49(3):231-245, 2022. e-Pub 2021. PMID: 34536035.
Wang J, Wang WL, Sun H, Huo L, Wu Y, Chen H, Gan Q, Meis JM, Maloney N, Lazar AJ, Yoon EC, Albarracin CT, Krishnamurthy S, Middleton LP, Resetkova E, Yu W, Tan D, Lu W, Solis Soto LM, Wang S, Wistuba II, Parwani AV, Prieto VG, Sahin AA, Li Z, Ding Q. Expression of TRPS1 in phyllodes tumor and sarcoma of the breast. Hum Pathol 121:73-80, 2022. e-Pub 2022. PMID: 35063444.
George MR, Johnson KA, Berg MP, Bryant BH, Childs JM, Dixon LR, Holloman A, Karp JK, Knollmann-Ritschel B, Lofgreen A, Prieto VG, Timmons CF, McCloskey CB. Factors influencing US osteopathic medical students to choose pathology as a specialty. Acad Pathol 9(1):100034, 2022. e-Pub 2022. PMID: 35722042.
Ronen S, Al-Rohil RN, Keiser E, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Middleton LP, Torres-Cabala CA, Gershenwald JE, Aung PP, Prieto VG. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management. Arch Pathol Lab Med 145(12):1505-1515, 2021. e-Pub 2021. PMID: 33577643.
Gill P, Prieto VG, Austin MT, Giubellino A, Torres-Cabala CA. Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi. J Cutan Pathol 48(11):1410-1415, 2021. e-Pub 2021. PMID: 34164835.
Wang M, Aung PP, Prieto VG. Standardized Method for Defining a 1-mm2 Region of Interest for Calculation of Mitotic Rate on Melanoma Whole Slide Images. Arch Pathol Lab Med 145(10):1255-1263, 2021. e-Pub 2021. PMID: 33417687.
Cho WC, Gill P, Aung PP, Gu J, Nagarajan P, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. The utility of digital pathology in improving the diagnostic skills of pathology trainees in commonly encountered pigmented cutaneous lesions during the COVID-19 pandemic. Ann Diagn Pathol 54:151807, 2021. e-Pub 2021. PMID: 34418768.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Nagarajan P, Curry JL, Ciurea AM, Rubin AI, Hwu WJ, Prieto VG, Aung PP. Prognostic Significance of Subungual Anatomic Site in Acral Lentiginous Melanoma. Arch Pathol Lab Med 145(8):943-952, 2021. e-Pub 2020. PMID: 33290520.
Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?. Virchows Arch 479(2):377-383, 2021. e-Pub 2021. PMID: 33604757.
Cho WC, Wang WL, Milton DR, Ingram DR, Nagarajan P, Curry JL, Ivan D, Lazar AJ, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Telomerase Reverse Transcriptase Protein Expression Is More Frequent in Acral Lentiginous Melanoma Than in Other Types of Cutaneous Melanoma. Arch Pathol Lab Med 145(7):842-850, 2021. e-Pub 2020. PMID: 33053175.
Gill P, Cho WC, Prieto VG, Nagarajan P. Metaplasia mimicking malignancy: A challenging case of florid eccrine squamous syringometaplasia. J Cutan Pathol 48(7):995-998, 2021. e-Pub 2021. PMID: 33749861.
Ronen S, Suster D, Chen WS, Ronen N, Arudra SKC, Trinidad C, Ivan D, Prieto VG, Suster S. Histologic Patterns of Cutaneous Metastases of Breast Carcinoma. Am J Dermatopathol 43(6):401-411, 2021. e-Pub 2021. PMID: 34006731.
Sweeney KJ, Tetzlaff MT, Vega F, Gillenwater A, Zuo Z, Gross N, Nagarajan P, Wargo J, Nelson K, Prieto VG, Torres-Cabala CA, Curry JL. Tertiary lymphoid structures with overlapping histopathologic features of cutaneous marginal zone lymphoma during neoadjuvant cemiplimab therapy are associated with antitumor response. J Cutan Pathol 48(5):674-679, 2021. e-Pub 2021. PMID: 33399228.
Saberian, C, Amaria, RN, Najjar, AM, Radvanyi, L, Haymaker, CL, Forget, MA, Bassett Jr, R, Faria, SC, Glitza, IC, Alvarez, EF, Parshottam, SR, Prieto, V, Lizee, GA, Wong, MK, McQuade, JL, Diab, A, Yee, C, Tawbi, H, Patel, SP, Shpall, E, Davies, MA, Hwu, P, Bernatchez, C. Randomized phase II trial of lymphodepletion plus adoptive cell transfer of tumor-infiltrating lymphocytes, with or without dendritic cell vaccination, in patients with metastatic melanoma. J Immunother Cancer 9(5):e002449, 2021. e-Pub 2021. PMID: 34021033.
Ai D, Yao J, Yang F, Huo L, Chen H, Lu W, Soto LMS, Jiang M, Raso MG, Wang S, Bell D, Liu J, Wang H, Tan D, Torres-Cabala C, Gan Q, Wu Y, Albarracin C, Hung MC, Meric-Bernstam F, Wistuba II, Prieto VG, Sahin AA, Ding Q. TRPS1. Mod Pathol 34(4):710-719, 2021. e-Pub 2020. PMID: 33011748.
Ronen S, Keiser E, Collins KM, Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Hymes S, Medeiros LJ, Torres-Cabala CA. Langerhans cell sarcoma involving skin and showing epidermotropism: a comprehensive review. J Cutan Pathol 48(4):547-557, 2021. e-Pub 2020. PMID: 32644218.
Kwon D, Ronen S, Giubellino A, Keiser E, Aung PP, Nagarajan P, Tetzlaff MT, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Cutaneous Adnexal Carcinosarcoma: Immunohistochemical and Molecular Evidence of Epithelial Mesenchymal Transition. J Cutan Pathol 48(4):526-534, 2021. e-Pub 2020. PMID: 32564423.
Cohen PR, Prieto VG, Kurzrock R. Tumor Lysis Syndrome: Introduction of a Cutaneous Variant and a New Classification System. Cureus 13(3):e13816, 2021. e-Pub 2021. PMID: 33859885.
Jebain J, Jr AS, Gill P, Prieto VG, Tyring SK. Recurrence of mucosal melanoma in Li-Fraumeni syndrome: A follow-up of an index case. JAAD Case Rep 10:31-33, 2021. e-Pub 2021. PMID: 33732843.
Hong BY, Ford JR, Glitza IC, Torres Cabala CA, Tetzlaff M, Prieto VG, Parker R, Daniel C, Esmaeli B. Immune Checkpoint Inhibitor Therapy as an Eye-Preserving Treatment for Locally Advanced Conjunctival Melanoma. Ophthalmic Plast Reconstr Surg 37(1):e9-e13, 2021. e-Pub 2021. PMID: 32618825.
Roy M, Teshome M, Damodaran S, Sahin AA, Khazai L, Arribas E, Candelaria RP, Scoggins ME, Lane DL, Giordano SH, Albarracin CT, Prieto VG, Nagarajan P. Male Mammary Paget Disease: A Tale of 2 Contrasting Cases. Am J Dermatopathol 42(12):981-985, 2020. e-Pub 2020. PMID: 33289978.
Collins K, Prieto VG, Aung PP. Unusual Presentations of Primary and Metastatic Adenoid Cystic Carcinoma Involving the Skin. Am J Dermatopathol 42(12):967-71, 2020. e-Pub 2020. PMID: 32618709.
Farah M, Reuben A, Spassova I, Yang RK, Kubat L, Nagarajan P, Ning J, Li W, Aung PP, Curry JL, Torres-Cabala CA, Hudgens CW, Ugurel S, Schadendorf D, Gumbs C, Little LD, Futreal A, Wistuba II, Prieto VG, Wang L, Wong MK, Wargo JA, Becker JC, Tetzlaff MT. T Cell Repertoire in combination with T cell density predicts clinical outcomes in patients with merkel cell carcinoma. J Invest Dermatol 140(11):2146-2156.e4, 2020. e-Pub 2020. PMID: 32304704.
Aung PP, Pemmaraju N, Torres-Cabala CA, Duvic M, Konopleva M, Khoury JD, Prieto VG. Apparent partial loss of CD123 expression in blastic plasmacytoid dendritic cell neoplasm after treatment with CD123-targeted therapy: A novel finding and possible diagnostic pitfall. J Dermatol 47(10):e354-e355, 2020. e-Pub 2020. PMID: 32770556.
Gonzàlez-Farré M, Ronen S, Keiser E, Prieto VG, Aung PP. Three Types of Nodal Melanocytic Nevi in Sentinel Lymph Nodes of Patients With Melanoma: Pitfalls, Immunohistochemistry, and a Review of the Literature. Am J Dermatopathol 42(10):739-744, 2020. e-Pub 2020. PMID: 32271206.
Marques-Piubelli ML, Tetzlaff MT, Nagarajan P, Duke TC, Glitza Oliva IC, Ledesma DA, Aung PP, Torres-Cabala CA, Wistuba II, Prieto VG, Nelson KC, Curry JL. Hypertrophic lichenoid dermatitis immune-related adverse event during combined immune checkpoint and exportin inhibitor therapy: A diagnostic pitfall for superficially invasive squamous cell carcinoma. J Cutan Pathol, 2020. e-Pub 2020. PMID: 32394425.
Ramani NS, Aung PP, Gu J, Sfamenos S, Sdringola-Maranga C, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Diab A, Prieto VG, Hwu WJ, Torres-Cabala CA. TERT amplification but not activation of canonical Wnt/β-catenin pathway is involved in acral lentiginous melanoma progression to metastasis. Mod Pathol 33(10):2067-2074, 2020. e-Pub 2020. PMID: 32404956.
Clarke LE, Mabey B, Flake Ii DD, Meek S, Cassarino DS, Duncan LM, High WA, Napekoski KM, Prieto VG, Tetzlaff MT, Vitale P, Elder DE. Clinical validity of a gene expression signature in diagnostically uncertain neoplasms. Per Med 17(5):361-371, 2020. e-Pub 2020. PMID: 32915688.
Ronen S, Prieto VG, Aung PP. Epithelioid Angioleiomyoma Mimicking Metastatic Melanoma in a Liver Tumor. J Cutan Pathol 47(9):824-828, 2020. e-Pub 2020. PMID: 32274822.
Altinmakas E, Perrier ND, Grubbs EG, Lee JE, Prieto VG, Ng CS. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma. Acta Radiol 61(8):284185119889568, 2020. e-Pub 2020. PMID: 31791129.
Vougiouklakis T, Aung PP, Vasudevaraja V, Prieto VG, Torres-Cabala CA, Sulman EP, Snuderl M, Jour G. Correlative study of epigenetic regulation of tumor microenvironment in spindle cell melanomas and cutaneous malignant peripheral nerve sheath tumors. Sci Rep 10(1):12996, 2020. e-Pub 2020. PMID: 32747660.
Ziemba YC, Razzano D, Allen TC, Booth AL, Anderson SR, Champeaux A, Feldman MD, Fitzhugh V, Gittens S, Grider M, Gupta M, Hanos C, Kelly K, Kothari T, Laudadio J, Lin AY, Mirza KM, Montone KT, Prieto VG, Remick DG, Riddle ND, Schubert M, Suskie K, Zafar N, Robboy SJ, Markwood PS. Social Media Engagement at Academic Conferences: Report of the Association of Pathology Chairs 2018 and 2019 Annual Meeting Social Media Committee. Acad Pathol 7:2374289520934019, 2020. e-Pub 2020. PMID: 32733989.
Farah M, Nelson KC, Tetzlaff MT, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL, Aung PP. Lichen planus related to transforming growth factor beta inhibitor in a patient with metastatic chondrosarcoma: a case report. J Cutan Pathol 47(5):490-493, 2020. e-Pub 2020. PMID: 31930527.
Chen PL, Neishaboori N, Tetzlaff MT, Chen WS, Aung PP, Curry JL, Nagarajan P, Ivan D, Hwu WJ, Prieto VG, Torres-Cabala CA. BAP-1 Expression Status by Immunohistochemistry in Cellular Blue Nevus and Blue Nevus-like Melanoma. Am J Dermatopathol 42(5):313-321, 2020. e-Pub 2020. PMID: 32310893.
Yildiz P, Aung PP, Milton DR, Hruska C, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala C, Prieto VG. Measurement of Tumor Thickness in Cutaneous Squamous Cell Carcinomas: Do the Different Methods Provide Better Prognostic Data?. Am J Dermatopathol 42(5):337-342, 2020. e-Pub 2020. PMID: 31464719.
Shyu I, Johnson KA, George MR, Gratzinger D, Brissette MD, Childs JM, Conran RM, Dixon LR, McCloskey CB, Prieto VG, Roberts CA, Rojiani AM, Timmons CF, Hoffman RD. Gender Parity in Gainful Employment and Other Gender Trends in the Job Market for Recent Pathology Graduates. Arch Pathol Lab Med 144(4):435-442, 2020. e-Pub 2020. PMID: 31816267.
Nagarajan P, Piao J, Ning J, Noordenbos LE, Curry JL, Torres-Cabala CA, Diwan AH, Ivan D, Aung PP, Ross MI, Royal RE, Wargo JA, Wang WL, Samdani R, Lazar AJ, Rashid A, Davies MA, Prieto VG, Gershenwald JE, Tetzlaff MT. Prognostic model for patient survival in primary anorectal mucosal melanoma: stage at presentation determines relevance of histopathologic features. Mod Pathol 33(3):496-513, 2020. e-Pub 2020. PMID: 31383963.
Timmons CF, Black-Schaffer WS, Naritoku WY, Powell SZ, Johnson KA, Brissette MD, Childs JM, Conran RM, Dixon LR, George MR, Gratzinger D, McCloskey CB, Prieto VG, Roberts CA, Rojiani AM, Shyu I, Hoffman RD. Entry of Graduates of US Pathology Residency Programs Into the Workforce: Cohort Data Between 2008 and 2016 Remain Positive and Stable. Acad Pathol 7:2374289520901833, 2020. e-Pub 2020. PMID: 32083168.
Mejbel HA, Nelson KC, Pradhan D, Ivan D, Zaleski M, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Prieto VG, Aung PP. Cutaneous neoplasms composed of melanoma and carcinoma: A rare but important diagnostic pitfall and review of the literature. J Cutan Pathol 47(1):36-46, 2020. e-Pub 2020. PMID: 31361351.
Pradhan D, Jour G, Milton D, Vasudevaraja V, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Long L, Ding Y, Ezhilarasan R, Sulman EP, Diab A, Hwu WJ, Prieto VG, Torres-Cabala CA, Aung PP. Aberrant DNA Methylation Predicts Melanoma-Specific Survival in Patients with Acral Melanoma. Cancers (Basel) 11(12):2031, 2019. e-Pub 2019. PMID: 31888295.
Esmaeli B, Rubin ML, Xu S, Goepfert RP, Curry JL, Prieto VG, Ning J, Tetzlaff MT. Greater Tumor Thickness, Ulceration, and Positive Sentinel Lymph Node Are Associated With Worse Prognosis in Patients With Conjunctival Melanoma: Implications for Future AJCC Classifications. Am J Surg Pathol 43(12):1701-1710, 2019. e-Pub 2019. PMID: 31425167.
Namikawa K, Aung PP, Milton DR, Tetzlaff MT, Torres-Cabala CA, Curry JL, Nagarajan P, Ivan D, Ross M, Gershenwald JE, Prieto VG. Correlation of Tumor Burden in Sentinel Lymph Nodes with Tumor Burden in Nonsentinel Lymph Nodes and Survival in Cutaneous Melanoma. Clin Cancer Res 25(24):7585-7593, 2019. e-Pub 2019. PMID: 31570567.
Yildiz P, Ronen S, Aung PP, Trinidad C, Kajoian A, Prieto VG. Extramammary Paget Disease-A Challenging Case. Am J Dermatopathol 41(11):867-868, 2019. e-Pub 2019. PMID: 30807292.
Tetzlaff MT, Tang S, Duke T, Grabell DA, Cabanillas ME, Zuo Z, Yao JC, Nagarajan P, Aung PP, Torres-Cabala CA, Duvic M, Prieto VG, Huen A, Curry JL. Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features. J Cutan Pathol 46(11):872-877, 2019. e-Pub 2019. PMID: 31254410.
Fang S, Xu T, Xiong M, Zhou X, Wang Y, Haydu LE, Ross MI, Gershenwald JE, Prieto VG, Cormier JN, Wargo J, Sui D, Wei Q, Amos CI, Lee JE. Role of Immune Response, Inflammation, and Tumor Immune Response-Related Cytokines/Chemokines in Melanoma Progression. J Invest Dermatol 139(11):2352-2358.e3, 2019. e-Pub 2019. PMID: 31176707.
Bell D, Bell AH, Kupferman ME, Prieto VG, Weber RS, Hanna EY. Comparative transcriptome analysis of sinonasal inverted papilloma and associated squamous cell carcinoma: Out-HOXing developmental genes. Head Neck 41(9):3090-3104, 2019. e-Pub 2019. PMID: 31041828.
Curry JL, Reuben A, Szczepaniak-Sloane R, Ning J, Milton DR, Lee CH, Hudgens C, George S, Torres-Cabala C, Johnson D, Subramanya S, Wargo JA, Mudaliar K, Wistuba II, Prieto VG, Diab A, Tetzlaff MT. Gene expression profiling of lichenoid dermatitis immune-related adverse event from immune checkpoint inhibitors reveals increased CD14+ and CD16+ monocytes driving an innate immune response. J Cutan Pathol 46(9):627-636, 2019. e-Pub 2019. PMID: 30883858.
Mauzo SH, Tetzlaff MT, Nelson K, Amaria R, Patel S, Aung PP, Nagarajan P, Torres-Cabala CA, Diab A, Prieto VG, Curry JL. Regressed melanocytic nevi secondary to pembrolizumab therapy: an emerging melanocytic dermatologic effect from immune checkpoint antibody blockade. Int J Dermatol, 2019. e-Pub 2017. PMID: 29152725.
Ibarra BS, Huen A, Nagarajan P, Torres-Cabala CA, Prieto VG, Aung PP. From mycosis fungoides to herpetic folliculitis: The significance of deeper H&E tissue sections in dermatopathology. J Cutan Pathol 46(8):624-626, 2019. e-Pub 2019. PMID: 30883857.
Bell AH, Prieto VG, Ferrarotto R, Goepfert RP, Myers JN, Weber R, Bell D. Magnifying glass on spiradenoma and cylindroma histogenesis and tumorigenesis using systematic transcriptome analysis. Ann Diagn Pathol 41:14-23, 2019. e-Pub 2019. PMID: 31128548.
Malke JC, Jin S, Sp C, Lari, Kell T, Simon JM, Prieto VG, Gershenwald JE, Haydu LE. Enhancing Case Capture, Quality, and Completeness of Primary Melanoma Pathology Records via Natural Language Processing:1-11, 2019. e-Pub 2019. PMID: 31442076.
Ruis, SJ, Al Salihi S, Prieto VG, Priyadharsin N, Tetzlaff MT, Curry JL, Ivan D, Torres-Cabala CA, Aung PA. Unusual cutanous metastatic carcinoma. Annals of Diagnostic Pathology(43), 2019. e-Pub 2019. PMID: 31675677.
Salihi A, Mejbel Haider A, Prieto VG, Aung Phyu P. Common cutaneous neoplasms in patients with immunodeficiency: A case series. Journal of Immunotherapy and Precision Oncology 2(3):79-84, 2019. e-Pub 2019.
Aung PP, Parra ER, Barua S, Sui D, Ning J, Mino B, Ledesma DA, Curry JL, Nagarajan P, Torres-Cabala CA, Efstathiou E, Hoang AG, Wong MK, Wargo JA, Lazar AJ, Rao A, Prieto VG, Wistuba I, Tetzlaff MT. B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clin Cancer Res 25(11):3455-67, 2019. e-Pub 2019. PMID: 30808776.
Aung PP, Nagarajan P, Tetzlaff MT, Curry JL, Tang G, Abdullaev Z, Pack SD, Ivan D, Prieto VG, Torres-Cabala CA. Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case Series. Am J Dermatopathol 41(3):167-179, 2019. e-Pub 2019. PMID: 30801340.
Jour G, Vasudevaraja V, Prieto VG, Snuderl M, Torres-Cabala CA, Al-Rohil R, Sulman EP, Ballester LY, Aung PP. BCAT1 and miR-2504: novel methylome signature distinguishes spindle/desmoplastic melanoma from superficial malignant peripheral nerve sheath tumor. Mod Pathol 32(3):338-345, 2019. e-Pub 2019. PMID: 30310175.
Tetzlaff MT, Curry JL, Ning J, Sagiv O, Kandl TL, Peng B, Bell D, Routbort M, Hudgens CW, Ivan D, Kim TB, Chen K, Eterovic AK, Shaw K, Prieto VG, Yemelyanova A, Esmaeli B. Distinct Biological Types of Ocular Adnexal Sebaceous Carcinoma: HPV-Driven and Virus-Negative Tumors Arise through Nonoverlapping Molecular-Genetic Alterations. Clin Cancer Res 25(4):1280-1290, 2019. e-Pub 2018. PMID: 30420449.
Farah M, Nagarajan P, Curry JL, Tang Z, Kim TB, Aung PP, Torres-Cabala CA, Eterovic AK, Wargo JA, Prieto VG, Tetzlaff MT. Spitzoid melanoma with histopathologic features of ALK gene rearrangement exhibiting ALK copy number gain: A novel mechanism of ALK activation in spitzoid neoplasia. Br J Dermatol 180(2):404-8, 2019. e-Pub 2018. PMID: 29897634.
Fedda F, Migden MR, Curry JL, Torres-Cabala CA, Tetzlaff MT, Aung PP, Prieto VG, Ivan D, Myers JN, Nagarajan P. Angiotropism in recurrent cutaneous squamous cell carcinoma: Implications for regional tumor recurrence and extravascular migratory spread. J Cutan Pathol 46(2):152-158, 2019. e-Pub 2019. PMID: 30414196.
Konopinski JC, Danialan R, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Curry JL, Ivan D, Prieto VG, Aung PP. Melanoma coexisting with solar elastosis: a potential pitfall in the differential diagnosis between nevus and melanoma. Hum Pathol 84:270-274, 2019. e-Pub 2019. PMID: 30359637.
Members TF, Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Hurley MY, Panel R, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Appropriate Use Criteria in Dermatopathology: Initial Recommendations from the American Society of Dermatopathology. J Am Acad Dermatol 80(1):189-207.e11, 2019. e-Pub 2019. PMID: 29689323.
Amaria RN, Reddy SM, Tawbi HA, Davies MA, Ross MI, Glitza IC, Cormier JN, Lewis C, Hwu WJ, Hanna E, Diab A, Wong MK, Royal R, Gross N, Weber R, Lai SY, Ehlers R, Blando J, Milton DR, Woodman S, Kageyama R, Wells DK, Hwu P, Patel SP, Lucci A, Hessel A, Lee JE, Gershenwald J, Simpson L, Burton EM, Posada L, Haydu L, Wang L, Zhang S, Lazar AJ, Hudgens CW, Gopalakrishnan V, Reuben A, Andrews MC, Spencer CN, Prieto V, Sharma P, Allison J, Tetzlaff MT, Wargo JA. Publisher Correction: Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma. Nat Med 24(12):1942, 2018. e-Pub 2018. PMID: 30361511.
Bell A, Bell D, Chakravarti N, Ma J, Henton N, Prieto VG. Detection of a MicroRNA molecular signature of ultraviolet radiation in the superficial regions of melanocytic nevi on sun-exposed skin. Mod Pathol 31(11):1744-1755, 2018. e-Pub 2018. PMID: 29955145.
Chen WS, Tetzlaff MT, Diwan H, Jahan-Tigh R, Diab A, Nelson K, Glitza IC, Kaunitz GJ, Johnson D, Torres-Cabala C, Pacha O, Taube JM, Maloney K, Prieto VG, Curry JL. Suprabasal acantholytic dermatologic toxicities associated checkpoint inhibitor therapy: A spectrum of immune reactions from paraneoplastic pemphigus-like to Grover-like lesions. J Cutan Pathol 45(10):764-773, 2018. e-Pub 2018. PMID: 29943453.
Arudra K, Patel R, Tetzlaff MT, Hymes S, Subbiah V, Meric-Bernstam F, Torres-Cabala C, Aung PP, Nagarajan P, Diab A, Prieto VG, Nelson K, Curry JL. Calcinosis cutis dermatologic toxicity associated with fibroblast growth factor receptor inhibitor for the treatment of Wilms tumor. J Cutan Pathol 45(10):786-790, 2018. e-Pub 2018. PMID: 30021048.
Middleton LP, Phipps R, Routbort M, Prieto VG, Medeiros LJ, Riben M, Contreras A, Kelley J, Patel K, Bingham J, Wagar EA. Fifteen-Year Journey to High Reliability in Pathology and Laboratory Medicine. Am J Med Qual 33(5):530-539, 2018. e-Pub 2018. PMID: 29512395.
Tetzlaff MT, Messina JL, Stein JE, Xu X, Amaria RN, Blank CU, van de Wiel BA, Ferguson PM, Rawson RV, Ross MI, Spillane AJ, Gershenwald JE, Saw RPM, van Akkooi ACJ, van Houdt WJ, Mitchell TC, Menzies AM, Long GV, Wargo JA, Davies MA, Prieto VG, Taube JM, Scolyer RA. Pathological assessment of resection specimens after neoadjuvant therapy for metastatic melanoma. Ann Oncol 29(8):1861-1868, 2018. e-Pub 2018. PMID: 29945191.
Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier ND, Lee JE, Prieto VG, Hobbs BP. Utility of Intermediate-Delay Washout CT Images for Differentiation of Malignant and Benign Adrenal Lesions: A Multivariate Analysis. AJR Am J Roentgenol 211(2):W109-W115, 2018. e-Pub 2018. PMID: 29949418.
AUC Task Force AUC, Vidal CI, Armbrect EA, Andea AA, Bohlke AK, Comfere NI, Hughes SR, Kim J, Kozel JA, Lee JB, Linos K, Litzner BR, Missall TA, Novoa RA, Sundram U, Swick BL, Yadira Hurley M, Panel R, Alam M, Argenyi Z, Duncan LM, Elston DM, Emanuel PO, Ferringer T, Fung MA, Hosler GA, Lazar AJ, Lowe L, Plaza JA, Prieto VG, Robinson JK, Schaffer A, Subtil A, Wang WL. Appropriate Use Criteria in Dermatopathology: Initial Recommendations from the American Society of Dermatopathology. J Cutan Pathol 45(8):563-80, 2018. e-Pub 2018. PMID: 29566273.
Al-Rohil RN, Milton DR, Nagarajan P, Curry JL, Feldmeyer L, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Intratumoral and Peritumoral Lymphovascular Invasion Detected by D2-40 Immunohistochemistry Correlates with Metastasis in Primary Cutaneous Merkel Cell Carcinoma. Hum Pathol 77:98-107, 2018. e-Pub 2018. PMID: 29601841.
Trinidad C, Nelson KC, Glitza Oliva IC, Torres-Cabala CA, Nagarajan P, Tetzlaff MT, Ivan D, Hwu WJ, Prieto VG, Curry JL, Aung PP. Dermatologic Toxicity from Immune Checkpoint Blockade Therapy with an Interstitial Granulomatous Pattern. J Cutan Pathol, 2018. e-Pub 2018. PMID: 29633300.
Farah M, Nagarajan P, Torres-Cabala CA, Curry JL, Amaria RN, Wargo J, Tawbi H, Ivan D, Prieto VG, Tetzlaff MT, Aung PP. Metastatic melanoma with balloon/histiocytoid cytomorphology after treatment with immunotherapy: A histologic mimic and diagnostic pitfall. J Cutan Pathol 45(7):545-49, 2018. e-Pub 2018. PMID: 29672900.
Dolkar T, Trinidad CM, Nelson KC, Amaria RN, Nagarajan P, Torres-Cabala CA, Ivan D, Prieto VG, Tetzlaff MT, Curry JL, Aung PP. Dermatologic Toxicity from Novel Therapy using Antimicrobial Peptide LL-37 in Melanoma: A Detailed Examination of the Clinicopathologic Features. J Cutan Pathol 45(7):539-44, 2018. e-Pub 2018. PMID: 29665030.
Mauzo SH, Milton DR, Prieto VG, Torres-Cabala CA, Wang WL, Chakravarti N, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Brown RE, Aung PP. Summary of expression of SPARC protein in cutaneous vascular neoplasms and mimickers. Ann Diagn Pathol 34:151-154, 2018. e-Pub 2018. PMID: 29660567.
Buchely N, Al-Rohil RN, Aung PP, Jour G, Torres-Cabala C, Prieto VG, Ivan D. Dermal xanthomatous infiltrates after brentuximab vedotin therapy in mycosis fungoides with large-cell transformation: A novel histologic finding. J Cutan Pathol. e-Pub 2018. PMID: 29806104.
Ng CS, Wei W, Altinmakas E, Li X, Ghosh P, Perrier NA, Grubbs E, Prieto VG, Lee JE, Hobbs BP. Differentiation of Malignant and Benign Adrenal Lesions With Delayed CT: Multivariate Analysis and Predictive Models. AJR Am J Roentgenol 210(4):W156-W163, 2018. e-Pub 2018. PMID: 29412015.
Bell AH, DeMonte F, Raza SM, Rhines LD, Tatsui CE, Prieto VG, Fuller GN, Bell D. Transcriptome comparison identifies potential biomarkers of spine and skull base chordomas. Virchows Arch, 2018. e-Pub 2017. PMID: 28844110.
Namikawa K, Aung PP, Gershenwald JE, Milton DR, Prieto VG. Clinical impact of ulceration width, lymphovascular invasion, microscopic satellitosis, perineural invasion, and mitotic rate in patients undergoing sentinel lymph node biopsy for cutaneous melanoma: a retrospective observational study at a comprehensive cancer center. Cancer Med 7(3):583-593, 2018. e-Pub 2018. PMID: 29464914.
Saenz-Ibarra B, Prieto VG, Torres-Cabala CA, Huen A, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Coccidioidomycosis Involving Lungs and Skin: A Mimicker of Metastatic Disease. Am J Dermatopathol 40(3):e41-e43, 2018. e-Pub 2017. PMID: 28857979.
Tetzlaff MT, Nelson KC, Diab A, Staerkel GA, Nagarajan P, Torres-Cabala CA, Chasen BA, Wargo JA, Prieto VG, Amaria RN, Curry JL. Granulomatous/sarcoid-like lesions associated with checkpoint inhibitors: a marker of therapy response in a subset of melanoma patients. J Immunother Cancer 6(1):14, 2018. e-Pub 2018. PMID: 29433571.
Khoury JD, Wang WL, Prieto VG, Medeiros LJ, Kalhor N, Hameed M, Broaddus R, Hamilton SR. Validation of Immunohistochemical Assays for Integral Biomarkers in the NCI-MATCH EAY131 Clinical Trial. Clin Cancer Res, 2018. e-Pub 2017. PMID: 28839110.
Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA. Differential expression of CCR4 in primary cutaneous gamma/delta (γ/δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy. J Dermatol Sci 89(1):88-91, 2018. e-Pub 2018. PMID: 29030090.
Jour G, Andeen NK, Al-Rohil R, Aung PP, Mehrotra M, Duose D, Hoch B, Argenyi Z, Luthra R, Wistuba II, Prieto VG. Novel enriched pathways in superficial malignant peripheral nerve sheath tumours and spindle/desmoplastic melanomas. J Pathol 244(1):97-106, 2018. e-Pub 2018. PMID: 28991373.
Boddu P, Chen PL, Nagarajan P, Prieto VG, Won A, Chambers M, Kornblau S. Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure. J Oral Maxillofac Surg Med Pathol 30(1):50-54, 2018. e-Pub 2018. PMID: 29404266.
Saluja K, Thomas J, Zhang S, Sturgis EM, Jain KS, Prieto VG, El-Naggar AK, Bell D. Malignant perivascular epithelioid cell tumor of the oropharynx with strong TFE3 expression mimicking alveolar soft part sarcoma: a case report and review of the literature. Hum Pathol 76:149-155. e-Pub 2017. PMID: 29208563.
Loghavi S, Curry JL, Garcia-Manero G, Patel KP, Xu J, Khoury JD, Torres-Cabala CA, Nagarajan P, Aung PP, Gibson BR, Goodwin BP, Kelly BC, Korivi BR, Medeiros LJ, Prieto VG, Kantarjian HM, Bueso-Ramos CE, Tetzlaff MT. Chronic myelomonocytic leukemia masquerading as cutaneous indeterminate dendritic cell tumor: expanding the spectrum of skin lesions in chronic myelomonocytic leukemia. J Cutan Pathol, 2017. e-Pub 2017. PMID: 28885734.
Tetzlaff MT, Jazaeri AA, Torres-Cabala CA, Korivi BR, Landon GA, Nagarajan P, Choksi A, Chen L, Uemura M, Aung PP, Diab A, Sharma P, Davies MA, Amaria R, Prieto VG, Curry JL. Erythema nodosum-like panniculitis mimicking disease recurrence: A novel toxicity from immune checkpoint blockade therapy-Report of 2 patients. J Cutan Pathol 44(12):1080-1086, 2017. e-Pub 2017. PMID: 28901560.
Ramani N, Aung PP, Hwu WJ, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Prieto VG, Torres-Cabala CA. Aberrant Expression of FLI-1 in Melanoma. J Cutan Pathol 44(9):790-93, 2017. e-Pub 2017. PMID: 28605142.
Leon-Castillo A, Chrisinger JSA, Panse G, Samdani RT, Ingram DR, Ravi V, Prieto VG, Wang WL, Lazar AJ. Index report of cutaneous angiosarcomas with strong positivity for tyrosinase mimicking melanoma with further evaluation of melanocytic markers in a large angiosarcoma series. J Cutan Pathol 44(8):692-697, 2017. e-Pub 2017. PMID: 28556023.
Erstine EM, Tetzlaff MT, Ko JS, Prieto VG, Cheah AL, Billings SD. Living on the Edge: Diagnosing Sarcomatoid Melanoma Using Histopathologic Cues at the Edge of a Dedifferentiated Tumor: A Report of 2 Cases and Review of the Literature. Am J Dermatopathol 39(8):593-598, 2017. e-Pub 2016. PMID: 27655123.
Shustef E, Torres-Cabala CA, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Aung PP. Intraepithelial Melanoma in the Stomach After Treatment With Immune Checkpoint Blockade Therapy. Am J Dermatopathol, 2017. e-Pub 2017. PMID: 28248716.
Agarwal A, Gopinath A, Tetzlaff MT, Prieto VG. Phosphohistone-H3 and Ki67: Useful Markers in Differentiating Dermatofibroma From Dermatofibrosarcoma Protuberans and Atypical Fibrohistiocytic Lesions. Am J Dermatopathol 39(7):504-7, 2017. e-Pub 2017. PMID: 28609344.
Konopinski J, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Torres-Cabala CA, Fuller GN, Aung PP. Isolated Ectopic Cutaneous Atypical Meningioma of the Scalp: Another Mimicker of Primary Adnexal Tumor. Am J Dermatopathol, 2017. e-Pub 2017. PMID: 28178009.
Valero-Torres A, Prieto VG, Nagarajan P, Torres-Cabala CA, Tetzlaff MT, Curry JL, Ivan D, Aung PP. Metastatic Melanoma With Papillary Features: A Mimic and Possible Diagnostic Pitfall. Am J Dermatopathol 39(6):468-470, 2017. e-Pub 2017. PMID: 28525424.
Aung PP, Nagarajan P, Prieto VG. Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance. Lab Invest 97(6):657-68, 2017. e-Pub 2017. PMID: 28240749.
Pfeiffer ML, Ozgur OK, Myers JN, Peng A, Ning J, Zafereo ME, Thakar S, Thuro B, Prieto VG, Ross MI, Esmaeli B. Sentinel lymph node biopsy for ocular adnexal melanoma. Acta Ophthalmol 95(4):e323-e328, 2017. e-Pub 2017. PMID: 27775232.
Aung PP, Rady PL, Nagarajan P, Ivan D, Tetzlaff MT, Curry JL, Tyring SK, Prieto VG, Torres-Cabala CA. Detection of Merkel Cell Polyoma Virus and Beta Human Papillomavirus in Multiple Eccrine Poromas in a Patient With Acute Leukemia Treated With Stem Cell Transplant. Am J Dermatopathol 39(6):489-491, 2017. e-Pub 2017. PMID: 27655121.
Jain P, Prieto VG, Manning JT, Fowler N, Medeiros LJ, Kanagal-Shamanna R. Synchronous Presentation of Intra-nodal Follicular Dendritic Cell Sarcoma and Castleman Disease. Am J Hematol 92(5):478-479, 2017. e-Pub 2016. PMID: 27862216.
Nagarajan P, Curry JL, Ning J, Piao J, Torres-Cabala CA, Aung PP, Ivan D, Ross MI, Levenback CF, Frumovitz M, Gershenwald JE, Davies MA, Malpica A, Prieto VG, Tetzlaff MT. Tumor Thickness and Mitotic Rate Robustly Predict Melanoma-Specific Survival in Patients with Primary Vulvar Melanoma: A Retrospective Review of 100 Cases. Clin Cancer Res 23(8):2093-2104, 2017. e-Pub 2017. PMID: 27864417.
Agbay RL, Torres-Cabala CA, Patel KP, Merril ED, Duvic M, Quesada A, Prieto VG, Aung PP, Loghavi S, Young KH, Hu S, Ferrufino-Schmidt MC, Tetzlaff M, Li S, Medeiros LJ, Miranda RN. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens. Am J Surg Pathol, 2017. e-Pub 2017. PMID: 28248813.
Roh W, Chen PL, Reuben A, Spencer CN, Prieto PA, Miller JP, Gopalakrishnan V, Wang F, Cooper ZA, Reddy SM, Gumbs C, Little L, Chang Q, Chen WS, Wani K, De Macedo MP, Chen E, Austin-Breneman JL, Jiang H, Roszik J, Tetzlaff MT, Davies MA, Gershenwald JE, Tawbi H, Lazar AJ, Hwu P, Hwu WJ, Diab A, Glitza IC, Patel SP, Woodman SE, Amaria RN, Prieto VG, Hu J, Sharma P, Allison JP, Chin L, Zhang J, Wargo JA, Futreal PA. Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance. Sci Transl Med 9(379), 2017. e-Pub 2017. PMID: 28251903.
Clarke LE, Flake DD, Busam K, Cockerell C, Helm K, McNiff J, Reed J, Tschen J, Kim J, Barnhill R, Elenitsas R, Prieto VG, Nelson J, Kimbrell H, Kolquist KA, Brown KL, Warf MB, Roa BB, Wenstrup RJ. An independent validation of a gene expression signature to differentiate malignant melanoma from benign melanocytic nevi. Cancer 123(4):617-628, 2017. e-Pub 2017. PMID: 27768230.
Chakravarti N, Ivan D, Trinh VA, Glitza IC, Curry JL, Torres-Cabala C, Tetzlaff MT, Bassett RL, Prieto VG, Hwu WJ. High cytotoxic T-lymphocyte-associated antigen 4 and phospho-Akt expression in tumor samples predicts poor clinical outcomes in ipilimumab-treated melanoma patients. Melanoma Res 27(1):24-31, 2017. e-Pub 2016. PMID: 27768639.
Altinmakas E, Hobbs BP, Ye H, Grubbs EG, Perrier ND, Prieto VG, Lee JE, Ng CS. Diagnostic performance of (18-)F-FDG-PET-CT in adrenal lesions using histopathology as reference standard. Abdom Radiol (NY) 42(2):577-584, 2017. e-Pub 2016. PMID: 27665482.
Tetzlaff MT, Nagarajan P, Chon S, Huen A, Diab A, Omar P, Aung PP, Torres-Cabala CA, Mays SR, Prieto VG, Curry JL. Lichenoid Dermatologic Toxicity From Immune Checkpoint Blockade Therapy: A Detailed Examination of the Clinicopathologic Features. Am J Dermatopathol 39(2):121-129, 2017. e-Pub 2017. PMID: 28134729.
Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas. Am J Surg Pathol 41(2):204-215, 2017. e-Pub 2017. PMID: 27879514.
Nagarajan P, Tetzlaff MT, Curry JL, Prieto VG. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry. Actas Dermosifiliogr 108(1):17-30, 2017. e-Pub 2016. PMID: 27344067.
Siroy AE, Aung PP, Torres-Cabala CA, Tetzlaff MT, Nagarajan P, Milton DR, Curry JL, Ivan D, Prieto VG. Clinical Significance of BRAF V600E Mutational Status in Capsular Nevi of Sentinel Lymph Nodes in Patients with Primary Cutaneous Melanoma. Hum Pathol 59:48-54, 2017. e-Pub 2017. PMID: 27666765.
Litvinov IV, Tetzlaff MT, Thibault P, Gangar P, Moreau L, Watters AK, Netchiporouk E, Pehr K, Prieto VG, Rahme E, Provost N, Gilbert M, Sasseville D, Duvic M. Gene expression analysis in Cutaneous T-Cell Lymphomas (CTCL) highlights disease heterogeneity and potential diagnostic and prognostic indicators. Oncoimmunology 6(5):e1306618, 2017. e-Pub 2017. PMID: 28638728.
Chen LL, Zhu J, Schumacher J, Wei C, Ramdas L, Prieto VG, Jimenez A, Velasco MA, Tripp SR, Andtbacka RHI, Gouw L, Rodgers GM, Zhang L, Chan BK, Cassidy PB, Benjamin RS, Leachman SA, Frazier ML. SCF-KIT signaling induces endothelin-3 synthesis and secretion: Thereby activates and regulates endothelin-B-receptor for generating temporally- and spatially-precise nitric oxide to modulate SCF- and or KIT-expressing cell functions. PLoS One 12(9):e0184154, 2017. e-Pub 2017. PMID: 28880927.
Pina-Oviedo S, Torres-Cabala CA, Miranda RN, Tetzlaff MT, Singh S, Rapini RP, Prieto VG, Aung PP. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis. Am J Dermatopathol 39(5):388-392, 2017. e-Pub 2016. PMID: 27759701.
Honarpisheh HH, Curry JL, Richards K, Nagarajan P, Aung PP, Torres-Cabala CA, Ivan D, Drucker CR, Cartun R, Prieto VG, Tetzlaff MT. Cutaneous histoplasmosis with prominent parasitization of epidermal keratinocytes: Report of a case. J Cutan Pathol 43(12):1155-1160, 2016. e-Pub 2016. PMID: 27516534.
Lazova R, Seeley EH, Kutzner H, Scolyer RA, Scott G, Cerroni L, Fried I, Kozovska ME, Rosenberg AS, Prieto VG, Shehata BM, Durham MM, Henry G, Rodriguez-Peralto JL, Riveiro-Falkenbach E, Schaefer JT, Danialan R, Fraitag S, Vollenweider-Roten S, Sepehr A, Sangueza M, Hijazi N, Corredoira Y, Kowal R, Harris OM, Bravo F, Boyd AS, Gueorguieva R, Caprioli RM. Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms. J Am Acad Dermatol 75(6):1176-1186, 2016. e-Pub 2016. PMID: 27502312.
Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, Curry JL, Miranda RN, Duvic M, Prieto VG, Aung PP. Loss of CD30 expression after treatment with Brentuximab Vedotin in a patient with Anaplastic Large Cell Lymphoma: a novel finding. J Cutan Pathol 43(12):1161-1166, 2016. e-Pub 2016. PMID: 27531242.
Feldmeyer L, Hudgens CW, Ray-Lyons G, Nagarajan P, Aung PP, Curry JL, Torres-Cabala CA, Mino B, Rodriguez-Canales J, Reuben A, Chen PL, Ko JS, Billings SD, Bassett RL, Wistuba II, Cooper ZA, Prieto VG, Wargo JA, Tetzlaff MT. Density, distribution, and composition of immune infiltrates correlate with survival in Merkel cell carcinoma. Clin Cancer Res, 2016. e-Pub 2016. PMID: 27166398.
Ramani NS, Curry JL, Merrill ED, Aung PP, Prieto V, Tetzlaff MT, Duvic M, Miranda R, Torres-Cabala C. Primary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings. Am J Dermatopathol 38(10):e147-9, 2016. e-Pub 2016. PMID: 27533072.
Tetzlaff MT, Singh RR, Seviour EG, Curry JL, Hudgens CW, Bell D, Wimmer DA, Ning J, Czerniak BA, Zhang L, Davies MA, Prieto VG, Broaddus RR, Ram P, Luthra R, Esmaeli B. Next-generation sequencing identifies high frequency of mutations in potentially clinically actionable genes in sebaceous carcinoma. J Pathol 240(1):84-95, 2016. e-Pub 2016. PMID: 27287813.
Ravishankar S, Nagarajan P, Curry JL, Tetzlaff MT, Ivan D, Torres-Cabala CA, Aung PP, Prieto VG. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas. J Cutan Pathol 43(8):722-4, 2016. e-Pub 2016. PMID: 27124588.
Jour G, Glitza IC, Ellis RM, Torres-Cabala CA, Tetzlaff MT, Li JY, Nagarajan P, Huen A, Aung PP, Ivan D, Drucker CR, Prieto VG, Rapini RP, Patel A, Curry JL. Autoimmune Dermatologic Toxicities from Immune Checkpoint Blockade with anti-PD-1 Antibody Therapy: A Report on Bullous Skin Eruptions. J Cutan Pathol 43(8):688-96, 2016. e-Pub 2016. PMID: 27086658.
Minca EC, Al-Rohil RN, Wang M, Harms PW, Ko JS, Collie AM, Kovalyshyn I, Prieto VG, Tetzlaff MT, Billings SD, Andea AA. Comparison between melanoma gene expression score and fluorescence in situ hybridization for the classification of melanocytic lesions. Mod Pathol 29(8):832-43, 2016. e-Pub 2016. PMID: 27174586.
Chen PL, Roh W, Reuben A, Cooper ZA, Spencer CN, Prieto PA, Miller JP, Bassett RL, Gopalakrishnan V, Wani K, De Macedo MP, Austin-Breneman JL, Jiang H, Chang Q, Reddy SM, Chen WS, Tetzlaff MT, Broaddus RJ, Davies MA, Gershenwald JE, Haydu L, Lazar AJ, Patel SP, Hwu P, Hwu WJ, Diab A, Glitza IC, Woodman SE, Vence LM, Wistuba II, Amaria RN, Kwong LN, Prieto V, Davis RE, Ma W, Overwijk WW, Sharpe AH, Hu J, Futreal PA, Blando J, Sharma P, Allison JP, Chin L, Wargo JA. Analysis of Immune Signatures in Longitudinal Tumor Samples Yields Insight into Biomarkers of Response and Mechanisms of Resistance to Immune Checkpoint Blockade. Cancer Discov 6(8):827-37, 2016. e-Pub 2016. PMID: 27301722.
Feldmeyer L, Tetzlaff M, Fox P, Nagarajan P, Curry J, Ivan D, Torres Cabala CA, Prieto VG, Aung PP. Prognostic Implication of Lymphovascular Invasion Detected by Double Immunostaining for D2-40 and MITF1 in Primary Cutaneous Melanoma. Am J Dermatopathol 38(7):484-91, 2016. e-Pub 2016. PMID: 26675354.
Falchook GS, Rady P, Konopinski JC, Busaidy N, Hess K, Hymes S, Nguyen HP, Prieto VG, Bustinza-Linares E, Lin Q, Parkhurst KL, Hong DS, Sherman S, Tyring SK, Kurzrock R. Merkel cell polyomavirus and human papilloma virus in proliferative skin lesions arising in patients treated with BRAF inhibitors. Arch Dermatol Res 308(5):357-65, 2016. e-Pub 2016. PMID: 27098388.
Al-Rohil RN, Curry JL, Torres-Cabala CA, Nagarajan P, Ivan D, Aung PP, Lyons GF, Bassett RL, Prieto VG, Tetzlaff MT. Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Hum Pathol 53:73-81, 2016. e-Pub 2016. PMID: 27004944.
Hung T, Argenyi Z, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Piepkorn MW, Prieto VG, Rabkin MS, Schmidt B, Selim MA, Shea CR, Trotter MJ, Barnhill RL. Cellular Blue Nevomelanocytic Lesions: Analysis of Clinical, Histological, and Outcome Data in 37 Cases. Am J Dermatopathol 38(7):499-503, 2016. e-Pub 2016. PMID: 26909585.
Ekmekcioglu S, Davies MA, Tanese K, Roszik J, Shin-Sim M, Bassett RL, Milton DR, Woodman SE, Prieto VG, Gershenwald JE, Morton DL, Hoon DS, Grimm EA. Inflammatory Marker Testing Identifies CD74 Expression in Melanoma Tumor Cells, and its Expression Associates with Favorable Survival for Stage III Melanoma. Clin Cancer Res 22(12):3016-24, 2016. e-Pub 2016. PMID: 26783288.
Shoshan E, Braeuer RR, Kamiya T, Mobley AK, Huang L, Vasquez ME, Velazquez-Torres G, Chakravarti N, Ivan C, Prieto V, Villares GJ, Bar-Eli M. NFAT1 directly regulates IL-8 and MMP-3 to promote melanoma tumor growth and metastasis. Cancer Res 76(11):3145-55, 2016. e-Pub 2016. PMID: 27013197.
Plaza JA, Toussaint S, Prieto VG, Mercadillo P, Diez de Medina JC, Lourenco S, Batdorf B, Sangueza M. Actinic Prurigo Cheilitis: A Clinicopathologic Review of 75 Cases. Am J Dermatopathol 38(6):418-22, 2016. e-Pub 2016. PMID: 26981737.
Plaza JA, Bonneau P, Prieto V, Sangueza M, Mackinnon A, Suster D, Bacchi C, Estrozi B, Kazakov D, Kacerovska D, Falconieri G, Suster S. Desmoplastic melanoma: an updated immunohistochemical analysis of 40 cases with a proposal for an additional panel of stains for diagnosis. J Cutan Pathol 43(4):313-23, 2016. e-Pub 2016. PMID: 26661921.
Bell D, Sniegowski MC, Wani K, Prieto V, Esmaeli B. Mutational landscape of lacrimal gland carcinomas and implications for treatment. Head Neck 38 Suppl 1:E724-9, 2016. e-Pub 2016. PMID: 25899808.
Wang LE, Li C, Xiong P, Gershenwald JE, Prieto VG, Duvic M, Lee JE, Grimm EA, Hsu TC, Wei Q. 4-Nitroquinoline-1-oxide-induced mutagen sensitivity and risk of cutaneous melanoma: a case-control analysis. Melanoma Res 26(2):181-7, 2016. e-Pub 2016. PMID: 24977319.
Mudaliar K, Tetzlaff MT, Duvic M, Ciurea A, Hymes S, Milton DR, Tsai KY, Prieto VG, Torres-Cabala CA, Curry JL. BRAF inhibitor therapy-associated melanocytic lesions lack the BRAF V600E mutation and show increased levels of cyclin D1 expression. Hum Pathol 50:79-89, 2016. e-Pub 2016. PMID: 26997441.
Danialan R, Tetzlaff MT, Torres-Cabala CA, Mays SR, Prieto VG, Bell D, Curry JL. Cutaneous metastasis from anaplastic thyroid carcinoma exhibiting exclusively a spindle cell morphology. A case report and review of literature. J Cutan Pathol 43(3):252-7, 2016. e-Pub 2016. PMID: 26347145.
Ko JS, Prieto VG, Elson PJ, Vilain RE, Pulitzer MP, Scolyer RA, Reynolds JP, Piliang MP, Ernstoff MS, Gastman BR, Billings SD. Histological pattern of Merkel cell carcinoma sentinel lymph node metastasis improves stratification of Stage III patients. Mod Pathol 29(2):122-30, 2016. e-Pub 2016. PMID: 26541273.
Martínez-Escala ME, Prieto VG, Ivan D. Recurrent nodule on the scalp: a differential diagnosis of a nodule on the scalp. J Eur Acad Dermatol Venereol 30(1):172-4, 2016. e-Pub 2016. PMID: 25175460.
Feldmeyer L, Prieto VG, Ivan D, Nagarajan P, Tetzlaff MT, Curry JL, Bell D, Moon BS, Torres-Cabala CA, Aung PP. Role of Radiotherapy in Aggressive Digital Papillary Adenocarcinoma. Ann Clin Lab Sci 46(2):222-4, 2016. e-Pub 2016. PMID: 27098633.
Bell D, Aung P, Prieto VG, Ivan D. Next-generation sequencing reveals rare genomic alterations in aggressive digital papillary adenocarcinoma. Ann Diagn Pathol 19(6):381-4, 2015. e-Pub 2015. PMID: 26386519.
Plaza JA, Mackinnon A, Carrillo L, Prieto VG, Sangueza M, Suster S. Role of Immunohistochemistry in the Diagnosis of Sebaceous Carcinoma: A Clinicopathologic and Immunohistochemical Study. Am J Dermatopathol 37(11):809-21, 2015. e-Pub 2015. PMID: 26485238.
Tetzlaff MT, Curry JL, Yin V, Pattanaprichakul P, Manonukul J, Uiprasertkul M, Manyam GC, Wani KM, Aldape K, Zhang L, Prieto VG, Esmaeli B. Distinct Pathways in the Pathogenesis of Sebaceous Carcinomas Implicated by Differentially Expressed MicroRNAs. JAMA Ophthalmol 133(10):1109-16, 2015. e-Pub 2015. PMID: 26203913.
Litvinov IV, Tetzlaff MT, Rahme E, Jennings MA, Risser DR, Gangar P, Netchiporouk E, Moreau L, Prieto VG, Sasseville D, Duvic M. Demographic patterns of cutaneous T-cell lymphoma incidence in Texas based on two different cancer registries. Cancer Med 4(9):1440-7, 2015. e-Pub 2015. PMID: 26136403.
Tetzlaff MT, Pattanaprichakul P, Wargo J, Fox PS, Patel KP, Estrella JS, Broaddus RR, Williams MD, Davies MA, Routbort MJ, Lazar AJ, Woodman SE, Hwu WJ, Gershenwald JE, Prieto VG, Torres-Cabala CA, Curry JL. Utility of BRAF V600E immunohistochemical expression pattern as a surrogate of BRAF mutation status in 154 patients with advanced melanoma. Hum Pathol 46(8):1101-10, 2015. e-Pub 2015. PMID: 26058727.
Ramani NS, Curry JL, Kapil J, Rapini RP, Tetzlaff MT, Prieto VG, Torres-Cabala CA. Panniculitis With Necrotizing Granulomata in a Patient on BRAF Inhibitor (Dabrafenib) Therapy for Metastatic Melanoma. Am J Dermatopathol 37(8):e96-9, 2015. e-Pub 2015. PMID: 25839886.
Atlas Network CG. Genomic Classification of Cutaneous Melanoma. Cell 161(7):1681-96, 2015. e-Pub 2015. PMID: 26091043.
Litvinov IV, Tetzlaff MT, Rahme E, Habel Y, Risser DR, Gangar P, Jennings MA, Pehr K, Prieto VG, Sasseville D, Duvic M. Identification of geographic clustering and regions spared by cutaneous T-cell lymphoma in Texas using 2 distinct cancer registries. Cancer 121(12):1993-2003, 2015. e-Pub 2015. PMID: 25728286.
Wang WL, Torres-Cabala C, Curry J, Ivan D, McLemore M, Tetzlaff M, Zembowicz A, Prieto VG, Lazar AJ. Metastatic Atypical Fibroxanthoma: A Series of 11 Cases Including With Minimal and No Subcutaneous Involvement. Am J Dermatopathol 37(6):455-61, 2015. e-Pub 2015. PMID: 25590287.
Stockman DL, Curry JL, Torres-Cabala CA, Watson IR, Siroy AE, Bassett RL, Zou L, Patel KP, Luthra R, Davies MA, Wargo JA, Routbort MA, Broaddus RR, Prieto VG, Lazar AJ, Tetzlaff MT. Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations. J Cutan Pathol 42(5):308-17, 2015. e-Pub 2015. PMID: 25754356.
Maher OM, Prieto VG, Stewart J, Herzog CE. Characterization of metastatic angiomatoid fibrous histiocytoma. J Pediatr Hematol Oncol 37(4):e268-71, 2015. e-Pub 2015. PMID: 25757019.
de la Garza Bravo MM, Patel KP, Loghavi S, Curry JL, Torres Cabala CA, Cason RC, Gangar P, Prieto VG, Medeiros LJ, Duvic M, Tetzlaff MT. Shared clonality in distinctive lesions of lymphomatoid papulosis and mycosis fungoides occurring in the same patients suggests a common origin. Hum Pathol 46(4):558-69, 2015. e-Pub 2015. PMID: 25666664.
Shulman HM, Cardona DM, Greenson JK, Hingorani S, Horn T, Huber E, Kreft A, Longerich T, Morton T, Myerson D, Prieto VG, Rosenberg A, Treister N, Washington K, Ziemer M, Pavletic SZ, Lee SJ, Flowers ME, Schultz KR, Jagasia M, Martin PJ, Vogelsang GB, Kleiner DE. NIH Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. The 2014 Pathology Working Group Report. Biol Blood Marrow Transplant 21(4):589-603, 2015. e-Pub 2015. PMID: 25639770.
Izraely S, Sagi-Assif O, Klein A, Meshel T, Ben-Menachem S, Zaritsky A, Ehrlich M, Prieto VG, Bar-Eli M, Pirker C, Berger W, Nahmias C, Couraud PO, Hoon DS, Witz IP. The Metastatic Microenvironment: Claudin-1 Suppresses the Malignant Phenotype of Melanoma Brain Metastasis. Int J Cancer 136(6):1296-307, 2015. e-Pub 2014. PMID: 25046141.
Torres-Cabala CA, Curry JL, Li Ning Tapia EM, Ramos C, Tetzlaff MT, Prieto VG, Miranda RN, Bravo F. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci 77(3):150-5, 2015. e-Pub 2015. PMID: 25676425.
Siroy AE, Boland GM, Milton DR, Roszik J, Frankian S, Malke J, Haydu L, Prieto VG, Tetzlaff M, Ivan D, Wang WL, Torres-Cabala C, Curry J, Roy-Chowdhuri S, Broaddus R, Rashid A, Stewart J, Gershenwald JE, Amaria RN, Patel SP, Papadopoulos NE, Bedikian A, Hwu WJ, Hwu P, Diab A, Woodman SE, Aldape KD, Luthra R, Patel KP, Shaw KR, Mills GB, Mendelsohn J, Meric-Bernstam F, Kim KB, Routbort MJ, Lazar AJ, Davies MA. Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol 135(2):508-15, 2015. e-Pub 2015. PMID: 25148578.
Kash N, Vin H, Danialan R, Prieto VG, Duvic M. Stenotrophomonas maltophilia with histopathological features mimicking cutaneous gamma/delta T-cell lymphoma. Int J Infect Dis 30:7-9, 2015. e-Pub 2015. PMID: 25462188.
Pemmaraju N, Shetty AV, Prieto VG, Jain N, Kontoyiannis DP, Borthakur G. Disseminated Saprochaete capitata (formerly known as Geotrichum capitatum and Blastoschizomyces capitatus) in a patient with acute myeloid leukemia. Eur J Haematol 93(6):543-4, 2014. e-Pub 2014. PMID: 24592915.
Chen G, Chakravarti N, Aardalen K, Lazar AJ, Tetzlaff MT, Wubbenhorst B, Kim SB, Kopetz S, Ledoux AA, Gopal YN, Pereira CG, Deng W, Lee JS, Nathanson KL, Aldape KD, Prieto VG, Stuart D, Davies MA. Molecular Profiling of Patient-Matched Brain and Extracranial Melanoma Metastases Implicates the PI3K Pathway as a Therapeutic Target. Clin Cancer Res 20(21):5537-46, 2014. e-Pub 2014. PMID: 24803579.
Loghavi S, Curry JL, Torres-Cabala CA, Ivan D, Patel KP, Mehrotra M, Bassett R, Prieto VG, Tetzlaff MT. Melanoma arising in association with blue nevus: a clinical and pathologic study of 24 cases and comprehensive review of the literature. Mod Pathol 27(11):1468-78, 2014. e-Pub 2014. PMID: 24743221.
Henderson SA, Tetzlaff MT, Pattanaprichakul P, Fox P, Torres-Cabala CA, Bassett RL, Prieto VG, Richards HW, Curry JL. Detection of mitotic figures and G2+ tumor nuclei with histone markers correlates with worse overall survival in patients with Merkel cell carcinoma. J Cutan Pathol 41(11):846-52, 2014. e-Pub 2014. PMID: 25263506.
Henderson SA, Torres-Cabala CA, Curry JL, Bassett RL, Ivan D, Prieto VG, Tetzlaff MT. p40 is more specific than p63 for the distinction of atypical fibroxanthoma from other cutaneous spindle cell malignancies. Am J Surg Pathol 38(8):1102-10, 2014. e-Pub 2014. PMID: 25029117.
Foo WC, Wang H, Prieto VG, Fleming JB, Abraham SC. Squamoid cystosis of pancreatic ducts: a variant of a newly-described cystic lesion, with evidence for an obstructive etiology. Rare Tumors 6(3):5286, 2014. e-Pub 2014. PMID: 25276318.
Gerami P, Busam K, Cochran A, Cook MG, Duncan LM, Elder DE, Fullen DR, Guitart J, LeBoit PE, Mihm MC, Prieto VG, Rabkin MS, Scolyer RA, Xu X, Yun SJ, Obregon R, Yazdan P, Cooper C, Weitner BB, Rademaker A, Barnhill RL. Histomorphologic Assessment and Interobserver Diagnostic Reproducibility of Atypical Spitzoid Melanocytic Neoplasms With Long-term Follow-up. Am J Surg Pathol 38(7):934-40, 2014. e-Pub 2014. PMID: 24618612.
Curry JL, Tetzlaff MT, Nicholson K, Duvic M, Kim KB, Tsai KY, Hwu WJ, Hong DS, Prieto VG, Torres-Cabala CA. Histological features associated with vemurafenib-induced skin toxicities: examination of 141 cutaneous lesions biopsied during therapy. Am J Dermatopathol 36(7):557-61, 2014. e-Pub 2014. PMID: 24950418.
De la Garza Bravo MM, Curry JL, Torres-Cabala CA, Ivan DS, Drucker C, Prieto VG, Tetzlaff MT. Pigmented extramammary Paget disease of the thigh mimicking a melanocytic tumor: report of a case and review of the literature. J Cutan Pathol 41(6):529-35, 2014. e-Pub 2014. PMID: 24698435.
Guadagnolo BA, Prieto VG, Weber R, Ross MI, Zagars GK. The role of adjuvant radiotherapy in the local management of desmoplastic melanoma. Cancer 120(9):1361-8, 2014. e-Pub 2014. PMID: 24142803.
Plaza JA, De Stefano D, Suster S, Prieto VG, Kacerovska D, Michal M, Sangueza M, Kazakov DV. Intradermal spitz nevi: a rare subtype of spitz nevi analyzed in a clinicopathologic study of 74 cases. Am J Dermatopathol 36(4):283-97, 2014. e-Pub 2014. PMID: 24736667.
Curry JL, Torres-Cabala CA, Kim KB, Tetzlaff MT, Duvic M, Tsai KY, Hong DS, Prieto VG. Dermatologic toxicities to targeted cancer therapy: shared clinical and histologic adverse skin reactions. Int J Dermatol 53(3):376-84, 2014. e-Pub 2014. PMID: 23879247.
Pattanaprichakul P, Tetzlaff MT, Lapolla WJ, Torres-Cabala CA, Duvic M, Prieto VG, Tsai KY, Curry JL. Sweet syndrome following vemurafenib therapy for recurrent cholangiocarcinoma. J Cutan Pathol 41(3):326-8, 2014. e-Pub 2014. PMID: 24372055.
McQuitty E, Curry JL, Tetzlaff MT, Prieto VG, Duvic M, Torres-Cabala C. The differential diagnosis of CD8-positive ("type D") lymphomatoid papulosis. J Cutan Pathol 41(2):88-100, 2014. e-Pub 2013. PMID: 24118002.
Buonaccorsi JN, Prieto VG, Torres-Cabala C, Suster S, Plaza JA. Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: a clinicopathological and immunohistochemical study of 70 cases. Am J Dermatopathol 36(2):124-30, 2014. e-Pub 2014. PMID: 23782678.
Frieling GW, Al-Zaid T, Prieto VG. Placental alkaline phosphatase positivity in metastatic melanoma. Am J Dermatopathol 36(2):189-90, 2014. e-Pub 2014. PMID: 24561965.
Chang J, Prieto VG, Sangueza M, Plaza JA. Diagnostic utility of p63 expression in the differential diagnosis of pagetoid squamous cell carcinoma in situ and extramammary Paget disease: a histopathologic study of 70 cases. Am J Dermatopathol 36(1):49-53, 2014. e-Pub 2014. PMID: 23863548.
Aung PP, Climent F, Muzzafar T, Curry JL, Patel KP, Servitje O, Prieto VG, Duvic M, Jaffe ES, Torres-Cabala CA. Immunophenotypic shift of CD4 and CD8 antigen expression in primary cutaneous T-cell lymphomas: a clinicopathologic study of three cases. J Cutan Pathol 41(1):51-7, 2014. e-Pub 2014. PMID: 24151865.
Zhou JH, Kim KB, Myers JN, Fox PS, Ning J, Bassett RL, Hasanein H, Prieto VG. Immunohistochemical expression of hormone receptors in melanoma of pregnant women, nonpregnant women, and men. Am J Dermatopathol 36(1):74-9, 2014. e-Pub 2014. PMID: 23812018.
Curry JL, Davies MA, Calderone TL, Nathanson K, Prieto VG, Gershenwald JE. Tissue resources for clinical use and marker studies in melanoma. Methods Mol Biol 1102:679-95, 2014. e-Pub 2014. PMID: 24259006.
Tetzlaff MT, Wang WL, Milless TL, Curry JL, Torres-Cabala CA, McLemore MS, Ivan D, Bassett RL, Prieto VG. Ambiguous melanocytic tumors in a tertiary referral center: the contribution of fluorescence in situ hybridization (FISH) to conventional histopathologic and immunophenotypic analyses. Am J Surg Pathol 37(12):1783-96, 2013. e-Pub 2013. PMID: 24061523.
Scolyer RA, Judge MJ, Evans A, Frishberg DP, Prieto VG, Thompson JF, Trotter MJ, Walsh MY, Walsh NM, Ellis DW, Cancer Reporting ICO. Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR). Am J Surg Pathol 37(12):1797-814, 2013. e-Pub 2013. PMID: 24061524.
Wangsiricharoen S, Wakely PE, Prieto VG, Yu W. Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review. Histopathology 83(5):712-721, 2013. e-Pub 2023. PMID: 37442637.
Plaza JA, Suster S, Prieto VG, Sangueza M. Acquired reactive digital fibroma: a clinicopathologic report of 5 cases of a new entity. J Am Acad Dermatol 69(4):603-8, 2013. e-Pub 2013. PMID: 23849562.
Paradela S, Fonseca E, Pita-Fernández S, Prieto VG. Spitzoid and non-spitzoid melanoma in children. A prognostic comparative study. J Eur Acad Dermatol Venereol 27(10):1214-21, 2013. e-Pub 2013. PMID: 22928628.
Tetzlaff MT, Curry JL, Ivan D, Wang WL, Torres-Cabala CA, Bassett RL, Valencia KM, McLemore MS, Ross MI, Prieto VG. Immunodetection of phosphohistone H3 as a surrogate of mitotic figure count and clinical outcome in cutaneous melanoma. Mod Pathol 26(9):1153-60, 2013. e-Pub 2013. PMID: 23558574.
McKay KM, Sambrano BL, Fox PS, Bassett RL, Chon S, Prieto VG. Thickness of superficial basal cell carcinoma (sBCC) predicts imiquimod efficacy: a proposal for a thickness-based definition of sBCC. Br J Dermatol 169(3):549-54, 2013. e-Pub 2013. PMID: 23627639.
Shiue LH, Ni X, Prieto VG, Jorgensen JL, Curry JL, Goswami M, Sweeney SA, Duvic M. A case of invisible leukemic cutaneous T cell lymphoma with a regulatory T cell clone. Int J Dermatol 52(9):1111-4, 2013. e-Pub 2013. PMID: 22257096.
Gerami P, Cooper C, Bajaj S, Wagner A, Fullen D, Busam K, Scolyer RA, Xu X, Elder DE, Abraham RM, Prieto VG, Guitart J, Liu P, Pestova E, Barnhill RL. Outcomes of atypical spitz tumors with chromosomal copy number aberrations and conventional melanomas in children. Am J Surg Pathol 37(9):1387-94, 2013. e-Pub 2013. PMID: 23797719.
Pižem J, Nicholson KM, Mraz J, Prieto VG. Melanocytic differentiation is present in a significant proportion of nonpigmented diffuse neurofibromas: a potential diagnostic pitfall. Am J Surg Pathol 37(8):1182-91, 2013. e-Pub 2013. PMID: 23715161.
Anzalone CL, Cohen PR, Tarrand JJ, Diwan AH, Prieto VG. Nocardia yamanashiensis in an Immunocompromised Patient Presenting as an Indurated Nodule on the Dorsal Hand. Tumori 99(4):e156-e158, 2013. e-Pub 2013. PMID: 24326852.
Nemlich Y, Greenberg E, Ortenberg R, Besser MJ, Barshack I, Jacob-Hirsch J, Jacoby E, Eyal E, Rivkin L, Prieto VG, Chakravarti N, Duncan LM, Kallenberg DM, Galun E, Bennett DC, Amariglio N, Bar-Eli M, Schachter J, Rechavi G, Markel G. MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest 123(6):2703-18, 2013. e-Pub 2013. PMID: 23728176.
Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, Prieto VG, Leboit PE, Barnhill RL, Cooper C, Yazdan P, Guitart J, Liu P, Pestova E, Busam K. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol 37(5):676-84, 2013. e-Pub 2013. PMID: 23388126.
Chakravarti N, Peddareddigari VG, Warneke CL, Johnson MM, Overwijk WW, Hwu P, Prieto VG. Differential Expression of the G-Protein-Coupled Formyl Peptide Receptor in Melanoma Associates With Aggressive Phenotype. Am J Dermatopathol 35(2):184-90, 2013. e-Pub 2013. PMID: 23147350.
Falchook GS, Rady P, Hymes S, Nguyen HP, Tyring SK, Prieto VG, Hong DS, Kurzrock R. Merkel cell polyomavirus and HPV-17 associated with cutaneous squamous cell carcinoma arising in a patient with melanoma treated with the BRAF inhibitor dabrafenib. JAMA Dermatol 149(3):322-6, 2013. e-Pub 2013. PMID: 23552670.
Curry JL, Falchook GS, Hwu WJ, Torres-Cabala CA, Duvic M, Tetzlaff MT, Prieto VG. Changes in Tumor Morphology and Cyclin-Dependent Kinase Inhibitor Expression in Metastatic Melanoma Treated With Selective Second-Generation BRAF Inhibitor. Am J Dermatopathol 35(1):125-8, 2013. e-Pub 2013. PMID: 22878367.
Anzalone CL, Cohen PR, Diwan AH, Prieto VG. Radiation-induced angiosarcoma. Dermatol Online J 19(1):2, 2013. e-Pub 2013. PMID: 23374944.
Lacouture ME, Duvic M, Hauschild A, Prieto VG, Robert C, Schadendorf D, Kim CC, McCormack CJ, Myskowski PL, Spleiss O, Trunzer K, Su F, Nelson B, Nolop KB, Grippo JF, Lee RJ, Klimek MJ, Troy JL, Joe AK. Analysis of dermatologic events in vemurafenib-treated patients with melanoma. Oncologist 18(3):314-22, 2013. e-Pub 2013. PMID: 23457002.
Chu VH, Tetzlaff MT, Torres-Cabala CA, Prieto VG, Bassett R, Gershenwald JE, McLemore MS, Ivan D, Wang WL, Ross MI, Curry JL. Impact of the 2009 (7th Edition) AJCC Melanoma Staging System in the Classification of Thin Cutaneous Melanomas. Biomed Res Int 2013:898719, 2013. e-Pub 2013. PMID: 24369020.
Vin H, Ojeda SS, Ching G, Leung ML, Chitsazzadeh V, Dwyer DW, Adelmann CH, Restrepo M, Richards KN, Stewart LR, Du L, Ferguson SB, Chakravarti D, Ehrenreiter K, Baccarini M, Ruggieri R, Curry JL, Kim KB, Ciurea AM, Duvic M, Prieto VG, Ullrich SE, Dalby KN, Flores ER, Tsai KY. BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling. Elife 2:e00969, 2013. e-Pub 2013. PMID: 24192036.
Curry JL, Torres-Cabala CA, Tetzlaff MT, Bowman C, Prieto VG. Molecular Platforms Utilized to Detect BRAF V600E Mutation in Melanoma. Semin Cutan Med Surg 31(4):267-73, 2012. e-Pub 2012. PMID: 23174497.
Suchak R, Wang WL, Prieto VG, Ivan D, Lazar AJ, Brenn T, Calonje E. Cutaneous digital papillary adenocarcinoma: a clinicopathologic study of 31 cases of a rare neoplasm with new observations. Am J Surg Pathol 36(12):1883-91, 2012. e-Pub 2012. PMID: 23026931.
Radvanyi LG, Bernatchez C, Zhang M, Fox PS, Miller P, Chacon J, Wu R, Lizee G, Mahoney S, Alvarado G, Glass M, Johnson VE, McMannis JD, Shpall E, Prieto VG, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Patel S, Ross MI, Lee JE, Gershenwald JE, Lucci A, Royal R, Cormier JN, Davies MA, Mansaray R, Fulbright OJ, Toth C, Ramachandran R, Wardell S, Gonzalez A, Hwu P. Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients. Clin Cancer Res 18(24):6758-70, 2012. e-Pub 2012. PMID: 23032743.
Esmaeli B, Roberts D, Ross M, Fellman M, Cruz H, Kim SK, Prieto VG. Histologic features of conjunctival melanoma predictive of metastasis and death (an American Ophthalmological thesis). Trans Am Ophthalmol Soc 110:64-73, 2012. e-Pub 2012. PMID: 23818735.
Marburger TB, Gardner JM, Prieto VG, Billings SD. Primary cutaneous rhabdomyosarcoma: a clinicopathologic review of 11 cases. J Cutan Pathol 39(11):987-95, 2012. e-Pub 2012. PMID: 22994900.
Cohen PR, Prieto VG, Piha-Paul SA, Kurzrock R. The "shield sign" in two men with metastatic salivary duct carcinoma to the skin: cutaneous metastases presenting as carcinoma hemorrhagiectoides. J Clin Aesthet Dermatol 5(9):27-36, 2012. e-Pub 2012. PMID: 23050032.
Leleux TM, Prieto VG, Diwan AH. Aberrant expression of HMB-45 in traumatized melanocytic nevi. J Am Acad Dermatol 67(3):446-50, 2012. e-Pub 2012. PMID: 22285619.
Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilcrease MZ, Bedrosian I, Dawood S, Arun B, Albarracin CT. Invasive Paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol 36(9):1353-8, 2012. e-Pub 2012. PMID: 22895267.
Kim KB, Prieto VG, Joseph RW, Diwan AH, Gallick GE, Papadopoulos NE, Bedikian AY, Camacho LH, Hwu P, Ng CS, Wei W, Johnson MM, Wittemer SM, Vardeleon A, Reckeweg A, Colevas AD. A randomized phase II study of cilengitide (EMD 121974) in patients with metastatic melanoma. Melanoma Res 22(4):294-301, 2012. e-Pub 2012. PMID: 22668797.
Rose CL, Chakravarti N, Curry JL, Torres-Cabala CA, Bassett R, Prieto VG, Tetzlaff MT. The utility of ATF3 in distinguishing cutaneous squamous cell carcinoma among other cutaneous epithelial neoplasms. J Cutan Pathol 39(8):762-8, 2012. e-Pub 2012. PMID: 22764884.
Prieto VG. Cutaneous melanocytic lesions: do not miss the invisible gorilla. Adv Anat Pathol 19(4):263-9, 2012. e-Pub 2012. PMID: 22692289.
Alexander LJ, Paravar T, Duvic M, Prieto VG, Hymes SR. Annular plaques: An unusual manifestation of graft-versus-host disease. Dermatol Online J 18(6):4, 2012. e-Pub 2012. PMID: 22747928.
Garcia-Uribe A, Zou J, Duvic M, Cho-Vega JH, Prieto VG, Wang LV. In vivo diagnosis of melanoma and nonmelanoma skin cancer using oblique incidence diffuse reflectance spectrometry. Cancer Res 72(11):2738-45, 2012. e-Pub 2012. PMID: 22491533.
Zhang YH, Wang WL, Rapini RP, Torres-Cabala C, Prieto VG, Curry JL. Syringocystadenocarcinoma Papilliferum With Transition to Areas of Squamous Differentiation: A Case Report and Review of the Literature. Am J Dermatopathol 34(4):428-33, 2012. e-Pub 2012. PMID: 22343110.
Rozas-Muñoz E, Martinez Escala ME, Wang WL, Ciurea AM, Pujol RM, Prieto VG. A Slowly Growing Plaque on the Lower Back: Challenge. Am J Dermatopathol 34(4):423; discussion 452-3, 2012. e-Pub 2012. PMID: 22317885.
Wang WL, Bones-Valentin RA, Prieto VG, Pollock RE, Lev DC, Lazar AJ. Sarcoma metastases to the skin: A clinicopathologic study of 65 patients. Cancer 118(11):2900-4, 2012. e-Pub 2012. PMID: 21989966.
Mu H, Calderone TL, Davies MA, Prieto VG, Wang H, Mills GB, Bar-Eli M, Gershenwald JE. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells. Am J Pathol 180(5):2170-81, 2012. e-Pub 2012. PMID: 22465753.
Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang WL, Lazar AJ. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors. J Cutan Pathol 39(5):493-9, 2012. e-Pub 2012. PMID: 22486434.
Haitz KA, Rady PL, Nguyen HP, He Q, Prieto VG, Tyring SK, Ciurea AM. Merkel cell polyomavirus DNA detection in a patient with Merkel cell carcinoma and multiple other skin cancers. Int J Dermatol 51(4):442-4, 2012. e-Pub 2012. PMID: 22435435.
Liu H, Wei Q, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wang LE. Influence of single nucleotide polymorphisms in the MMP1 promoter region on cutaneous melanoma progression. Melanoma Res 22(2):169-75, 2012. e-Pub 2012. PMID: 22198560.
McKay KM, Deavers MT, Prieto VG. Chondroid Melanoma Metastatic to Lung and Skin Showing SOX-9 Expression: A Potential Diagnostic Pitfall. Int J Surg Pathol 20(2):169-72, 2012. e-Pub 2012. PMID: 22334614.
McLemore MS, Bruner JM, Curry JL, Prieto VG, Torres-Cabala CA. Anaplastic Oligodendroglioma Involving the Subcutaneous Tissue of the Scalp: Report of an Exceptional Case and Review of the Literature. Am J Dermatopathol 34(2):214-9, 2012. e-Pub 2012. PMID: 22157246.
Hayes-Jordan A, Green H, Prieto VG, Wolff JE. Unusual cases: melanomatosis and nephroblastomatosis treated with hyperthermic intraperitoneal chemotherapy. J Pediatr Surg 47(4):782-7, 2012. e-Pub 2012. PMID: 22498396.
Davies MA, Fox PS, Papadopoulos NE, Bedikian AY, Hwu WJ, Lazar AJ, Prieto VG, Culotta KS, Madden TL, Xu Q, Huang S, Deng W, Ng CS, Gupta S, Liu W, Dancey JE, Wright JJ, Bassett RL, Hwu P, Kim KB. Phase I study of the combination of sorafenib and temsirolimus in patients with metastatic melanoma. Clin Cancer Res 18(4):1120-8, 2012. e-Pub 2012. PMID: 22223528.
Erdem O, Wyatt AJ, Lin E, Wang X, Prieto VG. Dermatofibrosarcoma Protuberans Treated With Wide Local Excision and Followed at a Cancer Hospital: Prognostic Significance of Clinicopathologic Variables. Am J Dermatopathol 34(1):24-34, 2012. e-Pub 2012. PMID: 21785324.
Braun RP, Gutkowicz-Krusin D, Rabinovitz H, Cognetta A, Hofmann-Wellenhof R, Ahlgrimm-Siess V, Polsky D, Oliviero M, Kolm I, Googe P, King R, Prieto VG, French L, Marghoob A, Mihm M. Agreement of dermatopathologists in the evaluation of clinically difficult melanocytic lesions: how golden is the 'gold standard'?. Dermatology 224(1):51-8, 2012. e-Pub 2012. PMID: 22433231.
Martinez DR, Richards HW, Lin Q, Torres-Cabala CA, Prieto VG, Curry JL, Medrano EE. H3K79me3T80ph is a Novel Histone Dual Modification and a Mitotic Indicator in Melanoma. J Skin Cancer 2012:823534, 2012. e-Pub 2012. PMID: 23227340.
Cangelosi JJ, Prieto VG, Ivan D. Cutaneous Rosai-Dorfman disease with increased number of eosinophils: coincidence or histologic variant?. Arch Pathol Lab Med 135(12):1597-600, 2011. e-Pub 2011. PMID: 22129191.
Gullett AE, Jimenez-Quintero LP, Prieto VG, Ivan D. Atypical cellular neurothekeoma in a pregnant woman. Arch Dermatol 147(11):1342-3, 2011. e-Pub 2011. PMID: 22106137.
McLemore MS, Huo L, Deavers MT, Curry JL, Torres-Cabala CA, Wang WL, Prieto VG. Cutaneous epithelioid angiomatous nodule of the chest wall with expression of estrogen receptor: a mimic of carcinoma and a potential diagnostic pitfall. J Cutan Pathol 38(10):818-22, 2011. e-Pub 2011. PMID: 21752053.
Shinder R, Jackson TL, Araujo D, Prieto VG, Guadagnolo BA, Esmaeli B. Preoperative Radiation Therapy in the Management of Recurrent Orbital Hemangiopericytoma. Ophthal Plast Reconstr Surg 27(5):e126-8, 2011. e-Pub 2011. PMID: 21242853.
Cabrera R, Daza F, Tom D, Castro A, Prieto VG. Dermatoscopy of an angiomatoid spitz nevus. Am J Dermatopathol 33(6):628-30, 2011. e-Pub 2011. PMID: 21712688.
Patel SP, Kim KB, Papadopoulos NE, Hwu WJ, Hwu P, Prieto VG, Bar-Eli M, Zigler M, Dobroff A, Bronstein Y, Bassett RL, Vardeleon AG, Bedikian AY. A phase II study of gefitinib in patients with metastatic melanoma. Melanoma Res 21(4):357-63, 2011. e-Pub 2011. PMID: 21738104.
Joseph RW, Peddareddigari VR, Liu P, Miller PW, Overwijk WW, Bekele NB, Ross MI, Lee JE, Gershenwald JE, Lucci A, Prieto VG, McMannis JD, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Hwu P, Radvanyi LG. Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy. Clin Cancer Res 17(14):4882-91, 2011. e-Pub 2011. PMID: 21632855.
Prieto VG, Shea CR. Immunohistochemistry of melanocytic proliferations. Arch Pathol Lab Med 135(7):853-9, 2011. e-Pub 2011. PMID: 21732774.
Ivan D, Prieto VG. An update on reporting histopathologic prognostic factors in melanoma. Arch Pathol Lab Med 135(7):825-9, 2011. e-Pub 2011. PMID: 21732769.
Zembowicz A, Prieto VG. Melanocytic Lesions: Current State of Knowledge-Part III. Arch Pathol Lab Med 135(7):824, 2011. e-Pub 2011. PMID: 21732768.
Hegarty PK, Suh J, Fisher MB, Taylor J, Nguyen TH, Ivan D, Prieto VG, Pagliaro LC, Pettaway CA. Penoscrotal Extramammary Paget's Disease: The University of Texas M. D. Anderson Cancer Center Contemporary Experience. J Urol 186(1):97-102, 2011. e-Pub 2011. PMID: 21571343.
Moore-Olufemi S, Herzog C, Warneke C, Gershenwald JE, Mansfield P, Ross M, Prieto VG, Lally KP, Hayes-Jordan A. Outcomes in Pediatric Melanoma: Comparing Prepubertal to Adolescent Pediatric Patients. Ann Surg 253(6):1211-5, 2011. e-Pub 2011. PMID: 21451389.
Riddel CE, Surovik JG, Chon SY, Wang WL, Cho-Vega JH, Cutlan JE, Prieto VG. Fungal foes: presentations of chromoblastomycosis post-hurricane Ike. Cutis 87(6):269-72, 2011. e-Pub 2011. PMID: 21838080.
Prieto VG. Sentinel lymph nodes in cutaneous melanoma. Clin Lab Med 31(2):301-10, 2011. e-Pub 2011. PMID: 21549243.
Swaby MG, Evans HL, Fletcher CD, Prieto VG, Patel KU, Lev DC, Lòpez-Terrada D, Lazar AJ, Wang WL. Dermatofibrosarcoma Protuberans With Unusual Sarcomatous Transformation: A Series of 4 Cases With Molecular Confirmation. Am J Dermatopathol 33(4):354-360, 2011. e-Pub 2011. PMID: 21478726.
Paradela S, Fonseca E, Prieto VG. Melanoma in children. Arch Pathol Lab Med 135(3):307-16, 2011. e-Pub 2011. PMID: 21366453.
Zembowicz A, Prieto VG. Melanocytic Lesions: Current State of Knowledge? Part II. Arch Pathol Lab Med 135(3):298-9, 2011. e-Pub 2011. PMID: 21366451.
Curry JL, Prieto VG, Jones DM, Vega F, Duvic M, Diwan AH. Transient iatrogenic immunodeficiency-related B-cell lymphoproliferative disorder of the skin in a patient with mycosis fungoides/Sézary syndrome. J Cutan Pathol 38(3):295-7, 2011. e-Pub 2011. PMID: 19889052.
Monheit G, Cognetta AB, Ferris L, Rabinovitz H, Gross K, Martini M, Grichnik JM, Mihm M, Prieto VG, Googe P, King R, Toledano A, Kabelev N, Wojton M, Gutkowicz-Krusin D. The Performance of MelaFind: A Prospective Multicenter Study. Arch Dermatol 147(2):188-94, 2011. e-Pub 2011. PMID: 20956633.
Garcia-Uribe A, Smith EB, Zou J, Duvic M, Prieto V, Wang LV. In-vivo characterization of optical properties of pigmented skin lesions including melanoma using oblique incidence diffuse reflectance spectrometry. J Biomed Opt 16(2):020501, 2011. e-Pub 2011. PMID: 21361657.
Ellerhorst JA, Greene VR, Ekmekcioglu S, Warneke CL, Johnson MM, Cooke CP, Wang LE, Prieto VG, Gershenwald JE, Wei Q, Grimm EA. Clinical Correlates of NRAS and BRAF Mutations in Primary Human Melanoma. Clin Cancer Res 17(2):229-35, 2011. e-Pub 2011. PMID: 20975100.
Wang LE, Huang YJ, Yin M, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wei Q. Promoter polymorphisms in matrix metallopeptidase 1 and risk of cutaneous melanoma. Eur J Cancer 47(1):107-15, 2011. e-Pub 2011. PMID: 20655738.
Scolyer RA, Prieto VG. Melanoma pathology: important issues for clinicians involved in the multidisciplinary care of melanoma patients. Surg Oncol Clin N Am 20(1):19-37, 2011. e-Pub 2011. PMID: 21111957.
Savar A, Oellers P, Myers J, Prieto VG, Torres-Cabala C, Frank SJ, Ivan D, Esmaeli B. Positive sentinel node in sebaceous carcinoma of the eyelid. Ophthal Plast Reconstr Surg 27(1):e4-6, 2011. e-Pub 2011. PMID: 20940661.
Savar A, Esmaeli B, Ho H, Liu S, Prieto VG. Conjunctival melanoma: local-regional control rates, and impact of high-risk histopathologic features. J Cutan Pathol 38(1):18-24, 2011. e-Pub 2011. PMID: 20860727.
Zembowicz A, Prieto VG. Melanocytic lesions: current state of knowledge. Arch Pathol Lab Med 134(12):1738-9, 2010. e-Pub 2010. PMID: 21128769.
Eskue K, Prieto VG, Malpica A. Cellular Blue Nevus of the Uterus: A Case Report and Review of the Literature. Int J Gynecol Pathol 29(6):583-6, 2010. e-Pub 2010. PMID: 20881851.
Ribas A, Camacho LH, Lee SM, Hersh EM, Brown CK, Richards JM, Rodriguez MJ, Prieto VG, Glaspy JA, Oseguera DK, Hernandez J, Villanueva A, Chmielowski B, Mitsky P, Bercovici N, Wasserman E, Landais D, Ross MI. Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma. J Transl Med 8:89, 2010. e-Pub 2010. PMID: 20875102.
Paradela S, Fonseca E, Pita-Fernández S, Kantrow SM, Diwan AH, Herzog C, Prieto VG. Prognostic factors for melanoma in children and adolescents: a clinicopathologic, single-center study of 137 Patients. Cancer 116(18):4334-44, 2010. e-Pub 2010. PMID: 20549825.
Torres-Cabala CA, Plaza JA, Diwan AH, Prieto VG. Severe architectural disorder is a potential pitfall in the diagnosis of small melanocytic lesions. J Cutan Pathol 37(8):860-5, 2010. e-Pub 2010. PMID: 19614731.
Cohen PR, Prieto VG. Radiation port xanthogranuloma: solitary xanthogranuloma occurring within the irradiated skin of a breast cancer patient-report and review of cutaneous neoplasms developing at the site of radiotherapy. J Cutan Pathol 37(8):891-4, 2010. e-Pub 2010. PMID: 20141550.
Ivan D, Prieto VG. Use of immunohistochemistry in the diagnosis of melanocytic lesions: applications and pitfalls. Future Oncol 6(7):1163-75, 2010. e-Pub 2010. PMID: 20624128.
Rao P, Fuller GN, Prieto VG. Expression of Sox-9 in Metastatic Melanoma-A Potential Diagnostic Pitfall. Am J Dermatopathol 32(3):262-6, 2010. e-Pub 2010. PMID: 20098296.
Nazarian RM, Prieto VG, Elder DE, Duncan LM. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study. J Cutan Pathol 37 Suppl 1:41-7, 2010. e-Pub 2010. PMID: 20482674.
Ostler DA, Prieto VG, Reed JA, Deavers MT, Lazar AJ, Ivan D. Adipophilin expression in sebaceous tumors and other cutaneous lesions with clear cell histology: an immunohistochemical study of 117 cases. Mod Pathol 23(4):567-73, 2010. e-Pub 2010. PMID: 20118912.
Plaza JA, Torres-Cabala C, Evans H, Diwan HA, Suster S, Prieto VG. Cutaneous Metastases of Malignant Melanoma: A Clinicopathologic Study of 192 Cases With Emphasis on the Morphologic Spectrum. Am J Dermatopathol 32(2):129-36, 2010. e-Pub 2010. PMID: 20010406.
Wang WL, Patel KU, Coleman NM, Smith-Zagone MJ, Ivan D, Reed JA, López-Terrada D, Lazar AJ, Prieto VG. COL1A1:PDGFB Chimeric Transcripts Are Not Present in Indeterminate Fibrohistiocytic Lesions of the Skin. Am J Dermatopathol 32(2):149-53, 2010. e-Pub 2010. PMID: 19940748.
Paradela S, Fonseca E, Pita-Fernandez S, Kantrow SM, Goncharuk VN, Ivan D, Herzog CE, Sturgis EM, Prieto VG. Melanoma under 18 years and pregnancy: report of three cases. Eur J Dermatol 20(2):186-8, 2010. e-Pub 2010. PMID: 20153997.
Ramirez R, Ivan D, Prieto VG, Hayek B, Diwan H, Savar A, Esmaeli B. Cutaneous melanoma metastatic to the eyelid and periocular skin. Ophthal Plast Reconstr Surg 26(2):88-94, 2010. e-Pub 2010. PMID: 20305506.
Rao P, Balzer BL, Lemos BD, Liegeois NJ, McNiff JM, Nghiem P, Prieto VG, Smith MT, Smoller BR, Wick MR, Frishberg DP. Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin. Arch Pathol Lab Med 134(3):341-4, 2010. e-Pub 2010. PMID: 20196661.
Barnhill RL, Cerroni L, Cook M, Elder DE, Kerl H, LeBoit PE, McCarthy SW, Mihm MC, Mooi WJ, Piepkorn MW, Prieto VG, Scolyer RA. State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol 17(2):73-90, 2010. e-Pub 2010. PMID: 20179431.
Ivan D, Prieto VG, Esmaeli B, Wistuba II, Tang X, Lazar AJ. Epidermal growth factor receptor (EGFR) expression in periocular and extraocular sebaceous carcinoma. J Cutan Pathol 37(2):231-6, 2010. e-Pub 2010. PMID: 19614729.
Pan L, Peng L, Jean-Gilles J, Zhang X, Wieczorek R, Jain S, Levine V, Osman I, Prieto VG, Lee P. Novel PRKAR1A gene mutations in Carney Complex. Int J Clin Exp Pathol 3(5):545-8, 2010. e-Pub 2010. PMID: 20606737.
Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, Woodman SE, Calderone TC, Ju Z, Lazar AJ, Prieto VG, Aldape K, Mills GB, Gershenwald JE. Integrated Molecular and Clinical Analysis of AKT Activation in Metastatic Melanoma. Clin Cancer Res 15(24):7538-7546, 2009. e-Pub 2009. PMID: 19996208.
Torres-Cabala CA, Wang WL, Trent J, Yang D, Chen S, Galbincea J, Kim KB, Woodman S, Davies M, Plaza JA, Nash JW, Prieto VG, Lazar AJ, Ivan D. Correlation between KIT expression and KIT mutation in melanoma: a study of 173 cases with emphasis on the acral-lentiginous/mucosal type. Mod Pathol 22(11):1446-56, 2009. e-Pub 2009. PMID: 19718013.
Savar A, Ross MI, Prieto VG, Ivan D, Kim S, Esmaeli B. Sentinel lymph node biopsy for ocular adnexal melanoma: experience in 30 patients. Ophthalmology 116(11):2217-23, 2009. e-Pub 2009. PMID: 19766318.
Petersson F, Diwan AH, Ivan D, Gershenwald JE, Johnson MM, Harrell R, Prieto VG. Immunohistochemical detection of lymphovascular invasion with D2-40 in melanoma correlates with sentinel lymph node status, metastasis and survival. J Cutan Pathol 36(11):1157-63, 2009. e-Pub 2009. PMID: 19222695.
Melnikova VO, Balasubramanian K, Villares GJ, Dobroff AS, Zigler M, Wang H, Petersson F, Price JE, Schroit A, Prieto VG, Hung MC, Bar-Eli M. Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis. J Biol Chem 284(42):28845-55, 2009. e-Pub 2009. PMID: 19703903.
Frishberg DP, Balch C, Balzer BL, Crowson AN, Didolkar M, McNiff JM, Perry RR, Prieto VG, Rao P, Smith MT, Smoller BR, Wick MR, Cancer Committee MOT, American Pathologists CO. Protocol for the examination of specimens from patients with melanoma of the skin. Arch Pathol Lab Med 133(10):1560-7, 2009. e-Pub 2009. PMID: 19792045.
Terushkin V, Dusza SW, Mullani NA, Duvic M, Zouridakis G, Weinstock M, Drugge R, Prieto VG, Dhawan A, Terry C, Talpur R, Marghoob AA. Transillumination as a means to differentiate melanocytic lesions based on their vascularity. Arch Dermatol 145(9):1060-2, 2009. e-Pub 2009. PMID: 19770455.
Cabrera R, Pulgar C, Daza F, Castro A, Prieto VG, Benedetto J, Fajre X. Dermatoscopy of a primary dermal melanoma. Am J Dermatopathol 31(6):574-7, 2009. e-Pub 2009. PMID: 19590417.
Adeniran AJ, Prieto VG, Chon S, Duvic M, Diwan AH. Atypical histologic and immunohistochemical findings in melanocytic nevi after liquid nitrogen cryotherapy. J Am Acad Dermatol 61(2):341-5, 2009. e-Pub 2009. PMID: 19362750.
Paradela S, Fonseca E, Pita S, Kantrow SM, Goncharuk VN, Diwan H, Prieto VG. Spitzoid melanoma in children: clinicopathological study and application of immunohistochemistry as an adjunct diagnostic tool. J Cutan Pathol 36(7):740-52, 2009. e-Pub 2009. PMID: 19032380.
Plaza JA, Torres-Cabala C, Evans H, Diwan AH, Prieto VG. Immunohistochemical expression of S100A6 in cellular neurothekeoma: clinicopathologic and immunohistochemical analysis of 31 cases. Am J Dermatopathol 31(5):419-22, 2009. e-Pub 2009. PMID: 19542912.
Plaza JA, Torres-Cabala C, Ivan D, Prieto VG. HER-2/neu expression in extramammary Paget disease: a clinicopathologic and immunohistochemistry study of 47 cases with and without underlying malignancy. J Cutan Pathol 36(7):729-33, 2009. e-Pub 2009. PMID: 19519604.
Wang WL, Hornick JL, Mallipeddi R, Zelger BG, Rother JD, Yang D, Lev DC, Trent JC, Prieto VG, Brenn T, Calonje E, Lazar AJ. Cutaneous and subcutaneous metastases of gastrointestinal stromal tumors: a series of 5 cases with molecular analysis. Am J Dermatopathol 31(3):297-300, 2009. e-Pub 2009. PMID: 19384074.
Petersson F, Ivan D, Kazakov DV, Michal M, Prieto VG. Pigmented Paget disease--a diagnostic pitfall mimicking melanoma. Am J Dermatopathol 31(3):223-6, 2009. e-Pub 2009. PMID: 19384061.
Cangelosi JJ, Nash JW, Prieto VG, Ivan D. Cutaneous adnexal tumor with an unusual presentation--discussion of a potential diagnostic pitfall. Am J Dermatopathol 31(3):278-281, 2009. e-Pub 2009. PMID: 19384070.
Kim KB, Legha SS, Gonzalez R, Anderson CM, Johnson MM, Liu P, Papadopoulos NE, Eton O, Plager C, Buzaid AC, Prieto VG, Hwu WJ, Frost AM, Alvarado G, Hwu P, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Benjamin RS, Bedikian AY. A randomized phase III trial of biochemotherapy versus interferon-alpha-2b for adjuvant therapy in patients at high risk for melanoma recurrence. Melanoma Res 19(1):42-9, 2009. e-Pub 2009. PMID: 19430405.
Diwan AH, Dang SM, Prieto VG, Ellerhorst JA. Lack of maturation with anti-leptin receptor antibody in melanoma but not in nevi. Mod Pathol 22(1):103-6, 2009. e-Pub 2009. PMID: 18836419.
Dubauskas Z, Kunishige J, Prieto VG, Jonasch E, Hwu P, Tannir NM. Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib. Clin Genitourin Cancer 7(1):20-23, 2009. e-Pub 2009. PMID: 19213663.
Diwan AH, Dang SM, Prieto VG, Ellerhorst JA. Lack of maturation with anti-leptin receptor antibody in melanoma but not in nevi. Mod Pathol 22(1):103-106, 2009. e-Pub 2009. PMID: 18836419.
Dubauskas Z, Kunishige J, Prieto VG, Jonasch E, Hwu P, Tannir NM. Cutaneous squamous cell carcinoma and inflammation of actinic keratoses associated with sorafenib. Clin Genitourin Cancer 7(1):20-3, 2009. e-Pub 2009. PMID: 19213663.
Chandra P, Plaza JA, Zuo Z, Diwan AH, Koeppen H, Duvic M, Medeiros LJ, Prieto VG. Clusterin expression correlates with stage and presence of large cells in mycosis fungoides. Am J Clin Pathol 131(4):511-515, 2009. e-Pub 2009. PMID: 19289586.
Li C, Zhao H, Hu Z, Liu Z, Wang LE, Gershenwald JE, Prieto VG, Lee JE, Duvic M, Grimm EA, Wei Q. Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum Mutat 29(12):1443-51, 2008. e-Pub 2008. PMID: 18563783.
Prieto VG, Shea CR. Use of immunohistochemistry in melanocytic lesions. J Cutan Pathol 35 Suppl 2:1-10, 2008. e-Pub 2008. PMID: 18976412.
Gomez-Rivera F, Santillan A, McMurphey AB, Paraskevopoulos G, Roberts DB, Prieto VG, Myers JN. Sentinel node biopsy in patients with cutaneous melanoma of the head and neck: recurrence and survival study. Head Neck 30(10):1284-94, 2008. e-Pub 2008. PMID: 18704971.
Sanchez AA, Wu TT, Prieto VG, Rashid A, Hamilton SR, Wang H. Comparison of primary and metastatic malignant melanoma of the esophagus: clinicopathologic review of 10 cases. Arch Pathol Lab Med 132(10):1623-9, 2008. e-Pub 2008. PMID: 18834221.
Gershenwald JE, Andtbacka RH, Prieto VG, Johnson MM, Diwan AH, Lee JE, Mansfield PF, Cormier JN, Schacherer CW, Ross MI. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol 26(26):4296-303, 2008. e-Pub 2008. PMID: 18606982.
Ivan D, Diwan AH, Lazar AJ, Prieto VG. The usefulness of p63 detection for differentiating primary from metastatic skin adenocarcinomas. J Cutan Pathol 35(9):880-1, 2008. e-Pub 2008. PMID: 18796086.
Paradela S, Sacristan F, Almagro M, Prieto VG, Kantrow SM, Fonseca E. Necrotizing vasculitis with a polyarteritis nodosa-like pattern and selective immunoglobulin A deficiency: case report and review of the literature. J Cutan Pathol 35(9):871-5, 2008. e-Pub 2008. PMID: 18494827.
Li ZG, Mathew P, Yang J, Starbuck MW, Zurita AJ, Liu J, Sikes C, Multani AS, Efstathiou E, Lopez A, Wang J, Fanning TV, Prieto VG, Kundra V, Vazquez ES, Troncoso P, Raymond AK, Logothetis CJ, Lin SH, Maity S, Navone NM. Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. J Clin Invest 118(8):2697-2710, 2008. e-Pub 2008. PMID: 18618013.
Chen LL, Holden JA, Choi H, Zhu J, Wu EF, Jones KA, Ward JH, Andtbacka RH, Randall RL, Scaife CL, Hunt KK, Prieto VG, Raymond AK, Zhang W, Trent JC, Benjamin RS, Frazier ML. Evolution from heterozygous to homozygous KIT mutation in gastrointestinal stromal tumor correlates with the mechanism of mitotic nondisjunction and significant tumor progression. Mod Pathol 21(7):826-36, 2008. e-Pub 2008. PMID: 18488000.
Hong DS, Reddy SB, Prieto VG, Wright JJ, Tannir NM, Cohen PR, Diwan AH, Evans HL, Kurzrock R. Multiple squamous cell carcinomas of the skin after therapy with sorafenib combined with tipifarnib. Arch Dermatol 144(6):779-82, 2008. e-Pub 2008. PMID: 18559769.
Kantrow S, Kalemeris GC, Prieto VG. Spitz nevus with rosette-like structures: a new histologic variant. J Cutan Pathol 35(5):510-512, 2008. e-Pub 2008. PMID: 18418914.
Friedman RJ, Gutkowicz-Krusin D, Farber MJ, Warycha M, Schneider-Kels L, Papastathis N, Mihm MC, Jr, Googe P, King R, Prieto VG, Kopf AW, Polsky D, Rabinovitz H, Oliviero M, Cognetta A, Rigel DS, Marghoob A, Rivers J, Johr R, Grant-Kels JM, Tsao H. The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol 144(4):476-482, 2008. e-Pub 2008. PMID: 18427041.
Abbasi NR, Yancovitz M, Gutkowicz-Krusin D, Panageas KS, Mihm MC, Googe P, King R, Prieto VG, Osman I, Friedman RJ, Rigel DS, Kopf AW, Polsky D. Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch Dermatol 144(4):469-474, 2008. e-Pub 2008. PMID: 18427040.
Patel KU, Szabo SS, Hernandez VS, Prieto VG, Abruzzo LV, Lazar AJ, López-Terrada D. Dermatofibrosarcoma protuberans COL1A1-PDGFB fusion is identified in virtually all dermatofibrosarcoma protuberans cases when investigated by newly developed multiplex reverse transcription polymerase chain reaction and fluorescence in situ hybridization assays. Hum Pathol 39(2):184-93, 2008. e-Pub 2008. PMID: 17950782.
Uzquiano MC, Prieto VG, Nash JW, Ivan DS, Gong Y, Lazar AJ, Diwan AH. Metastatic basal cell carcinoma exhibits reduced actin expression. Mod Pathol 21(5):540-3, 2008. e-Pub 2008. PMID: 18223552.
Diwan AH, Skelton HG, Horenstein MG, Kelly DR, Barrett TL, Bussian AH, Sanders DY, Lazar AJ, Prieto VG, Smith KJ. Dermatofibrosarcoma protuberans and giant cell fibroblastoma exhibit CD99 positivity. J Cutan Pathol 35(7):647-50, 2008. e-Pub 2008. PMID: 18201229.
LI C, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q. Haplotype and genotypes of the VDR gene and cutaneous melanoma risk in non-Hispanic whites in Texas: A case-control study, 2008. e-Pub 2008. PMID: 18183598.
Barnhill RL, Argenyi Z, Berwick M, Duray PH, Erickson L, Guitart J, Horenstein MG, Lowe L, Messina J, Paine S, Piepkorn MW, Prieto VG, Rabkin MS, Schmidt B, Selim A, Shea CR, Trotter MJ. Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma ("malignant blue nevus"). Am J Surg Pathol 32(1):36-44, 2008. e-Pub 2008. PMID: 18162768.
Cangelosi JJ, Prieto VG, Baker GF, Moore BA, Diwan AH. Unusual presentation of multiple epithelioid cell histiocytomas. Am J Dermatopathol 30(4):373-6, 2008. e-Pub 2008. PMID: 18645309.
Rothberg BE, Moeder CB, Kluger H, Halaban R, Elder DE, Murphy GF, Lazar A, Prieto VG, Duncan LM, Rimm DL. Nuclear to non-nuclear Pmel17/gp100 expression (HMB45 staining) as a discriminator between benign and malignant melanocytic lesions. Mod Pathol 21(9):1121-1129, 2008. e-Pub 2008. PMID: 18552823.
Hwang CS, Prieto VG, Diwan AH, Lizee G, Ellerhorst JA, Ekmekcioglu S, Liu P, Eton O, Kinney SA, Grimm EA, Hwu P, Kim KB. Changes in pERK1/2 and pAKT expression in melanoma lesions after imatinib treatment. Melanoma Res(18):241-245, 2008. e-Pub 2008. PMID: 18626307.
Prieto VG. Use of frozen sections in the examination of sentinel lymph nodes in patients with melanoma. Semin Diagn Pathol(25):112-115, 2008. e-Pub 2008. PMID: 18697714.
Kim KB, Eton O, Davis DW, Frazier ML, McConkey DJ, Diwan AH, Papadopoulos NE, Bedikian AY, Camacho LH, Ross MI, Cormier JN, Gershenwald JE, Lee JE, Mansfield PF, Billings LA, Ng CS, Charnsangavej C, Bar-Eli M, Johnson MM, Murgo AJ, Prieto VG. Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer(99):734-740, 2008. e-Pub 2008. PMID: 18728664.
Davies MA, Stemke-Hale K, Tellez C, Calderone TL, Deng W, Prieto VG, Lazar AJ, Gershenwald JE, Mills GB. A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer 99(8):1265-8, 2008. e-Pub 2008. PMID: 18813315.
Wang Q, Prieto VG, Esmaeli B, Kolda T, Lazar A, Ivan D, Diwan A. Cellular Blue nevi of the eyelid: A possible diagnostic pitfall. American Academy of Dermatology, Inc(58):257-260, 2008. e-Pub 2008. PMID: 18222322.
Walters RF, Groben PA, Busam K, Millikan RC, Rabinovitz H, Cognetta A, Mihm MC, Prieto VG, Googe PB, King R, Moore DT, Woosley J, Thomas NE. Consumption of the epidermis: a criterion in the differential diagnosis of melanoma and dysplastic nevi that is associated with increasing Breslow depth and ulceration. Am J Dermatopathol 29(6):527-33, 2007. e-Pub 2007. PMID: 18032946.
Li C, Chen K, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q. Polymorphisms of TP53 Arg72Pro, but not p73 G4C14>A4TA4 and p21 Ser31Arg, Contribute to Risk of Cutaneous Melanoma. J Invest Dermatol, 2007. e-Pub 2007. PMID: 18049450.
Wang LE, Li C, Strom SS, Goldberg LH, Brewster A, Guo Z, Qiao Y, Clayman GL, Lee JJ, El-Naggar AK, Prieto VG, Duvic M, Lippman SM, Weber RS, Kripke ML, Wei Q. Repair capacity for UV light induced DNA damage associated with risk of nonmelanoma skin cancer and tumor progression. Clin Cancer Res 13(21):6532-9, 2007. e-Pub 2007. PMID: 17975167.
Kantrow SM, Ivan D, Williams MD, Prieto VG, Lazar AJ. Metastasizing adenocarcinoma and multiple neoplastic proliferations arising in a nevus sebaceus. Am J Dermatopathol 29(5):462-6, 2007. e-Pub 2007. PMID: 17890915.
Chakravarti N, Lotan R, Diwan AH, Warneke CL, Johnson MM, Prieto VG. Decreased expression of retinoid receptors in melanoma: entailment in tumorigenesis and prognosis. Clin Cancer Res 13(16):4817-24, 2007. e-Pub 2007. PMID: 17699860.
Singh RS, Hafeez Diwan A, Prieto VG. Potential diagnostic pitfalls in melanoma arising in a cutaneous tattoo. Histopathology 51(2):283-5, 2007. e-Pub 2007. PMID: 17650221.
Ho VH, Ross MI, Prieto VG, Khaleeq A, Kim S, Esmaeli B. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa. Arch Otolaryngol Head Neck Surg 133(8):820-6, 2007. e-Pub 2007. PMID: 17709624.
Cho-Vega JH, Vega F, Schwartz MR, Prieto VG. Expression of dicarbonyl/L-xylulose reductase (DCXR) in human skin and melanocytic lesions: morphological studies supporting cell adhesion function of DCXR. J Cutan Pathol 34(7):535-42, 2007. e-Pub 2007. PMID: 17576332.
Khalifeh I, Taraif S, Reed JA, Lazar AF, Diwan AH, Prieto VG. A subgroup of melanocytic nevi on the distal lower extremity (ankle) shares features of acral nevi, dysplastic nevi, and melanoma in situ: a potential misdiagnosis of melanoma in situ. Am J Surg Pathol 31(7):1130-6, 2007. e-Pub 2007. PMID: 17592281.
Ivan D, Nash JW, Prieto VG, Calonje E, Lyle S, Diwan AH, Lazar AJ. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to skin. J Cutan Pathol 34(6):474-80, 2007. e-Pub 2007. PMID: 17518775.
Perna AG, Ostler DA, Ivan D, Lazar AJ, Diwan AH, Prieto VG, Reed JA. Renal cell carcinoma marker (RCC-Ma) is specific for cutaneous metastasis of renal cell carcinoma. J Cutan Pathol 34(5):381-5, 2007. e-Pub 2007. PMID: 17448192.
Ivan D, Bengana C, Lazar AJ, Diwan AH, Prieto VG. Merkel cell tumor in a trichilemmal cyst: collision or association?. Am J Dermatopathol 29(2):180-3, 2007. e-Pub 2007. PMID: 17414443.
Singh RS, Diwan AH, Zhang PS, Prieto VG. Phosphoinositide 3-kinase is not overexpressed in melanocytic lesions. J Cutan Pathol 34(3):220-5, 2007. e-Pub 2007. PMID: 17302605.
May SA, Jones D, Medeiros LJ, Duvic M, Prieto VG, Lazar AJ. Oral-cutaneous CD4-positive T-cell lymphoma: a study of two patients. Am J Dermatopathol 29(1):62-7, 2007. e-Pub 2007. PMID: 17284964.
Tellez CS, Davis DW, Prieto VG, Gershenwald JE, Johnson MM, McCarty MF, Bar-Eli M. Quantitative analysis of melanocytic tissue array reveals inverse correlation between activator protein-2alpha and protease-activated receptor-1 expression during melanoma progression. J Invest Dermatol 127(2):387-93, 2007. e-Pub 2007. PMID: 16946713.
Li C, Hu Z, Liu Z, Wang LE, Gershenwald JE, Lee JE, Prieto VG, Duvic M, Grimm EA, Wei Q. Polymorphisms of the neuronal and inducible nitric oxide synthase genes and the risk of cutaneous melanoma: a case-control study. Cancer 109(8):1570-8, 2007. e-Pub 2007. PMID: 17328085.
Li C, Liu Z, Zhang Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei Q. Genetic variants of the vitamin D receptor gene alter risk of cutaneous melanoma. J Invest Dermatol 127(2):276-80, 2007. e-Pub 2007. PMID: 16990805.
Lambert TJ, Prieto VG, Duvic M. Multiple plaques on the hands and feet. Mycosis fungoides (MF) palmaris et plantaris (MFPP). Arch Dermatol 143(1):109-14, 2007. e-Pub 2007. PMID: 17224554.
Ho VH, Prager TC, Diwan H, Prieto VG, Esmaeli B. Ultrasound biomicroscopy for estimation of tumor thickness for conjunctival melanoma. J Clin Ultrasound(35):533-537, 2007. e-Pub 2007. PMID: 17427214.
Vu J, Wallace GR, Singh R, Diwan H, Prieto VG, Rady P, Tyring S, Duvic M. Common variable immunodeficiency syndrome associated with epidermodysplasia verruciformis. Am J Clin Dermatol 8(5):307-310, 2007. e-Pub 2007. PMID: 17902733.
Li C, Hu Z, Liu Z, Wang LE, Strom SS, Gershenwald JE, Lee JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, Wei Q. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev 15(12):2526-32, 2006. e-Pub 2006. PMID: 17164380.
Gannon CJ, Rousseau DL, Ross MI, Johnson MM, Lee JE, Mansfield PF, Cormier JN, Prieto VG, Gershenwald JE. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma. Cancer 107(11):2647-52, 2006. e-Pub 2006. PMID: 17063497.
Treviño J, Prieto VG, Hearne R, Polk A, Diwan AH. Atypical lymphocytic reaction with epidermotropism and lymphocytic vasculopathic reaction (lymphocytic vasculitis) after treatment with imiquimod. J Am Acad Dermatol 55(5 Suppl):S123-5, 2006. e-Pub 2006. PMID: 17052533.
Prieto VG, Mourad-Zeidan AA, Melnikova V, Johnson MM, Lopez A, Diwan AH, Lazar AJ, Shen SS, Zhang PS, Reed JA, Gershenwald JE, Raz A, Bar-Eli M. Galectin-3 expression is associated with tumor progression and pattern of sun exposure in melanoma. Clin Cancer Res 12(22):6709-15, 2006. e-Pub 2006. PMID: 17121890.
Soldano AC, Vazquez-Martul E, Romero JA, Prieto VG. Subcutaneous ossifying fibromyxoid tumor. J Cutan Pathol 33(11):749-53, 2006. e-Pub 2006. PMID: 17083695.
Doherty SD, Prieto VG, George S, Hazarika P, Duvic M. High flotillin-2 expression is associated with lymph node metastasis and Breslow depth in melanoma. Melanoma Res 16(5):461-3, 2006. e-Pub 2006. PMID: 17013097.
Li C, Liu Z, Wang LE, Strom SS, Lee JE, Gershenwald JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, Wei Q. Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. Carcinogenesis 27(9):1894-901, 2006. e-Pub 2006. PMID: 16621887.
Ekmekcioglu S, Ellerhorst JA, Prieto VG, Johnson MM, Broemeling LD, Grimm EA. Tumor iNOS predicts poor survival for stage III melanoma patients. Int J Cancer 119(4):861-6, 2006. e-Pub 2006. PMID: 16557582.
Baptista MZ, Prieto VG, Chon S, Hortobagyi GN, Esteva FJ. Tamoxifen-related vasculitis. J Clin Oncol 24(21):3504-5, 2006. e-Pub 2006. PMID: 16849770.
Wyman K, Atkins MB, Prieto VG, Eton O, McDermott DF, Hubbard F, Byrnes C, Sanders K, Sosman JA. Multicenter Phase II trial of high-dose imatinib mesylate in metastatic melanoma: significant toxicity with no clinical efficacy. Cancer(106):2005-2011, 2006. e-Pub 2006. PMID: 16565971.
Ivan D, Niveiro M, Diwan AH, Eton O, Kim KB, Lacey C, Gonzalez C, Prieto VG. Analysis of protein tyrosine kinases expression in the melanoma metastases of patients treated with Imatinib Mesylate (STI571, Gleevec). J Cutan Pathol 33(4):280-5, 2006. e-Pub 2006. PMID: 16630177.
Li C, Larson D, Zhang Z, Liu Z, Strom SS, Gershenwald JE, Prieto VG, Lee JE, Ross MI, Mansfield PF, Cormier JN, Duvic M, Grimm EA, Wei Q. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 16(4):253-63, 2006. e-Pub 2006. PMID: 16538172.
Shepler TR, Prieto VG, Diba R, Neuhaus RW, Shore JW, Esmaeli B. Expression of the epidermal growth factor receptor in conjunctival squamous cell carcinoma. Ophthal Plast Reconstr Surg 22(2):113-5, 2006. e-Pub 2006. PMID: 16550055.
Ding Y, Prieto VG, Zhang PS, Rosenthal S, Smith KJ, Skelton HG, Diwan AH. Nuclear expression of the antiapoptotic protein survivin in malignant melanoma. Cancer 106(5):1123-9, 2006. e-Pub 2006. PMID: 16456815.
Pawlik TM, Ross MI, Prieto VG, Ballo MT, Johnson MM, Mansfield PF, Lee JE, Cormier JN, Gershenwald JE. Assessment of the role of sentinel lymph node biopsy for primary cutaneous desmoplastic melanoma. Cancer 106(4):900-6, 2006. e-Pub 2006. PMID: 16411225.
Johnson FM, Krug LM, Tran HT, Shoaf S, Prieto VG, Tamboli P, Peeples B, Patel J, Glisson BS. Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinoma. Cancer 106(2):366-74, 2006. e-Pub 2006. PMID: 16342249.
Donato ML, Feasel AM, Weber DM, Prieto VG, Giralt SA, Champlin RE, Duvic M. Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation. Blood 107(2):463-6, 2006. e-Pub 2006. PMID: 16179379.
Shulman HM, Kleiner D, Lee SJ, Morton T, Pavletic SZ, Farmer E, Moresi JM, Greenson J, Janin A, Martin PJ, McDonald G, Flowers ME, Turner M, Atkinson J, Lefkowitch J, Washington MK, Prieto VG, Kim SK, Argenyi Z, Diwan AH, Rashid A, Hiatt K, Couriel D, Schultz K, Hymes S, Vogelsang GB. Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: II. Pathology Working Group Report. Biol Blood Marrow Transplant 12(1):31-47, 2006. e-Pub 2006. PMID: 16399567.
Chakravarti N, El-Naggar AK, Lotan R, Anderson J, Diwan AH, Saadati HG, Diba R, Prieto VG, Esmaeli B. Expression of retinoid receptors in sebaceous cell carcinoma. J Cutan Pathol 33(1):10-7, 2006. e-Pub 2006. PMID: 16441406.
Doherty SD, George S, Prieto VG, Gershenwald JE, Duvic M. Segmental neurofibromatosis in association with a large congenital nevus and malignant melanoma. Dermatol Online J 12(7):22, 2006. e-Pub 2006. PMID: 17459308.
Esmaeli B, De Martelaere S, Ozkan Y, Prager T, Prieto VG, Diwan AH. Surgical specimen handling for conjunctival melanoma: implications for tumor thickness determination and sentinel lymph node biopsy. Ophthal Plast Reconstr Surg 22(3):238-239, 2006. e-Pub 2006. PMID: 16714950.
Wang LE, Xiong P, Strom SS, Goldberg LH, Lee JE, Ross MI, Mansfield PF, Gershenwald JE, Prieto VG, Cormier JN, Duvic M, Clayman GL, Weber RS, Lippman SM, Amos CI, Spitz MR, Wei Q. In vitro sensitivity to ultraviolet B light and skin cancer risk: a case-control analysis. J Natl Cancer Inst 97(24):1822-31, 2005. e-Pub 2005. PMID: 16368944.
Berger AJ, Davis DW, Tellez C, Prieto VG, Gershenwald JE, Johnson MM, Rimm DL, Bar-Eli M. Automated quantitative analysis of activator protein-2alpha subcellular expression in melanoma tissue microarrays correlates with survival prediction. Cancer Res 65(23):11185-92, 2005. e-Pub 2005. PMID: 16322269.
Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, Prieto VG. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms. J Cutan Pathol 32(8):533-6, 2005. e-Pub 2005. PMID: 16115050.
Moore BA, Weber RS, Prieto VG, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 115(9):1561-1567, 2005. e-Pub 2005. PMID: 16148695.
Lee P, Zhu CC, Sadick NS, Diwan AH, Zhang PS, Liu JS, Prieto VG. Expression of androgen receptor coactivator ARA70/ELE1 in androgenic alopecia. J Cutan Pathol 32(8):567-71, 2005. e-Pub 2005. PMID: 16115056.
Chen LL, Sabripour M, Wu EF, Prieto VG, Fuller GN, Frazier ML. A mutation-created novel intra-exonic pre-mRNA splice site causes constitutive activation of KIT in human gastrointestinal stromal tumors. Oncogene 24(26):4271-80, 2005. e-Pub 2005. PMID: 15824741.
Sánchez-Ortiz R, Huang SF, Tamboli P, Prieto VG, Hester G, Pettaway CA. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. J Urol 173(6):1958-65, 2005. e-Pub 2005. PMID: 15879790.
Prieto VG, Zhang PS, Sadick NS. Evaluation of pulsed light and radiofrequency combined for the treatment of acne vulgaris with histologic analysis of facial skin biopsies. J Cosmet Laser Ther 7(2):63-8, 2005. e-Pub 2005. PMID: 16537210.
Prieto VG, Diwan AH, Shea CR, Zhang P, Sadick NS. Effects of intense pulsed light and the 1,064 nm Nd:YAG laser on sun-damaged human skin: histologic and immunohistochemical analysis. Dermatol Surg 31(5):522-5, 2005. e-Pub 2005. PMID: 15962734.
Diwan AH, Prieto VG, Herling M, Duvic M, Jone D. Primary Sézary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism. Am J Clin Pathol 123(4):510-5, 2005. e-Pub 2005. PMID: 15743738.
Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SM. Mortality risk from squamous cell skin cancer. J Clin Oncol 23(4):759-65, 2005. e-Pub 2005. PMID: 15681519.
Ward JL, Prieto VG, Joseph A, Chevray P, Kronowitz S, Sturgis EM. Neurothekeoma. Otolaryngol Head Neck Surg 132(1):86-9, 2005. e-Pub 2005. PMID: 15632914.
Ivan D, Hafeez Diwan A, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol 18(1):137-42, 2005. e-Pub 2005. PMID: 15389254.
Torres HA, Prieto VG, Raad II, Kontoyiannis DP. Proven pulmonary cryptococcosis due to capsule-deficient Cryptococcus neoformans does not differ clinically from proven pulmonary cryptococcosis due to capsule-intact Cr. neoformans. Mycoses 48(1):21-4, 2005. e-Pub 2005. PMID: 15679661.
Esmaeli B, Prieto VG, Gonnering R, Hawes MJ, Diba R, Saadati HG, Shepler TR, Karcioglu Z. Growth factor receptor expression in orbital lymphangioma: possible therapeutic implications. Orbit 23(4):263-9, 2004. e-Pub 2004. PMID: 15590529.
Hazarika P, McCarty MF, Prieto VG, George S, Babu D, Koul D, Bar-Eli M, Duvic M. Up-regulation of Flotillin-2 is associated with melanoma progression and modulates expression of the thrombin receptor protease activated receptor 1. Cancer Res 64(20):7361-9, 2004. e-Pub 2004. PMID: 15492257.
Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, Raymond AK, Prieto VG, Oyedeji CO, Hunt KK, Pollock RE, Feig BW, Hayes KJ, Choi H, Macapinlac HA, Hittelman W, Velasco MA, Patel S, Burgess MA, Benjamin RS, Frazier ML. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res 64(17):5913-9, 2004. e-Pub 2004. PMID: 15342366.
Ellerhorst JA, Naderi AA, Johnson MK, Pelletier P, Prieto VG, Diwan AH, Johnson MM, Gunn DC, Yekell S, Grimm EA. Expression of thyrotropin-releasing hormone by human melanoma and nevi. Clin Cancer Res 10(16):5531-6, 2004. e-Pub 2004. PMID: 15328193.
Butler CE, Prieto VG. Reduction of adhesions with composite AlloDerm/polypropylene mesh implants for abdominal wall reconstruction. Plast Reconstr Surg 114(2):464-73, 2004. e-Pub 2004. PMID: 15277815.
Pisters PW, Patel SR, Prieto VG, Thall PF, Lewis VO, Feig BW, Hunt KK, Yasko AW, Lin PP, Jacobson MG, Burgess MA, Pollock RE, Zagars GK, Benjamin RS, Ballo MT. Phase I trial of preoperative doxorubicin-based concurrent chemoradiation and surgical resection for localized extremity and body wall soft tissue sarcomas. J Clin Oncol 22(16):3375-80, 2004. e-Pub 2004. PMID: 15310783.
Ivan D, Diwan AH, Esteva FJ, Prieto VG. Expression of cell cycle inhibitor p27Kip1 and its inactivator Jab1 in melanocytic lesions. Mod Pathol 17(7):811-8, 2004. e-Pub 2004. PMID: 15154004.
Bayer-Garner IB, Prieto VG, Smoller BR. Detection of clonality with kappa and lambda immunohistochemical analysis in cutaneous plasmacytomas. Arch Pathol Lab Med 128(6):645-8, 2004. e-Pub 2004. PMID: 15163236.
Garcia-Uribe A, Kehtarnavaz N, Marquez G, Prieto VG, Duvic M, Wang LV. Skin cancer detection by spectroscopic oblique-incidence reflectometry: classification and physiological origins. Appl Opt 43(13):2643-50, 2004. e-Pub 2004. PMID: 15130003.
Kim KB, Sanguino AM, Hodges C, Papadopoulos NE, Eton O, Camacho LH, Broemeling LD, Johnson MM, Ballo MT, Ross MI, Gershenwald JE, Lee JE, Mansfield PF, Prieto VG, Bedikian AY. Biochemotherapy in patients with metastatic anorectal mucosal melanoma. Cancer 100(7):1478-83, 2004. e-Pub 2004. PMID: 15042682.
Smith-Zagone MJ, Prieto VG, Hayes RA, Timperman WW, Diwan AH. HMB-45 (gp103) and MART-1 expression within giant cells in an atypical fibroxanthoma: a case report. J Cutan Pathol 31(3):284-6, 2004. e-Pub 2004. PMID: 14984584.
Dillon BJ, Prieto VG, Curley SA, Ensor CM, Holtsberg FW, Bomalaski JS, Clark MA. Incidence and distribution of argininosuccinate synthetase deficiency in human cancers. Cancer 100(4):826-33, 2004. e-Pub 2004. PMID: 14770441.
Esmaeli B, Reifler D, Prieto VG, Amir Ahmadi M, Hidaji L, Delpassand E, Ross MI. Conjunctival melanoma with a positive sentinel lymph node. Arch Ophthalmol 121(12):1779-83, 2003. e-Pub 2003. PMID: 14662601.
Wang H, Shen SS, Wang H, Diwan AH, Zhang W, Fuller GN, Prieto VG. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol 30(10):599-605, 2003. e-Pub 2003. PMID: 14744083.
Shen SS, Zhang PS, Eton O, Prieto VG. Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array. J Cutan Pathol 30(9):539-47, 2003. e-Pub 2003. PMID: 14507401.
Wong R, Couriel D, Prieto VG. The graft-versus-leukemia effect in leukemia cutis. Transplantation 76(3):619-20, 2003. e-Pub 2003. PMID: 12923456.
Prieto VG, Argenyi ZB, Barnhill RL, Duray PH, Elenitsas R, From L, Guitart J, Horenstein MG, Ming ME, Piepkorn MW, Rabkin MS, Reed JA, Selim MA, Trotter MJ, Johnson MM, Shea CR. Are en face frozen sections accurate for diagnosing margin status in melanocytic lesions?. Am J Clin Pathol 120(2):203-8, 2003. e-Pub 2003. PMID: 12931550.
Kontoyiannis DP, Chagua MR, Ramirez I, Prieto VG. Locally invasive auricular aspergillosis after ear piercing in a neutropenic patient with leukemia. Am J Hematol 73(4):296-7, 2003. e-Pub 2003. PMID: 12879439.
Esmaeli B, Burnstine MA, Ahmadi MA, Prieto VG. Docetaxel-induced histologic changes in the lacrimal sac and the nasal mucosa. Ophthal Plast Reconstr Surg 19(4):305-8, 2003. e-Pub 2003. PMID: 12878879.
Rousseau DL, Ross MI, Johnson MM, Prieto VG, Lee JE, Mansfield PF, Gershenwald JE. Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients. Ann Surg Oncol 10(5):569-74, 2003. e-Pub 2003. PMID: 12794025.
Biddle DA, Evans HL, Kemp BL, El-Naggar AK, Harvell JD, White WL, Iskandar SS, Prieto VG. Intraparenchymal nevus cell aggregates in lymph nodes: a possible diagnostic pitfall with malignant melanoma and carcinoma. Am J Surg Pathol 27(5):673-81, 2003. e-Pub 2003. PMID: 12717252.
Humble SD, Prieto VG, Horenstein MG. Cytokeratin 7 and 20 expression in epithelioid sarcoma. J Cutan Pathol 30(4):242-6, 2003. e-Pub 2003. PMID: 12680954.
Wang S, Stewart JM, Ross MI, Prieto VG. Extensive pigmented villonodular synovitis with markedly pigmented lymphadenopathy and its implication for differential diagnosis with malignant melanoma. Ann Diagn Pathol 7(2):95-9, 2003. e-Pub 2003. PMID: 12715334.
Clark SH, Duvic M, Prieto VG. Mycosis fungoides-like reaction in a patient treated with Gleevec. J Cutan Pathol 30(4):279-81, 2003. e-Pub 2003. PMID: 12680962.
Sadick NS, Prieto VG. The use of a new diode laser for hair removal. Dermatol Surg 29(1):30-3; discussion 33-4, 2003. e-Pub 2003. PMID: 12534509.
Ekmekcioglu S, Ellerhorst JA, Mumm JB, Zheng M, Broemeling L, Prieto VG, Stewart AL, Mhashilkar AM, Chada S, Grimm EA. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. Mol Cancer Ther 2(1):9-17, 2003. e-Pub 2003. PMID: 12533668.
Pichardo RO, Lu D, Sangueza OP, Prieto VG. What is your diagnosis? Bacterial dermatitis due to Corynebacterium species. Am J Dermatopathol 24(6):510-1, 2002. e-Pub 2002. PMID: 12481775.
Ballo MT, Gershenwald JE, Zagars GK, Lee JE, Mansfield PF, Strom EA, Bedikian AY, Kim KB, Papadopoulos NE, Prieto VG, Ross MI. Sphincter-sparing local excision and adjuvant radiation for anal-rectal melanoma. J Clin Oncol 20(23):4555-8, 2002. e-Pub 2002. PMID: 12454112.
Huttenbach Y, Prieto VG, Reed JA. Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation. J Cutan Pathol 29(9):562-8, 2002. e-Pub 2002. PMID: 12358815.
Esmaeli B, Prieto VG, Butler CE, Kim SK, Ahmadi MA, Kantarjian HM, Talpaz M. Severe periorbital edema secondary to STI571 (Gleevec). Cancer 95(4):881-7, 2002. e-Pub 2002. PMID: 12209733.
Prieto VG, Sadick NS, Shea CR. Androgenetic alopecia: analysis of proliferation and apoptosis. Arch Dermatol 138(8):1101-2, 2002. e-Pub 2002. PMID: 12164759.
Trejo O, Reed JA, Prieto VG. Atypical cells in human cutaneous re-excision scars for melanoma express p75NGFR, C56/N-CAM and GAP-43: evidence of early Schwann cell differentiation. J Cutan Pathol 29(7):397-406, 2002. e-Pub 2002. PMID: 12139634.
Sumner WE, Ross MI, Mansfield PF, Lee JE, Prieto VG, Schacherer CW, Gershenwald JE. Implications of lymphatic drainage to unusual sentinel lymph node sites in patients with primary cutaneous melanoma. Cancer 95(2):354-60, 2002. e-Pub 2002. PMID: 12124836.
Choi HR, Batsakis JG, Callender DL, Prieto VG, Luna MA, El-Naggar AK. Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindroma?. Am J Surg Pathol 26(6):778-83, 2002. e-Pub 2002. PMID: 12023583.
Esmaeli B, Naderi A, Hidaji L, Blumenschein G, Prieto VG. Merkel cell carcinoma of the eyelid with a positive sentinel node. Arch Ophthalmol 120(5):646-8, 2002. e-Pub 2002. PMID: 12003618.
Guitart J, Lowe L, Piepkorn M, Prieto VG, Rabkin MS, Ronan SG, Shea CR, Tron VA, White W, Barnhill RL. Histological characteristics of metastasizing thin melanomas: a case-control study of 43 cases. Arch Dermatol 138(5):603-8, 2002. e-Pub 2002. PMID: 12020220.
Esmaeli B, Cleary KL, Ho L, Safar S, Prieto VG. Leiomyosarcoma of the esophagus metastatic to the eyelid: a clinicopathologic report. Ophthal Plast Reconstr Surg 18(2):159-61, 2002. e-Pub 2002. PMID: 11897960.
Ballo MT, Strom EA, Zagars GK, Bedikian AY, Prieto VG, Mansfield PF, Lee JE, Gershenwald JE, Ross MI. Adjuvant irradiation for axillary metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 52(4):964-72, 2002. e-Pub 2002. PMID: 11958890.
Ellerhorst JA, Prieto VG, Ekmekcioglu S, Broemeling L, Yekell S, Chada S, Grimm EA. Loss of MDA-7 expression with progression of melanoma. J Clin Oncol 20(4):1069-74, 2002. e-Pub 2002. PMID: 11844832.
Prieto VG, Sadick NS, Lloreta J, Nicholson J, Shea CR. Effects of intense pulsed light on sun-damaged human skin, routine, and ultrastructural analysis. Lasers Surg Med 30(2):82-5, 2002. e-Pub 2002. PMID: 11870785.
Carlson JA, Mu XC, Slominski A, Weismann K, Crowson AN, Malfetano J, Prieto VG, Mihm MC. Melanocytic proliferations associated with lichen sclerosus. Arch Dermatol 138(1):77-87, 2002. e-Pub 2002. PMID: 11790170.
Lenert JT, Barnett CC, Kudelka AP, Sellin RV, Gagel RF, Prieto VG, Skibber JM, Ross MI, Pisters PW, Curley SA, Evans DB, Lee JE. Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 130(6):1060-7, 2001. e-Pub 2001. PMID: 11742339.
Esmaeli B, Eicher S, Popp J, Delpassand E, Prieto VG, Gershenwald JE. Sentinel lymph node biopsy for conjunctival melanoma. Ophthal Plast Reconstr Surg 17(6):436-42, 2001. e-Pub 2001. PMID: 11766025.
Ackley CD, Prieto VG, Horenstein MG, Bentley RC, Seigler HF, Shea CR. Primary cutaneous melanoma with cartilaginous differentiation. J Cutan Pathol 28(9):482-485, 2001. e-Pub 2001. PMID: 11553315.
Ekmekcioglu S, Ellerhorst J, Mhashilkar AM, Sahin AA, Read CM, Prieto VG, Chada S, Grimm EA. Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer 94(1):54-9, 2001. e-Pub 2001. PMID: 11668478.
Hoang MP, Prieto VG, Burchette JL, Shea CR. Recurrent melanocytic nevus: a histologic and immunohistochemical evaluation. J Cutan Pathol 28(8):400-6, 2001. e-Pub 2001. PMID: 11493377.
Sadick NS, Shea CR, Nicholson J, Gat M, Lunievski S, Prieto VG. A comparative clinical and histologic study of hair transplantation using Er:YAG, Er:YAG/CO2, and standard punch techniques. Dermatol Surg 27(9):807-12, 2001. e-Pub 2001. PMID: 11553169.
Ahmadi MA, Prieto VG, Clayman GL, Ginsberg LE, Esmaeli B. Lymphoepitheliomalike carcinoma of the orbit. Arch Ophthalmol 119(8):1206-8, 2001. e-Pub 2001. PMID: 11483092.
Allee JE, Saria EA, Rosenblum D, Prose NS, Prieto VG, Shea CR. Intrauterine epidermal necrosis. J Cutan Pathol 28(7):383-6, 2001. e-Pub 2001. PMID: 11437946.
Sadick NS, Prieto VG, Shea CR, Nicholson J, McCaffrey T. Clinical and pathophysiologic correlates of 1064-nm Nd:Yag laser treatment of reticular veins and venulectasias. Arch Dermatol 137(5):613-7, 2001. e-Pub 2001. PMID: 11346339.
Yeh YA, Hudson AR, Prieto VG, Shea CR, Smoller BR. Reassessment of lymphocytic atypia in the diagnosis of mycosis fungoides. Mod Pathol 14(4):285-8, 2001. e-Pub 2001. PMID: 11301344.
Licato LL, Prieto VG, Grimm EA. A novel preclinical model of human malignant melanoma utilizing bioreactor rotating-wall vessels. In Vitro Cell Dev Biol Anim 37(3):121-6, 2001. e-Pub 2001. PMID: 11370802.
Bettencourt MS, Burton CS, Prieto VG, Bossen EH, Shea CR. Recurrent papules on the left upper extremity of a 50-year-old man. Arch Dermatol 137(3):365-70, 2001. e-Pub 2001. PMID: 11255341.
Ekmekcioglu S, Ellerhorst J, Smid CM, Prieto VG, Munsell M, Buzaid AC, Grimm EA. Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res 6(12):4768-75, 2000. e-Pub 2000. PMID: 11156233.
Ruhoy SM, Prieto VG, Eliason SL, Grichnik JM, Burchette JL, Shea CR. Malignant melanoma with paradoxical maturation. Am J Surg Pathol 24(12):1600-14, 2000. e-Pub 2000. PMID: 11117780.
Sen F, Sen F, Zhang XX, Zhang XX, Prieto VG, Prieto VG, Shea CR, Shea CR, Qumsiyeh MB, Qumsiyeh MB. Increased incidence of trisomy 8 in acute myeloid leukemia with skin infiltration (leukemia cutis). Diagn Mol Pathol 9(4):190-4, 2000. e-Pub 2000. PMID: 11129442.
Sadick NS, Weiss RA, Shea CR, Nagel H, Nicholson J, Prieto VG. Long-term photoepilation using a broad-spectrum intense pulsed light source. Arch Dermatol 136(11):1336-40, 2000. e-Pub 2000. PMID: 11074695.
Horenstein MG, Prieto VG, Burchette JL, Shea CR. Keratotic melanocytic nevus: a clinicopathologic and immunohistochemical study. J Cutan Pathol 27(7):344-50, 2000. e-Pub 2000. PMID: 10917161.
Horenstein MG, Prieto VG, Nuckols JD, Burchette JL, Shea CR. Indeterminate fibrohistiocytic lesions of the skin: is there a spectrum between dermatofibroma and dermatofibrosarcoma protuberans?. Am J Surg Pathol 24(7):996-1003, 2000. e-Pub 2000. PMID: 10895822.
Antaya RJ, Prieto VG, Prose NS. Mucosal erosions and bullae in a child. Pemphigus vulgaris in a child with tinea. Arch Dermatol 136(5):669-70, 2000. e-Pub 2000. PMID: 10815864.
Diaz de Leon E, Carcangiu ML, Prieto VG, McCue PA, Burchette JL, To G, Norris BA, Kovatich AJ, Sanchez RL, Krigman HR, Gatalica Z. Extramammary Paget disease is characterized by the consistent lack of estrogen and progesterone receptors but frequently expresses androgen receptor. Am J Clin Pathol 113(4):572-5, 2000. e-Pub 2000. PMID: 10761460.
Carag HR, Prieto VG, Yballe LS, Shea CR. Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis. Arch Dermatol 136(4):471-5, 2000. e-Pub 2000. PMID: 10768645.
Cummings TJ, Shea CR, Reed JA, Burchette JL, Prieto VG. Expression of the intermediate filament peripherin in extraskeletal myxoid chondrosarcoma. J Cutan Pathol 27(3):141-6, 2000. e-Pub 2000. PMID: 10728817.
Hanft VN, Shea CR, McNutt NS, Pullitzer D, Horenstein MG, Prieto VG. CD34 in sclerotic plywood fibromas. Am J Dermatopathol 22(1):17-21, 2000. e-Pub 2000. PMID: 10698210.
Ruhoy, Prieto VG, Eliason SL, Grichnik JM, Burchette JL, Shea CR. Pseudomaturation pattern in invasive melanoma. . Am J Surg Pathol 24:1600-1614, 2000. e-Pub 2000.
Bettencourt MS, Prieto VG, Shea CR. Trichoepithelioma: a 19-year clinicopathologic re-evaluation. J Cutan Pathol 26(8):398-404, 1999. e-Pub 1999. PMID: 10551412.
Harris GR, Shea CR, Horenstein MG, Reed JA, Burchette JL, Prieto VG. Desmoplastic (sclerotic) nevus: an underrecognized entity that resembles dermatofibroma and desmoplastic melanoma. Am J Surg Pathol 23(7):786-94, 1999. e-Pub 1999. PMID: 10403301.
Calvert JT, Riney TJ, Kontos CD, Cha EH, Prieto VG, Shea CR, Berg JN, Nevin NC, Simpson SA, Pasyk KA, Speer MC, Peters KG, Marchuk DA. Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet 8(7):1279-89, 1999. e-Pub 1999. PMID: 10369874.
Sadick NS, Shea CR, Burchette JL, Prieto VG. High-intensity flashlamp photoepilation: a clinical, histological, and mechanistic study in human skin. Arch Dermatol 135(6):668-76, 1999. e-Pub 1999. PMID: 10376694.
Chai C, White WL, Shea CR, Prieto VG. Epstein Barr virus-associated lymphoproliferative-disorders primarily involving the skin. J Cutan Pathol 26(5):242-7, 1999. e-Pub 1999. PMID: 10408349.
Shea CR, Vollmer RT, Prieto VG. Correlating architectural disorder and cytologic atypia in Clark (dysplastic) melanocytic nevi. Hum Pathol 30(5):500-5, 1999. e-Pub 1999. PMID: 10333217.
Nuckols JD, Shea CR, Horenstein MG, Burchette JL, Prieto VG. Quantitation of intraepidermal T-cell subsets in formalin-fixed, paraffin-embedded tissue helps in the diagnosis of mycosis fungoides. J Cutan Pathol 26(4):169-75, 1999. e-Pub 1999. PMID: 10335893.
Dong XD, DeMatos P, Prieto VG, Seigler HF. Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer 85(1):32-9, 1999. e-Pub 1999. PMID: 9921971.
Nasi, Lieberman P, Busam KJ, Prieto VG, Panageas KS, Lewis JJ, Houghton AN, Chapman PB. Intradermal injection of granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with metastatic melanoma recruits dendritic cells. . Cytok Cell Mol Therapy 5:139-144, 1999. e-Pub 1999.
Perry BP, Gregg CM, Myers S, Lilly S, Mann KP, Prieto VG. Rosai-Dorfman disease (extranodal sinus histiocytosis) in a patient with HIV. Ear Nose Throat J 77:855-8, 1998. e-Pub 1998. PMID: 9818538.
Prieto VG. HIV/AIDS case histories: diagnostic problems. Diagnosis: Kaposi's sarcoma. AIDS Patient Care STDS 12:715-6, 1998. e-Pub 1998. PMID: 15468446.
Prieto VG, Woodruff JM. Expression of basement membrane antigens in spindle cell melanoma. J Cutan Pathol 25(6):297-300, 1998. e-Pub 1998. PMID: 9694618.
Prieto VG, Sadick NS, McNutt NS. Quantitative immunohistochemical differences in Langerhans cells in dermatitis due to internal versus external antigen sources. J Cutan Pathol 25(6):301-10, 1998. e-Pub 1998. PMID: 9694619.
Rosenbaum M, Prieto VG, Hellmer J, Boschmann M, Krueger J, Leibel RL, Ship AG. An exploratory investigation of the morphology and biochemistry of cellulite. Plast Reconstr Surg 101:1934-9, 1998. e-Pub 1998. PMID: 9623840.
Mancini AJ, Prieto VG, Smoller BR. Role of cellular proliferation and apoptosis in the growth of xanthogranulomas. Am J Dermatopathol 20(1):17-21, 1998. e-Pub 1998. PMID: 9504664.
Wallace ML, Grichnik JM, Prieto VG, Shea CR. Numbers and differentiation status of melanocytes in idiopathic guttate hypomelanosis. J Cutan Pathol 25(7):375-379, 1998. e-Pub 1998. PMID: 9765023.
Motzer RJ, Amsterdam A, Prieto VG, Sheinfeld J, Murty VVS, Mazumdar M, Bosl GJ, Chaganti RSK, Reuter VE. Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell. . J Urol 159:133-138, 1998. e-Pub 1998.
Prieto VG, McNutt NS, Lugo J, Reed JA. Differential expression of the intermediate filament peripherin in cutaneous neural lesions and neurotized melanocytic nevi. Am J Surg Pathol 21(12):1450-4, 1997. e-Pub 1997. PMID: 9414188.
Horenstein MG, Cesarman E, Wang X, Linkov I, Prieto VG, Louie DC. Cyclin D1 and retinoblastoma protein expression in Kaposi's sarcoma. J Cutan Pathol 24(10):585-9, 1997. e-Pub 1997. PMID: 9449484.
Prieto VG, Woodruff J. Expression of HMB45 antigen in spindle cell melanoma. J Cutan Pathol 24(9):580-581, 1997. e-Pub 1997. PMID: 9404857.
Prieto VG, Kenet BJ, Varghese M. Malignant mesothelioma metastatic to the skin, presenting as inflammatory carcinoma. Am J Dermatopathol 19(3):261-5, 1997. e-Pub 1997. PMID: 9185913.
Prieto VG, McNutt NS, Lugo J, Reed JA. The intermediate filament peripherin is expressed in cutaneous melanocytic lesions. J Cutan Pathol 24(3):145-50, 1997. e-Pub 1997. PMID: 9085149.
Prieto VG, McNutt NS, Prioleau PG, Shea CR. Scaly erythematous lesion in a patient with extensive solar damage. Malignant melanoma in situ, amelanotic type. Arch Dermatol 132(10):1239, 1242, 1996. e-Pub 1996. PMID: 8859038.
Trager JD, Prieto VG, McNutt N, Granstein RD, Scott RA. Multiple inguinal nodules in a seventy year-old man. J Cutan Med Surg 1(1):19-24, 1996. e-Pub 1996.
Prieto VG, Lugo J, McNutt NS. Intermediate- and low-molecular-weight keratin detection with the monoclonal antibody MNF116. An immunohistochemical study on 232 paraffin-embedded cutaneous lesions. J Cutan Pathol 23(3):234-41, 1996. e-Pub 1996. PMID: 8793658.
Prieto VG, Ali SZ, DiFrancesco LM, Delgado R. Endobronchial polypoid adenocarcinoma of the lung with osseous metaplasia. . J Surg Pathol 2:1-4, 1996. e-Pub 1996.
Prieto VG, Reed JA, McNutt NS, Bogdany JK, Lugo J, Shea CR. Differential expression of CD44 in malignant cutaneous epithelial neoplasms. Am J Dermatopathol 17(5):447-51, 1995. e-Pub 1995. PMID: 8599448.
Kirchmann TT, Prieto VG, Smoller BR. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms. J Cutan Pathol 22(5):422-6, 1995. e-Pub 1995. PMID: 8594074.
Prieto VG, Reed JA, Shea CR. Immunohistochemistry of dermatofibromas and benign fibrous histiocytomas. J Cutan Pathol 22(4):336-41, 1995. e-Pub 1995. PMID: 7499573.
Prieto VG, Reed JA, Shea CR. CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans. J Cutan Pathol 21(4):324-9, 1994. e-Pub 1994. PMID: 7528229.
Reed JA, McNutt NS, Prieto VG, Albino AP. Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Am J Pathol 145(1):97-104, 1994. e-Pub 1994. PMID: 8030760.
Kirchmann TT, Prieto VG, Smoller BR. CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch Dermatol 130(5):589-92, 1994. e-Pub 1994. PMID: 7513986.
Prieto VG, McNutt NS. Immunohistochemical detection of keratin with the monoclonal antibody MNF116 is useful in the diagnosis of epidermolysis bullosa simplex. J Cutan Pathol 21(2):118-22, 1994. e-Pub 1994. PMID: 7518848.
Albino AP, Vidal MJ, McNutt NS, Shea CR, Prieto VG, Nanus DM, Palmer JM, Hayward NK. Mutation and expression of the p53 gene in human malignant melanoma. Melanoma Res 4(1):35-45, 1994. e-Pub 1994. PMID: 8032216.
Prieto VG, Kanik A, Salob S, McNutt NS. Primary cutaneous myxoid melanoma: immunohistologic clues to a difficult diagnosis. J Am Acad Dermatol 30:335-9, 1994. e-Pub 1994. PMID: 8294593.
Shea CR, Prieto VG. Mast cells in lipomas and hemangiomas of human skin: are they important for angiogenesis? . J Cutan Pathol 21:247-251, 1994. e-Pub 1994.
Bielsa O, Vesa Llanes J, Arango Toro O, Llado Carbonell C, Prieto VG, Corominas JM, Gelabert Mas C. [Undifferentiated small cell carcinoma of the urinary bladder. Clinicopathologic and immunohistochemical study]. Arch Esp Urol 46:525-7, 1993. e-Pub 1993. PMID: 8397496.
Prieto VG, Casal M, McNutt NS. Immunohistochemistry detects differences between lichen planus-like keratosis, lichen planus, and lichenoid actinic keratosis. J Cutan Pathol 20(2):143-7, 1993. e-Pub 1993. PMID: 8320359.
Prieto VG, Casal M, McNutt NS. Lichen planus-like keratosis. A clinical and histological reexamination. Am J Surg Pathol 17(3):259-63, 1993. e-Pub 1993. PMID: 8434706.
McNutt, Trimble CL, Prieto VG. El papel de las células positivas para el Factor XIIIa en el tejido conectivo del feto y tumores de las partes blandas del adulto (The role of Factor XIIIa-positive cells in fetal connective tissue and connective tissue tumors in adults). . Patología 26:1-6, 1993. e-Pub 1993.
Lloreta J, Tusquets I, Prieto VG, Serrano S, Prat J. Primary neuroectodermal tumor of bone. Report of a case in an adult. . Surg Pathol 3:325-331, 1990. e-Pub 1990.
Corominas JM, Munné A, Serrano S, Lloreta J, Nogueroles A, Prieto VG. Utilidad de las microondas en el laboratorio de Anatomía Patológica (Usefulness of the microwave oven in the laboratory of pathology). Patología 20:288-294, 1987. e-Pub 1987.

Invited Articles

Wang WL, Torres-Cabala C, Curry JL, Ivan D, McLemore M, Tetzlaff M, Zembowicz A, Prieto VG, Lazar AJ. Metastatic atypical fibroxanthoma: a series of 11 cases including with minimal and no subcutaneous involvement:455-61, 2015. e-Pub 2015.
Shea CR, Prieto VG. Memories of the McNutt fellowship. J Cutan Pathol 35 Suppl 2:iv-vi, 2008. e-Pub 2008. PMID: 18976411.
Yee KW, Hymes SR, Heller L, Prieto VG, Welch MA, Giles FJ. Cutaneous leukocytoclastic vasculitis in a patient with myelodysplastic syndrome after therapy with the rapamycin analogue everolimus: case report and review of the literature. Leuk Lymphoma 47(5):926-9, 2006. e-Pub 2006. PMID: 16753882.
Chagua MR, Prieto VG, Ramirez I, Kontoyiannis DP. Locally Invasive Auricular Aspergillosis after Ear Piercing in a Neutropenic Patient with Leukemia. Am J Hematol(73):296-297, 2003. e-Pub 2003.

Review Articles

Shea CR, Prieto VG, Shachaf CM, Florell SR. Grading Melanocytic Dysplasia. J Cutan Pathol 53(1):29-37, 2026. e-Pub 2026. PMID: 39532696.
de la Fouchardière, A, Mazzei, ME, Pastor, M, Forster, AM, Prieto, V. Spitz tumours and mimickers. Virchows Archiv 486(1):143-164, 2025. e-Pub 2025. PMID: 39500756.
Li YJ, Prieto VG, Tayar J. Case of new-onset scleromyxoedema-scleroedema spectrum disorder in a patient with CLL. RMD Open 9(4):e003638, 2023. e-Pub 2023. PMID: 38016711.
Dimopoulos YP, Ivan D, Prieto VG, Aung PP. Chordoma metastatic to skin: A report of two cases and a brief review of the literature. J Cutan Pathol 50(6):500-504, 2023. e-Pub 2023. PMID: 36349402.
Liu YA, Dai J, Nagarajan P, Torres-Cabala CA, Aung PP, Prieto VG, Cho WC. Pityriasis Rubra Pilaris after Moderna COVID-19 Vaccination. Am J Dermatopathol 45(3):185-188, 2023. e-Pub 2023. PMID: 36626570.
Trinidad CM, Wangsiricharoen S, Prieto VG, Aung PP. Rare Variants of Dermatofibrosarcoma Protuberans. Dermatopathology (Basel) 10(1):54-62, 2023. e-Pub 2023. PMID: 36810566.
Seervai RNH, Friske SK, Chu EY, Phillips R, Nelson KC, Huen A, Cho WC, Aung PP, Torres-Cabala CA, Prieto VG, Curry JL. The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapy. J Cutan Pathol 50(1):72-95, 2023. e-Pub 2023. PMID: 36069496.
Seervai RNH, Cho WC, Chu EY, Marques-Piubelli ML, Ledesma DA, Richards K, Heberton MM, Nelson KC, Nagarajan P, Torres-Cabala CA, Prieto VG, Curry JL. Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy. J Cutan Pathol 49(1):61-81, 2022. e-Pub 2021. PMID: 34622477.
Gill P, Richards K, Cho WC, Nagarajan P, Aung PP, Ivan D, Curry JL, Prieto VG, Torres-Cabala CA. Localized cutaneous argyria: Review of a rare clinical mimicker of melanocytic lesions. Ann Diagn Pathol 54:151776, 2021. e-Pub 2021. PMID: 34214703.
Shyu I, Johnson KA, Gratzinger D, Brissette MD, Childs JM, Dixon LR, George MR, McCloskey CB, Prieto VG, Rojiani AM, Timmons CF, Hoffman RD. Positive Job Search Experience for New Pathologists Seeking First Employment Between 2017-2019. Arch Pathol Lab Med 145(9):1117-1122, 2021. e-Pub 2021. PMID: 33417677.
Cho WC, Prieto VG, Aung PP. Melanocytic lesions with blue naevus-like (dendritic) morphology. Histopathology 79(3):291-305, 2021. e-Pub 2021. PMID: 33772838.
Prieto VG. Common traps/pitfalls and emergency diagnosis in dermatopathology. Mod Pathol 33(Suppl 1):128-139, 2020. e-Pub 2020. PMID: 31673083.
Scolyer RA, Rawson RV, Gershenwald JE, Ferguson PM, Prieto VG. Melanoma pathology reporting and staging. Mod Pathol 33(Suppl 1):15-24, 2020. e-Pub 2020. PMID: 31758078.
Trinidad CM, Torres-Cabala CA, Prieto VG, Aung PP. Update on eighth edition American Joint Committee on Cancer classification for Merkel cell carcinoma and histopathological parameters that determine prognosis. J Clin Pathol 72(5):337-340, 2019. e-Pub 2019. PMID: 30636696.
Trinidad CM, Torres-Cabala CA, Curry JL, Prieto VG, Aung PP. Update on eighth edition American Joint Committee on Cancer classification for cutaneous melanoma and overview of potential pitfalls in histological examination of staging parameters. J Clin Pathol 72(4):265-270, 2019. e-Pub 2019. PMID: 30275100.
Shustef E, Kazlouskaya V, Prieto VG, Ivan D, Aung PP. Cutaneous angiosarcoma: a current update. J Clin Pathol 70(11):917-925, 2017. e-Pub 2017. PMID: 28916596.
Prieto VG. Sentinel Lymph Nodes in Cutaneous Melanoma. Clin Lab Med 37(3):417-430, 2017. e-Pub 2017. PMID: 28802493.
Tetzlaff MT, Reuben A, Billings SD, Prieto VG, Curry JL. Toward a Molecular-Genetic Classification of Spitzoid Neoplasms. Clin Lab Med 37(3):431-448, 2017. e-Pub 2017. PMID: 28802494.
Curry JL, Tetzlaff MT, Nagarajan P, Drucker C, Diab A, Hymes SR, Duvic M, Hwu WJ, Wargo JA, Torres-Cabala CA, Rapini RP, Prieto VG. Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol 44(2):158-176, 2017. e-Pub 2017. PMID: 27859479.
Mauzo SH, Ferrarotto R, Bell D, Torres-Cabala CA, Tetzlaff MT, Prieto VG, Aung PP. Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma. J Clin Pathol 69(5):382-90, 2016. e-Pub 2016. PMID: 26818033.
Chakravarti N, Prieto VG. Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis. Transl Lung Cancer Res 4(6):743-51, 2015. e-Pub 2015. PMID: 26798583.
Aung PP, Mutyambizi KK, Danialan R, Ivan D, Prieto VG. Differential diagnosis of heavily pigmented melanocytic lesions: challenges and diagnostic approach. J Clin Pathol 68(12):963-70, 2015. e-Pub 2015. PMID: 26602414.
Danialan R, Mutyambizi K, Aung P, Prieto VG, Ivan D. Challenges in the diagnosis of cutaneous adnexal tumours. J Clin Pathol 68(12):992-1002, 2015. e-Pub 2015. PMID: 26602416.
Tetzlaff MT, Torres-Cabala CA, Pattanaprichakul P, Rapini RP, Prieto VG, Curry JL. Emerging clinical applications of selected biomarkers in melanoma. Clin Cosmet Investig Dermatol 8:35-46, 2015. e-Pub 2015. PMID: 25674009.
Nicholson KM, Patel KP, Duvic M, Prieto VG, Tetzlaff MT. Bi-clonal, multifocal primary cutaneous marginal zone B-cell lymphoma: report of a case and review of the literature. J Cutan Pathol 39(9):866-71, 2012. e-Pub 2012. PMID: 22809282.
Requena L, Prieto VG, Requena C, Sarasa JL, Manzano R, Seco M, Rütten A, Kazakov DV, Cerroni L, Kutzner H. Primary signet-ring cell/histiocytoid carcinoma of the eyelid: a clinicopathologic study of 5 cases and review of the literature. Am J Surg Pathol 35(3):378-91, 2011. e-Pub 2011. PMID: 21317710.
Patnana M, Bronstein Y, Szklaruk J, Bedi DG, Hwu WJ, Gershenwald JE, Prieto VG, Ng CS. Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma. Clin Radiol 66(3):224-36, 2011. e-Pub 2011. PMID: 21295201.
Prieto VG. Sentinel lymph nodes in cutaneous melanoma: handling, examination, and clinical repercussion. Arch Pathol Lab Med 134(12):1764-9, 2010. e-Pub 2010. PMID: 21128773.
Jain S, Xu R, Prieto VG, Lee P. Molecular classification of soft tissue sarcomas and its clinical applications. Int J Clin Exp Pathol 3(4):416-28, 2010. e-Pub 2010. PMID: 20490332.
Fox MC, Carter S, Khouri IF, Giralt SA, Prieto VG, Nash JW, Hymes SR. Adult Henoch-schönlein purpura in a patient with myelodysplastic syndrome and a history of follicular lymphoma. Cutis 81(2):131-7, 2008. e-Pub 2008. PMID: 18441766.
Cho-Vega JH, Medeiros L, Prieto VG, Vega F. Leukemia cutis. Am J Clin Pathol 129(1):130-42, 2008. e-Pub 2008. PMID: 18089498.
Radhakrishnan R, Donato ML, Prieto VG, Mays SR, Raad II, Kuerer HM. Invasive cutaneous fungal infections requiring radical resection in cancer patients undergoing chemotherapy. J Surg Oncol 88(1):21-26, 2004. e-Pub 2004. PMID: 15384060.
Singh A, Prieto VG, Czelusta A, McClain KL, Duvic M. Adult Langerhans cell histiocytosis limited to the skin. Dermatology 207(2):157-61, 2003. e-Pub 2003. PMID: 12920365.
Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol 6(4):257-64, 2002. e-Pub 2002. PMID: 12170459.
Hwong H, Jones D, Prieto VG, Schulz C, Duvic M. Persistent atypical lymphocytic hyperplasia following tick bite in a child: report of a case and review of the literature. Pediatr Dermatol 18(6):481-4, 2001. e-Pub 2001. PMID: 11841632.
Fowler VG, Maxwell GL, Myers SA, Shea CR, Livengood CN, Prieto VG, Hicks CB. Failure of benzathine penicillin in a case of seronegative secondary syphilis in a patient with acquired immunodeficiency syndrome: case report and review of the literature. Arch Dermatol 137(10):1374-6, 2001. e-Pub 2001. PMID: 11594871.
Prieto VG, Shea CR. Selected cutaneous vascular neoplasms. A review. Dermatol Clin 17(3):507-20, viii, 1999. e-Pub 1999. PMID: 10410855.
DeMatos P, Wolfe WG, Shea CR, Prieto VG, Seigler HF. Primary malignant melanoma of the esophagus. J Surg Oncol 66(3):201-6, 1997. e-Pub 1997. PMID: 9369967.
Cortadellas R, Prieto VG, Castellanos R, Guzman A, Ballesteros JJ. Metastasis ureteral de adenocarcinoma de prostata. Revision de la literature.( Usefulness of the microwave oven in the laboratory of pathology). Arch Esp Urol 42:19-22, 1989. e-Pub 1989. PMID: 2653236.

Abstracts

Prieto VG. Yes-Associated Protein 1 (YAP1) Expression is Higher in Metastatic than Primary Melanoma in an Acral Lentiginous Melanoma-Enriched Series of Cases. 2026 USCAP 115th Annual Meeting. e-Pub 2025.
Prieto VG. Primary Cutaneous Apocrine Carcinomas Frequently Harbor Breast Carcinoma-Associated Somatic Mutations, Including Those Involved in PI3K/AKT/mTOR Pathway Activation, as Well as Gene Fusions. 2026 USCAP 115th Annual Meeting. e-Pub 2025.
Prieto VG. Skeletal Muscle Invasion in Merkel Cell Carcinomas of the Head and Neck Is Associated With Adverse Clinical and Pathologic Outcomes: A Tertiary Cancer Center Experience. 2026 USCAP 115th Annual Meeting. e-Pub 2025.
Prieto VG. Dedifferentiated and Undifferentiated Melanomas Frequently Harbor BRAF, NRAS, or NF1 Mutations Activating the MAPK Pathway and TERT Promoter Mutations. 2026 USCAP 115th Annual Meeting. e-Pub 2025.
Prieto VG. Next-Generation Sequencing Reveals Subtype-Specific Gene Amplifications in Melanomas. 2026 USCAP 115th Annual Meeting. e-Pub 2025.
Wangsiricharoen S, Wakely Jr PE, Prieto VG, Yu W. Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review. Histopathology 83(5):712-721, 2023. e-Pub 2023. PMID: 37442637.
Cho WC, Vanderbeck K, Nagarajan P, Milton DR, Gill P, Wang WL, Curry JL, Torres-Cabala CA, Ivan D, Prieto VG, Aung PP. SOX11 Serves as an Effective Discriminatory Marker, When Used in Conjunction with CK20 and TTF1, for Merkel Cell Carcinoma: A Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expressions in Merkel Cell Carcinomas and Pulmonary Small Cell Carcinomas. Arch Pathol Lab Med 147(7):758-766, 2023. e-Pub 2023.
Ronen S, Billings S, Mcniff J, Torres-Cabala C, George S, Heberton M, Thomas V, Aung P, Curry J, Cho WC, Ivan D, Prieto VG, Nagarajan P. Extramammary Post-Radiation Atypical Vascular Lesions: A Clinicopathologic Study of Eight Cases. Mod Pathol 35(Suppl 2):350-351, 2022. e-Pub 2022.
Aung P, Gill P, Lai Z, Zhu K, Vasudevaraja V, Ivan D, Nagarajan P, Cho WC, Ballester L, Curry J, Torres-Cabala C, Prieto VG, Jour G. Multi-omics analysis of digital papillary adenocarcinoma reveals upregulation of MAGEA4 and infrequent zinc finger genes rearrangements. Mod Pathol 35(Suppl 2):319-320, 2022. e-Pub 2022.
Rothrock A, Cho WC, Nagarajan P, Curry J, Vanderbeck K, Ivan D, Prieto VG, Torres-Cabala C, Aung P. Diagnostic Utility of PRAME Immunohistochemistry in Subungual and Acral Melanocytic Lesions. Mod Pathol 35(Suppl 2):351-352, 2022. e-Pub 2022.
Gill P, John T, Tarrand J, Jiang X, Ning J, Aung P, Cho WC, Curry J, Torres-Cabala C, Ivan D, Prieto VG, Nagarajan P. Cutaneous Deep Fungal Infections: Retrospective Review at a Tertiary Care Cancer Center. Mod Pathol 35(Suppl 2):329-330, 2022. e-Pub 2022.
Nagarajan P, Gleber-Netto F, Parra E, Pickering C, Davies M, Aung P, Cho WC, Torres-Cabala C, Curry J, Ivan D, Prieto VG, Pettaway C. Exploratory Analyses of Tumor-Infiltrating Inflammatory Cells in Male Genitourinary Melanoma. Mod Pathol 35(Suppl 2):344-345, 2022. e-Pub 2022.
Ronen S, Al-Rohil RN, Keiser E, Jour G, Nagarajan P, Tetzlaff MT, Curry JL, Ivan D, Middleton LP, Torres-Cabala CA, Gershenwald JE, Aung PP, Prieto VG. Discordance in Diagnosis of Melanocytic Lesions and Its Impact on Clinical Management. Arch Pathol Lab Med 145(12):1505-1522, 2021. e-Pub 2021. PMID: 33577643.
Gill P, Prieto VG, Austin MT, Giubellino A, Torres-Cabala CA. Diagnostic utility of PRAME in distinguishing proliferative nodules from melanoma in giant congenital melanocytic nevi. J Cutan Pathol 48(11):1410-1415, 2021. e-Pub 2021. PMID: 34164835.
Collins K, Gu J, Aung PP, Nagarajan P, Curry JL, Huen A, Ivan D, Prieto VG, Tetzlaff MT, Duvic M, Miranda RN, Vega F, Torres-Cabala CA. Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders?. Virchows Arch 479(2):377-383, 2021. e-Pub 2021. PMID: 33604757.
Gill P, Cho WC, Prieto VG, Nagarajan P. Metaplasia Mimicking Malignancy: A Challenging Case of Florid Eccrine Squamous Syringometaplasia. J Cutan Pathol, 2021. e-Pub 2021. PMID: 33749861.
Jebain J, Siller A, Gill P, Prieto VG, Tyring SK. Recurrence of mucosal melanoma in Li-Fraumeni syndrome. JAAD Case Rep 10:31-33, 2021. e-Pub 2021. PMID: 33732843.
Mejbel HA, Torres-Cabala CA, Milton DR, Ivan D, Feldmeyer L, Namikawa K, Nagarajan P, Tetzlaff MT, Curry JL, Ross MI, Hwu WJ, Prieto VG, Aung PP. Prognostic significance of acral lentiginous histologic type in T1 melanoma. Mod Pathol 34(3):572-583, 2021. e-Pub 2021. PMID: 32759976.
Chin KE, Kwon D, Gan Q, Ramalingam PX, Wistuba II, Prieto VG, Aung PP. Transition From a Standard to a Hybrid On-Site and Remote Anatomic Pathology Training Model During the Coronavirus Disease 2019 (COVID-19) Pandemic. Arch Pathol Lab Med 145(1):22-31, 2021. e-Pub 2021. PMID: 32937659.
Tzelaff M, Mublbauer A, Wang J, Nelson KC, Nagarajan P, Aung PP, Torres Cabalas CA, Pacha, O, Prieto VG, Subramanya, S, Wistuba II, Curry JL. Differentially Expressed Genes in Bullous Pemphigoid Immune-related Adverse Event (BP-irAE) from Immune Checkpoint Inhibitor Thera[y: Implications in the Immunopathogenic Mechanisms Driving BP-irAE Compared to de novo BP Control. 2020 USCAP Annual Meeting, 2020. e-Pub 2020.
Ronen S, Ivan D, Torres-Cabala CA, Curry JL, Tetzlaff MT, Aung PP, Nagarajan P, Suster S, Prieto VG. Post-radiation vascular lesions of the breast. J Cutan Pathol 46(1):52-58, 2019. e-Pub 2019. PMID: 30251277.
Curry JL, Tetzlaff MT, Wang SA, Landon G, Alouch N, Patel SP, Nagarajan P, Gupta S, Aung PP, Devine CE, Khoury JD, Loghavi S, Prieto VG, DiNardo CD, Gershenwald JE. Case Report of Myeloid Sarcoma Masquerading as In-Transit Metastasis at a Previous Melanoma Site: Avoiding a Diagnostic Pitfall. Am J Dermatopathol 40(11):831-835, 2018. e-Pub 2018. PMID: 29863571.
Ng CS, Altinmakas E, Wei W, Ghosh P, Li X, Grubbs EG, Perrier NA, Prieto VG, Lee JE, Hobbs BP. Combining Washout and Noncontrast Data From Adrenal Protocol CT: Improving Diagnostic Performance. Acad Radiol, 2018. e-Pub 2018. PMID: 29398440.
Mauzo SH, Ferrarotto R, Bell D, Cabala CT, Tetzlaff MT, Prieto VG, Aung PP. Molecular characteristics and potential therapeutic targets in Merkel cell carcinoma. J Clin Pathol 69(5):382-90, 2016. e-Pub 2016. PMID: 26818033.
Stockman DL, Curry JL, Russell BR, Lazar AJ, Prieto VG, Tetzlaff MT. Clinical Next Generation Sequencing (NGS) Identifies a Subset of Melanomas Harboring SMARCB1 Mutations. Laboratory Investigation, 2014. e-Pub 2014.
Siroy AE, Prieto VG, Gershenwald JE, Woodman SE, Roszik J, Aldape KD, Luthra R, Patel KP, Routbort MJ, Davies MA, Lazar AJ. Clinical Next-Generation Sequencing Reveals Divergent Mutational Patterns in BRAFV600,BRAF Non-V600, and NRAS Mutations in Advanced Melanoma. Laboratory Investigation, 2014. e-Pub 2014.
Henderson SA, Tetzlaff MT, Pattanaprichakul P, Fox PS, Torres-Cabala CA, Bassett RL, Prieto VG, Richards HW, Curry JL. Immunohistochemistry for Histone H3K79me3T80ph Is Superior to PHH3 in the Detection of Mitotic Chromatin and G2 Positive Nuclei in Merkel Cell Carcinoma. Lab Invest, 2014. e-Pub 2014.
Henderson SA, Curry JL, Cabala CAT, Ivan DS, Bassett RL, Prieto VG, Tetzlaff MT. p40 Improves Diagnostic Specificity between Atypical Fibroxanthoma and Poorly Differentiated Squamous Cell Carcinoma. Laboratory Investigation, 2014. e-Pub 2014.
Bucheit AD, Joseph RW, Milton D, Fox P, Bassett R, Gershenwald JE, Tetzlaff MT, Prieto VG, Lazar AJ, Davies MA. PTEN loss correlates with shorter time to brain metastasis and overall survival in stage IIIB/C melanoma patients. European Journal of Cancer, 2013. e-Pub 2013.
Chakravarti N, Bassett RL, Curry JL, Tetzlaff M, Prieto VG. Differential cellular localization of activating transcription factor 3 (ATF3) in melanoma progression. Journal of Investigative Dermatology, 2013. e-Pub 2013.
Litvinov IV, Tetzlaff MT, Rahme E, Gangar P, Tetzlaff M, Pehr K, Prieto VG, Sasseville D, Duvic M. Identification of cutaneous T-cell lymphoma geographic hotspots in Houston metropolitan area. J Invest Dermatol 133(Suppl 1):S1-311, 2013. e-Pub 2013.
Tetzlaff MT, Curry JL, Stockman DL, Ivan K, Wang WL, Valendia KM, Bassett R, Torres-Cabala CA, Prieto VG. Immunodetection of Phosphohistone H3 (PHH3) as a Surrogate of Mitotic Figure Count and Clinical Outcome in Cutaneous Melanoma. Laboratory Investigation, 2013. e-Pub 2013.
Kapil JP, Chakravarti N, Curry JL, Wang WL, Prieto VG, Tetzlaff MT, Torres-Cabala C. Evaluation of Fumarate Hydratase and Hypoxia-Associated Proteins in HLRCC Syndrome and Sporadic Cutaneous Leiomyomas. Laboratory Investigation 93(Suppl 1):110A, 2013. e-Pub 2013.
Lawrence TJ, Lai SY, Bassett RL, Prieto VG. Metastatic Melanoma to the Parotid Gland: Different Clinical Outcomes Based upon the Presence of Known or Unknown Primary. Laboratory Investigation, 2013. e-Pub 2013.
Agarwal A, Torres-Cabal CA, Tetzlaff MT, Stockman DL, Chu V, Prieto VG, Curry JL. The Impact on Final Breslow Thickness and Sentinel Lymph Node Status with Initial Biopsies of Cutaneous Melanomas Transected at the Base. Laboratory Investigation, 2013. e-Pub 2013.
Zhou JH, Kim KB, Fox P, Myers JN, Prieto VG. Immunohistochemical Expression of Hormone Receptors In Melanoma of Pregnant Women, Non-Pregnant Women and Men: A Comparison Study. Laboratory Investigation, 2013. e-Pub 2013.
Albarracin CT, Sneige N, Gullett AE, Prieto VG, Resetkova E, Andino LM, Wu Y, Gilgrease MZ, Bedrosian I, Dawood S, Arun B, Duan X. Clinicopathologic features of invasive Paget disease of breast: experience from a single institution. Histopathology, 2012. e-Pub 2012.
Vin H, Leung ML, Chitsazzadeh V, Ojega S, Dwyer DW, Richards KN, Stewart LR, Curry JL, Kim Km Ciurea AM, Duvic M, Prieto VG, Ullrich SE, Flores ER, Tsai KY. BRAF inhibitors suppress apoptosis through off-target inhibition of JNK signaling. Journal of Investigative Dermatology, 2012. e-Pub 2012.
Syklawer EE, Jakob J, Bassett RL, Gershenwald JE, Prieto VG, Curry JL, Davies MA, Lazar AJ. Clinical Correlates of Specific BRAF and NRAS Mutations in Melanoma. Laboratroy Investigation, 2012. e-Pub 2012.
Erdem O, Ivan D, Prieto VG. Use of Immunohistochemistry (HMB-45,p16 and Ki-67) in the Diagnosis of Spitzoid Lesions. Laboratory Investigation, 2012. e-Pub 2012.
Chu VH, Tetzlaff MT, Prieto VG, Torres-Cabala C, Bassett R, McLemore MS, Ivan D, Wang WL, Curry JL. Implications of the 2009 AJCC Melanoma Staging Classification System for Thin Melanomas. Laboratory Investigation, 2012. e-Pub 2012.
Buonaccorsi JN, Suster S, Prieto VG, Plaza JA. Diagnostic Utility and Comparative Immunohistochemical Analysis of MITF and SOX10 in Melanoma In-Situ: A Clinicopathological and Immunohistochemical Study of 50 Cases. Laboratory Investigation, 2012. e-Pub 2012.
Gullett AE, Sneige N, Prieto VG, Kelly CM, Bassett RL, Resetkova E, Duan X, Li Y, Rosen D, Wu Y, Huo L, Klein K, Bedrosian I, Arun B, Hunt K, Albarracin CT. Pathological and Clinical Characteristics of Mammary Paget Disease: 25-Year Experience from a Major Tertiary Referral Center. Laboratory Investigation, 2012. e-Pub 2012.
Marburger TB, Gardner JM, Prieto VG, Billings SD. Primary Cutaneous Rhabdomyosarcoma: A Clinicopathologic Review of 11 Cases. Laboratory INvestigation, 2012. e-Pub 2012.
Rose CL, Curry JL, Cabala CAT, Chakravarti N, Prieto VG, Tetzlaff MT. The Utility of ATF3 in Cutaneous Epithelial Neoplasms. Laboratory Investigation, 2012. e-Pub 2012.
Solano FJ, Kapil J, Deavers MT, McLemore MS, Prieto VG. Is the Anti-S-100 Antibody Decreasing Its Affinity for Epidermal Melanocytes? A Possible Diagnostic Pitfall. Laboratory Investigation, 2011. e-Pub 2011.
Zenali M, Deavers MT, Kalhor N, Prieto VG. Malignant Mesothelioma Expresses Melan-A (A-103), a Possible Diagnostic Pitfall. Laboratory Investigation, 2011. e-Pub 2011.
Torres-Cabala CA, Li-Ning-Tapia EML, Ramos C, Curry JL, Prieto VG, Bravo F. Evidence of Regulatory T-Cell Immunophenotype in a Subset of HTLV-I-Associated Infective Dermatitis: An Early Sign of Progression?. Lab Invest(90`):123A, 2010. e-Pub 2010.
Kapil J, McLemore M, Prieto VG. D2-40 Expression in Epitheliod Fibrous Histiocytoma, 2010. e-Pub 2010.
Duan X, Sneige N, Gullett AE, Prieto VG, Resetkova E, Albarracin C. Invasive Paget disease of the breast: clinicopathologic study of an underrecognized entity in the breast. Am J Surg Pathol 36(9):1353-1358, 2010. e-Pub 2010. PMID: 22895267.
Li-Ning-Tapia EML, Wang WL, Curry JL, Prieto VG, Torres-Cabala CA. Expression of P16 and MITF-1 in Acral Lentiginous/Mucosal Melanomas. Lab Invest, 2010. e-Pub 2010.
Grimm EA, Ekmekcioglu S, Ellerhorst J, Prieto VG. Melanoma Tumor expression of INOS (inducible nitric oxide synthase) protein is an independent prognostic marker and the NO produce appears to regulate resistance to apoptosis and intracellular stress. Chemistry in Cancer Research, 2007. e-Pub 2007.
Prieto VG, Mourad-Zeidan AA, Johnson MM, Diwan AH, Lazar AJF, Shen SS, Reed JA, Raz A, Bar-Eli M. Analysis of Galectin-3 Expression in Melanocytic Lesions by Tissue Array. Possible involvement in Tumor Progression, 2006. e-Pub 2006.
Andtbacka RH, Gershenwald JE, Prieto VG, Johnson MM, Diwan AH, Lee JE, Mansfield PF, Schacherer CW, Ross MI. Microscopic tumor burden in sentinel lymph nodes (SLNs) best predicts nonsentinel lymph node (NSLN) involvement in patients with melanoma 24(8), 2006. e-Pub 2006.
Hayes-Jordan, Gershenwald JE, Herzog CE, Lee JE, Ross MI, Mansfield PF, Prieto VG, Lally KP. Identification and Outcome of Regional Nodal Metastasis in Children with Melanoma: The MD Anderson Cancer Center Experience, 2006. e-Pub 2006.
Cohn ML, Goncharuk V, Diwan AH, Zhang P, Prieto VG. Loss of Claudin-1 Expression Correlates with Malignant Progression in Melanocytic Neoplasms. Journal of Cutaneous Pathology, 2004. e-Pub 2004.
Bengana C, Prieto VG, Zhang P, Diwan AH. Nuclear and Cytoplasmic Expression of the DNA-Repairing and Anti-Apoptotic Ku-70 in Melanocytic Neoplasms, 2004. e-Pub 2004.
Boiko I, Goncharuk V, Cohn M, Diwan AH, Gershenwald JE, Prieto VG. Cutaneous Desmoplastic Melanomas Are Clinically and Histologically Different from Spindle Cell Melanomas, NOS, 2004. e-Pub 2004.
Prudkin ML, Prieto VG, Malpica A, Diwan AH, Silva EG, Levenback CF, Deavers MT. Mucinous Carcinoma of the Vulva: A Clinicopathologic Study of 4 Cases, 2004. e-Pub 2004.
Wang H, Shen SS, Fuller GN, Zhang W, Diwan AH, Prieto VG. Constitutive activation of Stat3 and Stat5 in melanoctic lesions, 2004. e-Pub 2004.
Niu T, Poindexter N, Prieto VG, Liao X. Low Cytometric Assay of T cell-mediated Cytotoxicity on Tumor Cells. Am Soc of Hematology, 2004. e-Pub 2004.
Goncharuk VN, Cohn ML, Diwan AH, Herzog C, Prieto VG. Malignant Melanoma of Childhood: Immunohistochemical and Clinicopathologic Study of 21 Cases. Journal of Cutaneous Pathology, 2004. e-Pub 2004.
Mathew P, Sikes C, Multani A, Bucana C, Prieto VG, Troncoso P, Raymond K, Logothetis C, Navone N. An androgen-receptor (AR)-negative human prostate cancer xenograft induces mouse-derived osteogenesis, 2004. e-Pub 2004.
Wang H, Shen SS, Wang H, Diwan A, Zhang W, Fuller GN, Prieto VG. Expression of insulin-like growth factor-binding protein 2 in melanocytic lesions. J Cutan Pathol 30(10):599-605, 2003. e-Pub 2003. PMID: 14744083.
Shen SS, Zhang PS, Eton O, Prieto VG. Analysis of protein tyrosine kinase expression in melanocytic lesions by tissue array. J Cutan Pathol 30(9):539-47, 2003. e-Pub 2003. PMID: 14507401.
Prieto VG, Argenyi ZB, Barnhill RL, Duray PH, Elenitsas R, From L, Horenstein MG, Ming ME, Piepkorn MW, Rakin MS, Reed JA, Selim A, Trotter MJ, Shea CR. Are en face frozen sections accurate enough for diagnosis of margin status in melanocytic lesions?. Lab Invest 120(2):203-8, 2003. e-Pub 2003. PMID: 12931550.
Prieto VG, Zhang P, Holtsberg FW, Ensor CM, Clark MA. Normal melanocytes and melanocytic lesions do not express argininosuccinate synthetase: implications for therapy 31(1):78-9, 2003. e-Pub 2003.
Prieto VG, Zhang P, Holtsberg FW, Ensor CM, Clark MA. Normal melanocytes and melanocytic lesions do not express argininosuccinate synthetase. J Cutan Pathol 30(1):78-79, 2003. e-Pub 2003.
Tamboli P, Prieto VG, Bekele BN, Mathew P. The tyrosine kinase receptor c-kit is overexpressed in sarcomatoid renal carcinomas. Am Soc of Clin Oncol, 2003. e-Pub 2003.
Eton O, Billings L, Kim K, Prieto VG, Davis D, Frazier M, Diwan A, McGary E, Papadopoulos N, Y Bedikian AA. Phase II trial of imatinib mesylate (STI-571) in metastatic melanoma (MM). J Clin Oncol 22(14 Suppl), 2003. e-Pub 2003.
Prieto VG, Diwan AH, Sadick NS, Liu JS, Lee P. Expression of Androgen Receptor CoActivator ARA70 in Androgenic Alopecia. Lab Invest 83:98A, 2003. e-Pub 2003.
Ekmekcioglu S, Ellerhorst JA, Mumm JB, Zheng M, Broemeling L, Prieto VG, Mhasilkar AM, Chada S, Grimm EA. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma. Mol Cancer Ther 2(1):9-17, 2003. e-Pub 2003. PMID: 12533668.
Huttenbach Y, Prieto VG, Reed JA. Desmoplastic and spindle cell melanomas express protein markers of the neural crest but not of later committed stages of Schwann cell differentiation. J Cutan Pathol 29(9):562-8, 2002. e-Pub 2002. PMID: 12358815.
Hazarika P, George S, Prieto VG, Ni X, Bar-Eli M, Duvic M. Over-expression of a novel caveolae associated protein, flotillin-2, is associated with melanoma progression. J Invest Dermatol 119(1):223, 2002. e-Pub 2002.
Choi HR, Batsakis JG, Callender DL, Prieto VG, Luna MA, El-Naggar AK. Molecular analysis of chromosome 16q regions in dermal analogue tumors of salivary glands: a genetic link to dermal cylindromas. Lab Invest 26(6):778-83, 2002. e-Pub 2002. PMID: 12023583.
Rosenthal S, Prieto VG, Diwan AH, Ding Y, Clayman G, Strom S, El-Naggar A. Loss of heterozygosity in pre-malignant and malignant epithelial tumors of the skin: analysis in patients with multiple tumors, 2002. e-Pub 2002.
Ding Y, Rosenthal S, Prieto VG, Smith KJ, Skelton HG, Diwan AH. Expression of the anti-apoptotic surviving in melanocytic lesions, 2002. e-Pub 2002.
Ekmekcioglu S, Ellerhorst JA, Broemling L, Mhashilkar AM, Sahin AA, Prieto VG, Chada S, Grimm EA. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma. Mol Cancer Ther 2(1):9-17, 2002. e-Pub 2002. PMID: 12533668.
Prieto VG, Zhang P, Eton O. Expression of the tyrosine-kinase receptors c-kit, PDGFr-a, PDGFr-B, abl, and abl-related gene (ARG) in metastatic melanoma. Possible implications for therapy, 2002. e-Pub 2002.
Sadick NS, Prieto VG, Shea CR. A new 810 nm diode laser for photoepilation - Clinical and histopathologic findings. Laser Surg Med 148, 2002. e-Pub 2002.
Esnaola NF, Ross IM, Prieto VG, al E. Role of intraoperative frozen-section analysis of Cloquet's node during superficial groin dissection in patients with positive inguinal sentinel lymph nodes. Ann Surg Oncol 9:131, 2002. e-Pub 2002.
Prieto VG, Sadick NS, Lloreta J, Nicholson J, Shea CR. Effects of intense pulsed light on sun-damaged human skin, routine, and ultrastructural analysis. Laser Surg Med 30(2):82-5, 2002. e-Pub 2002. PMID: 11870785.
Selli BW, Clark SH, Prieto VG. Melanoma re-excision: extensive versus representative histologic sampling, does it matter?. Lab Invest 82:107A, 2002. e-Pub 2002.
Herman CM, Gomez S, Ballo MT, Prieto VG. Is clear cell sarcoma different from malignant melanoma? An immunohistochemical study of 20 cases. Lab Invest 82:100A, 2002. e-Pub 2002.
Biddle DA, Evans HL, Kemp BL, Harvell JD, White WL, Iskandar S, Prieto VG. Intraparenchymal and sinusoidal nevus cells in lymph nodes. A possible diagnostic pitfall with malignant melanoma and carcinoma. Lab Invest 82:96A, 2002. e-Pub 2002.
Prieto VG. Patterns of failure and survival analysis in sentinel lymph node positive melanoma patients, 2001. e-Pub 2001.
Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma: Proposal for an alternative method to serial sectioning. Ann Diagn Pathol 6(4):257-64, 2001. e-Pub 2001. PMID: 12170459.
Prieto VG. TRPS1 May be an Effective Discriminatory Marker for Basal Cell Carcinoma and Squamous Cell Carcinoma: An Immunohistochemical Analysis of TRPS1 in Non-Melanocytic Cutaneous Neoplasms. USCAP.
Prieto VG. Histopathologic Determinants of Outcome in Cutaneous Invasive Fungal Infections. 114th Annual Meeting of the United States and Canadian Academy of Pathology.
Prieto VG. INSM1: A Highly Sensitive Marker for Primary and Metastatic Merkel Cell Carcinoma, Superior to SOX11, Pancytokeratin, and CK20. 114th Annual Meeting of the United States and Canadian Academy of Pathology.
Prieto VG. Pathological and Clinical Features of Lymphomatoid Papulosis in Children and Adolescents from a Tertiary Cancer Center. 114th Annual Meeting of the United States and Canadian Academy of Pathology.
Prieto VG. Primary Cutaneous CD30-Positive Lymphoproliferative Disorders with IRF4/DUSP22-Associated Chromosomal Alterations, including Rearrangements, Gains, and Deletions. 114th Annual Meeting of the United States and Canadian Academy of Pathology.
Prieto VG. TROP2 is Highly Expressed in Cutaneous Squamous Cell Carcinomas and a Subset of Adnexal Carcinomas. 114th Annual Meeting of United States and Canadian Academy of Pathology.
Prieto VG. PD-L1 (CD274) gene alteration in melanoma: relationship to immunotherapy, disease progression and tumor mutation burden. 114th Annual Meeting of the United States and Canadian Academy of Pathology.
Prieto VG. Clinicopathologic and Molecular Characterization of BRAF-Fused Melanomas. 114th Annual Meeting of the United States and Canadian Academy of Pathology.

Book Chapters

Prieto, V, Shea, CR, Busam, KJ. Adnexal tumors, 428-490, 2025.
Prieto, and She VG, Christopher R. Extramammary Paget and Vulvar Melanocytic Lesions. In: Gynecologic Pathology. 2nd. Elsevier, 2020.
Prieto, Victor G. In: WHO Classification of Skin Tumours, 2019.
Nagarajan, Priyadharsini, Euscher, Elizabeth D, Tamboli, Pheroze, Prieto, Victor G. Miscellaneous Lesions of the Vulva and Penis. In: Gynecologic and Urologic Pathology, 2019.
Nagarajan, Priyadharsini, Euscher, Elizabeth D, Tamboli, Pheroze, Prieto, Victor G. Malignant Neoplasm of the Vulva and Penis. In: Gynecologic and Urologic Pathology, 2019.
Prieto, VG, Shea, Christopher R. Pathology of Melanoma. In: Genetics of Melanoma. Springer Nature, 85-113, 2016.
Tetzlaff MT, Curry JL, Prieto VG. Application of Molecular Pathology to Tissue Identification in Cutaneous Pathology. In: Precision Molecular Pathology of Dermatologic Diseases. New York, NY : Springer New York : Imprint: Springer, 125-133, 2015.
Prieto, VG, Reed, RJ. In: Histopathology of the Skin. 11th, 2015.
Curry JL, Tetzlaff MT, Lazar, AJ, Prieto VG. Application of Molecular Pathology to Cutaneous Melanocytic Lesions. In: Precision Molecular Pathology of Dermatologic Diseases, 103-124, 2015.
Prieto VG, Shea CR. Adnexal Neoplasms. In: Dermatopathology (Foundations in Diagnostics Pathology), 2014.
Prieto VG, Reed RJ. Tumors of Neural Tissue. In: Lever's Histopathology of the Skin, 2014.
Prieto VG. Diagnostic Immunohistochemistry. In: Immunohistology of Skin Tumors, 2014.
Prieto VG. Immunohistology of Melanocytic Neoplasm. In: Diagnostic Immunohistochemistry. 4th, 2014.
Scoyler, Richard A, Prieto, Victor G. Melanoma Pathology: Important Issues for Clinicians Involved in the Multidisciplinary Care of Melanoma Patients. In: Surgical Oncology Clinics. Saunder Elsevier, 19-37, 2011.
Diwan AH and Prieto VG. Histologic Stains and Special Studies. In: Dermatology: A Pictorial Review. 2nd, 585-592, 2010.
Shea CR, Prieto VG. Merkel Cell Carcinoma. In: eMedicine from WebMD, 2009.
Plaza, Antonio J, Prieto, Victor G. Inflammatory Skin Conditions. In: Modern Surgical Pathology. Saunder Elsevier, 1843-1889, 2009.
Prieto VG, Shea CR, Celbi JT and Busam KJ. Adnexal Tumors. In: Dermatopathology. Saunder Elsevier, 2009.
Prieto VG, Shea CR. Adnexal Neoplasms. In: Dermatopathology (Foundations in Diagnostics Pathology), 2009.
Prieto V. Sentinel Lymph NOdes in Cutaneous Melanoma. In: Current Concepts in Dermatopathology: Surgical Pathology Clinics. 3. Saunders an imprint of Elsevier, Onc, 553-563, 2009.
Diwan AH and Prieto VG. Histologic Stains and Special Studies. In: Dermatology: A Pictorial Review, 305-308, 2007.
Herzog CE, Diwan AH, Ross MI, Prieto VG. Pediatric Melanoma. In: Pediatric Oncology, 2005.
Wong R, Couriel D, Prieto VG. The graft-versus-leukemia effect in leukemia cutis. In: Transplantation. 76, 619-620, 2003.
Prieto VG. Pathology of cutaneous melanocytic lesions of the Head and Neck. In: Electronic Book (MDACC), 2001.
Prieto, VG and Shea VG, Christopher R. Skin: Melanoma. In: Pathology of Incipient Neoplasia. 3rd. Oxford University Press, Inc, 41-56, 2001.
Prieto VG. Pathology of cutaneous, non-melanocytic lesions of the Head and Neck. In: Electronic Book, 2001.
Prieto VG, Shea CR. Sentinel lymph node pathology for malignant. In: Mastery of Lymphatic Mapping, 2001.
Prieto VG, Shea CR. Trichoepithelioma. In: eMedicine from WebMD, 2000.
Prieto VG, Shea CR. Malignant melanoma. In: Pathology of Incipient Neoplasm, 2000.
Horenstein MG, Prieto VG. Muir-Torre Syndrome. In: Electronic Medicine Book, 2000.
Shea CR, Prieto VG. Syringoma. In: Electronic Medicine Book, 2000.
Prieto VG, Shea CR. In: History and pathophysiology of selected cutaneous vascular lesions, 507-520, 1999.
Shea CR, Prieto VG. Recent developments in the pathology of melanocytic neoplasia. In: Dermatol Clin. 3, 615-30, ix, 1999.
Prieto, and Shea VG, Christopher R. Selected Cutaneous Vacular Neoplasms: A Review. In: Dermatologic Clinics, 517-520, 1999.
Prieto VG, Rosai J. Kaposi Sarcoma. In: In Clinical Dermatology. Demis, 1-19, 1997.
Prieto VG. Female Genital Tumours. In: WHO Classification of Tumours. 6.

Books (edited and written)

Prieto VG. Precision Molecular Pathology of Dermatologic Diseases. Ed(s) 2015. New York, NY : Springer New York : Imprint: Springer, 2015.
Shea, Christopher R, Reed, Jon A, Prieto, Victor G. Pathology of Challenging Melanocytic Neoplasms. Springer Science and Business Media, 2015.
Plaza, Jose A, Prieto, Victor G. Neoplastic Lesions of The Skin. Demos Medical Publishing, LLC, 2014.
Plaza JA, Prieto VG. Neoplastic Lesions of the Skin. Ed(s) 1. demosMedical, 2013.
Plaza, Jose A, Prieto, Victor G. Inflammatory Skin Disorder. Demos Medical Publishing, LLC, 2012.
Plaza JA, Prieto VG. Inflammatory Skin Disorders. Ed(s) 1. demosMedical, 2012.

Letters to the Editor

Cho, WC, Yang, RK, Lenskaya, V, Prieto, V. SBF1::BRAF-Fused Melanoma With Prominent Rhabdoid Morphology and Reed–Sternberg-Like Cells: Potential Morphologic Clues to BRAF-Fused Melanomas of Non-Spitz Lineage?. American Journal of Dermatopathology 47: 733-735, 2025.
Ibrahim, E, Yang, RK, Gubbiotti, M, Prieto, V, Cho, WC. Primary Cutaneous NUT Adnexal Carcinoma With BRD4::NUTM1 Fusion: A 19-Year Follow-Up. American Journal of Dermatopathology 47: 731-733, 2025.
Cohen PR, Prieto VG, Kurzrock R. The Shield Sign of Cutaneous Metastases Is Associated With Carcinoma Hemorrhagiectoides. Cutis 114: E41-E42, 2024.
Lennerz JK, Pantanowitz L, Amin MB, Eltoum IE, Hameed MR, Kalof AN, Khanafshar E, Kunju LP, Lazenby AJ, Montone KT, Otis CN, Reid MD, Staats PN, Whitney-Miller CL, Abendroth CS, Aron M, Birdsong GG, Bleiweiss IJ, Bronner MP, Chapman J, Cipriani NA, de la Roza G, Esposito MJ, Fadare O, Ferrer K, Fletcher CD, Frishberg DP, Garcia FU, Geldenhuys L, Gill RM, Gui D, Halat S, Hameed O, Hornick JL, Huber AR, Jain D, Jhala N, Jorda M, Jorns JM, Kaplan J, Khalifa MA, Khan A, Kim GE, Lee EY, LiVolsi VA, Longacre T, Magi-Galluzzi C, McCall SJ, McPhaul L, Mehta V, Merzianu M, Miller SB, Molberg KH, Moreira AL, Naini BV, Nosé V, O'Toole K, Picken M, Prieto VG, Pullman JM, Quick CM, Reynolds JP, Rosenberg AE, Schnitt SJ, Schwartz MR, Sekosan M, Smith MT, Sohani A, Stowman A, Vanguri VK, Wang B, Watts JC, Wei S, Whitney K, Younes M, Zee S, Bracamonte ER. Ensuring remote diagnostics for pathologists. Nat Med 28: 2453-2455, 2022.
George MR, Johnson KA, Childs JM, Dixon LR, Gratzinger DA, Hoffman RD, Holloman A, Karp JK, Knollmann-Ritschel BEC, Lofgreen A, Prieto VG, Timmons CF, McCloskey CB. The Impact of the COVID-19 Pandemic on the 2019-2020 Job Search for Newly Trained Pathologists. Arch Pathol Lab Med 145: 261-262, 2021.
Fang1 S, 14. Melanoma Expression Genes Identified through Genome-Wide Association Study of Breslow Tumor Thickness. Journal of Investigative Dermatology, 2016.
Ravishankar, Sanjita, Nagarajan, Priyadharsini, Curry, Jonathan L, Tetzlaff, Michael T, Ivan, Doina, Cabala T, Carlos A, Aung, Phyu P, Prieto, Victor G. Giemsa is the optimal counterstain for immunohistochemical detection of BRAF V600E mutation status in pigmented melanomas, 2016.
Guitart J, Lowe L, Piepkorn M, Prieto VG, Rabkin MS, Shea CR, White W, Barnhill RL. Metastasizing thin melanoma or multiple primary melanomas?. Arch Dermatol: 388-389, 2003.
Prieto VG. Practical Immunopathology of the Skin. Archives of Dermatology, 2003.
Prieto VG. Dermatopathology in Systemic Disease. Archives of Dermatology, 2002.
Prieto VG. Quandaries in Dermatopathology. Journal of Cutaneous Pathology: 572, 2002.
Shea CR, Carag HR, Prieto VG. Histopathologist: To step section or not? Reply. Arch Dermatol: 376-377, 2001.
Cano A, Roquer J, Prieto VG. Absceso cerebral primario por actinomyces en un paciente con cardiopatía congénita cianótica. Med Clin (Barc) 97: 58, 1991.
Roquer J, Cano A, Prieto VG, Corominas JM. Signos inflamatorios como hallazgo histologico en la distrofia oculofaríngea. Neurologia 5: 333-334, 1990.

Less

CV information above last modified March 24, 2026

Victor G. Prieto, M.D., Ph.D.

About Dr. Victor G. Prieto

Present Title & Affiliation

Primary Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Other Professional Positions

Intramural Institutional Committee Activities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Victor G. Prieto, M.D., Ph.D.

About Dr. Victor G. Prieto

Present Title & Affiliation

Primary Appointment

Education & Training

Degree-Granting Education

Postgraduate Training

Licenses & Certifications

Experience & Service

Other Professional Positions

Intramural Institutional Committee Activities

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

Regional Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Invited Articles

Review Articles

Other Articles

Abstracts

Book Chapters

Books (edited and written)

Letters to the Editor

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson